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CHAPTER I GENERAL INTRODUCTION 
Gastrointestinal disorders form an important category 
of diseases with an often obscure etiology or biochemical 
basis. Extension of the fundamental knowledge about struc-
ture and function of the enterocyte is essential for a 
better understanding of the intestinal pathophysiology and 
may probably permit a more rational approach to prevention 
or therapeutic treatment of these diseases. 
In the small intestinal epithelium, absorptive villous 
cells continuously arise by rapid proliferation and dif-
ferentiation of stem cells in the crypts of Lieberklihn (see 
Fig. 1.1). A drastic change in cell kinetics is frequently 
associated with gastrointestinal disfunction. Inhibition of 
biosynthetic processes in the crypt cell by way of irradia-
tion or chemical inhibitors (colchicine, nitrogen mustard, 
cycloheximide) does not only influence the rate of cell re-
newal but may also affect cell maturation and the number and 
functional state of mature villous cells. One class of in-
hibitors (but seldom recognized in this quality) consists 
of two important groups of antibiotics, the tetracyclines 
and chloramphenicol with its derivatives. It is now 
commonly accepted that mitochondria contain an autonomous 
protein synthetizing system, possessing a high sensi-
tivity for these inhibitors of bacterial protein synthesis. 
The intestinal crypt cell may be considered as an excellent 
target for this type of antibiotics. The first part of this 
thesis (Chapter II) is devoted to a biochemical study of 
the consequences of antibiotic treatment for small intesti-
nal structure and function. The clinical experience that 
gastrointestinal complications are extremely rare during 
therapeutic application of these antibiotics has been made 
more understandable by the results of this study. 
Pathological changes of gastrointestinal functions may 
also arise from a direct influence of toxic agents on the 
9 
non-proliferative epithelial cells. This is most clearly 
demonstrated in the case of diarrhoeal diseases in which 
the absorptive function of the intestine is disturbed by 
hormonal serum factors, bacterial toxins or bacterial in-
vasion (dysentery) . Investigation of the biochemical al-
terations in the cell in this situation would not only 
give a deeper insight in the regulation of absorptive and 
secretory processes in the epithelium but might also 
reveal a common basis for apparently different clinical 
syndromes. The recognition of cyclic AMP as the intracel-
lular mediator of choleratoxin action was the first indi-
cation that also in this tissue cyclic nucleotides may 
function as important regulators of biological functions. 
The second part of this thesis (Chapters III-V) deals with 
some aspects of cyclic nucleotide formation and regulation 
in the small intestinal epithelium in relation to its ab-
sorptive and proliferative function. This study clearly 
demonstrates the advantages of using relatively homogeneous 
cell preparations from crypt and villous regions. Some 
basic properties of these isolated cells are discussed in 
ref. 1. An important feature of the intestinal epithelial 
cell is the clearcut distinction of luminal and basal-
lateral plasma membranes. Both membrane fractions from 
enterocytes can be easily separated and the study of the 
biochemical differences between the two (e.g. in enzyme 
composition: see Papers 3-6) may contribute to the know-
ledge of membrane polarity in general. 
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CHAPTER II t!ITOCHONDRIAL PROTEIN SYNTHESIS AND ANTI-
BIOTICS 
2.1 Introduction 
The use of antibiotics as therapeutic agents is based 
upon some fundamental structural and functional differen-
ces between prokaryotic (bacterial) and eukaryotic (mam-
malian) cells. A number of widely used antibiotics (chlor-
amphenicol, streptomycin and neornycins, lincomycin, macro-
lides, tetracyclines) exert their antimicrobial activity 
by inhibiting bacterial protein synthesis on the 70S-ribo-
somes. Cytoplasmic 80S-ribosomes in eukaryotic cells are 
almost completely (chloramphenicol) or relatively (tetra-
cyclines) insensitive to their action. The mitochondrial 
protein synthesis in the animal cell however, carried out 
on 55S-ribosomes 2 is as much sensitive to the antibiotics 
as the bacterial system. The sensitivity for erythromycin 
and most of the other macrolides is latent because the 
inner membrane of intact mammalian mitochondria or the 
plasma membrane of the cell serves as a permeability 
barrier3 . Unfortunately, a similar protection does not 
exist against chloramphenicol and tetracyclines. Although 
these compounds may be of great value in studies concer-
ning the development and function of mitochondrial protein 
synthesis, their clinical use may harbour some potential 
hazards, because most of the mitochondrial translation 
products are essential components of the mitochondrial 
respiratory chain (see Section 2.3). A depletion of these 
components during antibiotic treatment is to be expected 
first in those cell types in which the biogenesis of mi to-
chondria or mitochondrial constituents proceeds at a high 
rate: proliferating cells (neoplastic cells, regenerating 
liver, erythroid precursor cells, basal layers of epider-
mis, intestinal crypt cells) or non-dividing cells with a 
relatively high turnover or differentiation of mitochon-
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drial proteins (e.g. villous epithelium, see Paper 1). 
Pioneering work of Firkin and Linnane (1968) 4 has shown 
that a drastic decrease of the level of mitochondrial 
translation products in cultured Hela cells grown for two 
generations in the presence of CAP (20 ~g/ml) was accom-
panied by a large inhibition of cellular respiration and 
cell growth. In subsequent studies by the same authors 5 
and, independently, by de Vries and Kroon6 , using there-
generating liver of rats as an in vivo model, it appeared 
impossible to evoke a similar drastic change in mitochon-
drial enzyme composition and function as in Hela cells be-
cause of the restricted number of cell divisions needed 
for regeneration (<2). As pointed out in the Introduction 
of the Papers 1 and 2, the small intestinal epithelium of 
adult rats seemed a superior model due to the presence of 
continuous and rapid cell divisions in the crypt and the 
differential development and turnover of mitochondrial com-
ponents in the next stage of cell life. If it would be 
possible to inhibit the mitochondrial protein synthesis in 
the proliferating crypt cells by antibiotic treatment in 
vivo as efficaciously as in Hela cell cultures, an energy 
crisis in this cell type might be expected to occur as 
early as 1-2 days (corresponding with 2-3 cell divisions) 
following first contact to the antibiotics or even earlier 
if the mitochondrial energetic function in the crypt cells 
would be more sensitive to a partial loss of mitochondrial 
translation products than in Hela cells. 
The first aim of our studies was to characterize the 
products of mitochondrial protein synthesis in rat small 
intestinal epithelium and to investigate the consequences 
of a continuous inhibition of their synthesis for the 
mitochondrial energetic function in this tissue. Secondly, 
we hoped to get more insight into the relative importance 
of mitochondrial and extra-mitochondrial energy production 
for the energy-demanding functions of the epithelium in 
vivo. In previous studies from this laboratory it had been 
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found that epithelial cells in vitro, isolated by means of 
the high-frequency vibration technique of Harrison and 
Webster, as well as everted pieces of intestine, displayed 
a high rate of aerobic glycolysis and missed a Pasteur 
effect7 . Similar phenomena were also observed with mucosal 
sheets 8 , everted sacs or rings 9 and small intestinal 
pieces 10 from adult rats in other laboratories. An explana-
tion of this behaviour by assuming an uncoupled or "loose-
ly" coupled state of oxidative phosphorylation, as suggest-
ed by earlier experiments with isolated mitochondria7 , 
could be excluded by our subsequent finding that tightly 
coupled mitochondria could be liberated from the isolated 
cells by using a mild homogenization procedure (see Paper 
2). A strong resemblance seemed to exist between the 
metabolism of intestinal epithelium and that of cultured 
neoplastic cells, also characterized by a high rate of 
aerobic glycolysis in the presence of normal functioning 
mitochondria11 . For this reason too, it seemed interesting 
to know whether this pattern of energy metabolism could be 
considered as an artifact of isolation or as a typical 
property of the epithelial cell in vivo, possibly related 
to its absorptive function12 . One way to determine the 
importance of extra-mitochondrial energy production in 
vivo seemed to be the induction of a mitochondrial defi-
ciency in the epithelium by a pretreatment with the anti-
biotics followed by a study of the various functions of 
the cell {proliferation, differentiation, absorption) 
under these conditions~ 
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The results described in Paper 2 explain why this aim 
has never been reached: even prolonged antibiotic treat-
ment was not able to impair the mitochondrial energetic 
function. However, the development of a new perfusion 
technique for rat intestine in situ has solved the 
guestion13 . It is now clear that the epithelium in situ 
displays a normal Pasteur effect and low rates of lactate 
production13 . The high level of glycolysis in vitro pro-
bably arises from two factors: tissue hypoxia, as has been 
shown for everted sacs14 and other preparations in which 
the submucosal musculature and connective tissue is still 
present15 , and the stimulation of energy-consuming repair 
processes or ion pumps due to a slight tissue damage 
during the isolation (isolated cells). Both factors lower 
the energy charge of the cell to such a level that the 
glycolytic pathway functions at optimal rates (compare 
ref. 13). 
2.2 Some structural and functional properties of mito-
chondria from rat small intestinal epithelium 
The difference spectrum shown in Paper 1 indicates 
that mitochondria from villous cells contain quantities 
of the cytochromes aa3 , b and c and of flavoproteins 
comparable to those of other epithelial tissues 16 There 
exists a differential development of some of these pro-
teins (cytochromes aa3 and c
18 ) during the transition 
from crypt to villus. In contrast, matrix enzymes 
(e.g. glutamate dehydrogenase) and outer membrane markers 
(e.g. monoamine oxydase) are kept at constant levels 
during cell maturation. Isolated villous cell mitochondria 
oxidize pyruvate, S-hydroxybutyrate and glutamate with 
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appreciable rates (Paper 2). Halate could be oxidized 
in the presence of citrate and vice versa (unpublished 
results). This gives a strong indication for the existence 
of a tricarboxylate carrier in the enterocyte, previously 
found in liver19 . Palmitate (in the presence of malate, 
ATP, CoASH and carnitine) could not further stimulate the 
endogenous respiratior. of the mitochondria. Addition of 
palmitoylcarnitine gave no better results (unpublished) 
Isolated cells may oxidize added fatty acids but with 
appreciably low rates 1 . Most probably, fatty acids may 
be used in the intact cell as endogenous substrates in the 
absence of sufficient amounts of aminoacids. However, glu-
tamine and glutamate (but no other aminoacid) are the 
preferential substrates for the intestinal mucosa in vivo 
15,20 h . . . . •t f b l" f ; t e 1ntest1ne 1s a maJor s1 e or meta o 1sm o 
glutamine released by other tissues 20 . 
2.3 Structure and function of intestinal mitochondria 
after antibiotic treatment* 
Inhibition of mitochondrial protein synthesis by 
chloramphenicol (CAP) and oxytetracycline (OTC) led to a 
rapid fall of the levels of the cytochromes aa 3 , b and, 
most probably also of c 1 , to about 30 per cent of their 
normal values. A large number of other mitochondrial and 
extra-mitochondrial enzyme activities were not affected in 
the antibiotic-treated rats {Papers l and 2) . In a similar 
study of Gijzel et a1. 17 the synthesis of F1-ATPase appear-
ed also unchanged but its sensitivity to oligomycin was 
strongly decreased. All these data together perfectly 
agree with the recent concept about the function of mito-
chondrial protein synthesis 22 . The following proteins are 
now considered as real mitochondrial translation products: 
x Parallel morphological and histochemical studies (de 
Pijper and Hiilsmann, 1972) are reported in ref. 21. 
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(1) The two or three largest polypeptides of the cyto-
chrome ~ oxydase complex. The residual four polypep-
tides are synthetized on cytoplasmic ribosomes. 
(2) The cytochrome b apoprotein. 
(3) The four hydrophobic proteins of the ATPase complex. 
F 1 -ATPase itself and the oligomycin sensitivity-con-
ferring protein are cytoplasmic products. One of the 
four mitochondrial products is additionally needed for 
oligomycin-sensitivity. 
The apoprotein of cytochrome c1 is made on cytoplasmic 
ribosomes. Incorporation of its heme group is dependent on 
mitochondrial protein synthesis. 
The normal content of most of the mitochondrial en-
zymes in the treated rats indicated that the cytoplasmic 
synthesis of these proteins was not controlled by or depen-
dent on the mitochondrial protein-synthetizing system. 
This independency of both systems is in fact the basis for 
the preservation of the mitochondrial function during long-
term treatment with the antibiotics 1 documented in Paper 
2 (Table 2). Most of the experiments have been done with 
total homogenates to exclude a possible selection of in-
tact mitochondria in the mitochondrial pellet after dif-
ferential centrifugation. As a general conclusion from 
this study and that of others 5 , 23 it may be stated that 
in many 
tine) a 
tissues of the rat (liver, heart, brain, intes-
50-70 
content and a 
per cent reduction of cytochrome b and aa3-
loss of oligomycin-sensitivity is not suffi-
cient to impair the mitochondrial energetic function in 
vitro9 After a further reduction of cytochrome levels, the 
electron transport chain would become rate-limiting for 
the oxidation of some substrates (e.g. succinate; see 
Table 2, Paper 2). 
The maintenance of a normal energy charge and creatinephos-
phate level in freeze-clamped intestine from rats, treated 
for 48-72 h with CAP or for 48 h with OTC (Paper 2, Table 
3) confirmed the intact function of the cytochrome-poor 
mitochondria. The preservation of a normal proliferative 
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activity in the crypt cells from rats, treated for 100 h 
with OTC, was an even stronger indication because thymi-
dine incorporation into crypt cell DNA {at least in vitro) 
is strongly dependent on the intactness of oxidative 
energy metabolism (unpublished observations) and because 
a cytochrome depletion will become manifest first in the 
proliferative cells. 
The incomplete inhibition of the mitochondrial pro-
tein synthesis in the enterocytes by CAP and OTC at con-
tinuous serum levels between 10 and 40 ~g/ml may be ex-
plained by a relatively low affinity of the intestinal 
mitoribosomes (or a low permeability of the mitochondrial 
IT'.embrane) for the antibiotics, accumulation of these com-
pounds in other regions of the cell (e.g. OTC in 
24 
microsomes ), intracellular inactivation (glucuronic acid 
conjugation of CAP) or a low permeability of the plasma 
rr~embrane for the antibiotics. In the case of tetracyclines 
this tissue permeability is mainly a function of lipid 
solubility and divalent cation binding, but there is also 
some indication that "cytoplasmic anion binding" proteins 
("Y" and "zn 25 ) might participate in the overall transport 
of tetracyclines through the plasma membrane (Arias, per-
sonal communication) . The accumulation of tetracyclines in 
liver and kidney would agree with the high concentration 
of Y-protein in these tissues. The luminal absorption is 
possibly regulated by a competition between fatty acids 
and tetracyclines for binding sites on the Z-protein. This 
also provides a possible explanation for the decreased 
absorption of fat after tetracycline-administration26 (see 
Paper 2). 
An apparently normal cell proliferation and/or de-
velopment in the presence of low concentrations of CAP 
(<30 l-lg/ml) has also been shown for regenerating liver5 , 
mouse embryo cultures 27 and rat embryos in vivo 28 , despite 
a 50 per cent reduction of cytochrome aa 3 content in these 
tissues. In these studies mitochondrial morphogenesis 
17 
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"' Table 2.1 ANTIBIOTIC-SENSITIVE PROCESSES IN ~~LIAN CELLS, NOT RELATED TO MITOCHONDRIAL PROTEIN SYNTHESIS% 
Antibiotic Concentration Tissue Function studied Degree of inhibi- Ref. 
tion (%) 
CAP 
OTC 
TC 
OTC 
TC 
TC 
TC 
TC 
Anhydro-TC 
TC 
OTC, DOC 
TC 
DMC 
DOC 
MC 
TC 
OTC 
DC, TC 1 OTC 
20 ug/ml 
100 Jlg/ml 
100 ug/ml 
SO )lg/ml 
100 ug/ml 
100 ).lg/ml 
T4h)Bone marrow (human) 
Hela cells 
150-300 lJg/ml 
250 )lg/ml 
30-60 )Jg/ml 
2x 125 mg/kg IM 
( 34 h) 
400 mg/kg IP 
(4 h) 
250 mg/kg IM 
(4 h) 
5 l.lg/ml 
35 mg/kg IM 
(4 weeks) 
10-100 JJg/ml 
0.6-1 mg/ml 
50 )Jg/ml 
Therapeutical 
dosages 
2-3 )Jg/ml 
Bone marrow 
Lymphocytes 
Bone marrow 
Heart muscle 
Liver, brain, 
intestine 
Liver 
Yeast 
Liver 
Intestine 
Intestine 
Pancreas 
Hela cells 
Liver 
Intestinal smooth muscle 
Fat cell 
Nephron and 
toad bladder 
Serum 
Haem and globin synthesis 
Mitochondrial respiration 
RNA synthesislt:t 
Hexose transport 
Impaired mechanical performance 
Respiration, oxidative 
phosphorylation 
(Cytoplasmic) protein synthesis 
in vitro 
Polyphenylalanyl synthesis 
on 80S ribosomes 
Aminoacid,incorporation 
Amylase secretion 
Aminoacid incorporation 
Fatty acid and 
cholesterol synthesis 
Contraction amplitude 
Adenylate cyclase 
ADH-stimulatedXX 
water flow 
Bacteriocidal activity 
X Our own results (Paper 2) are not included in this survey 
XX (Possibly) related to inhibition of adenylate cyclase activity 
40 
50 
30 
50 
50 
40 
78 
27 
50 
25 
35 
30 
47 
60 
80 
- (25-46) 
60-95 
20 
71 
63 
56 
53 
1 
31 
4 
29 
32 
32 
33 
34 
35 
35 
36 
37 
37 
38 
39 
40 
41 
42 
42 
43 
44 
44 
44 
44 
44 
45 
Abbreviations: TC, tetracycline; DOC, doxycycline; CTC, chlortetracycline; DMC, demeclocycline; MC, minocycline. 
IM = intramuscularly injected; ADH = anti-diuretic hormone (vasopressin); IP = intraperitoneally 
injected. 
was also nearly normal except for the appearance of dila-
ted and vesicular cristae. In studies concerning rever-
sible bone marrow depression resulting from large 
doses of CAP 29 , 30 , these ultrastructural changes are 
often taken as evidence for a causal relationship between 
the myelotoxic effect of CAP and its role as an inhibitor 
of mitochondrial protein synthesis. To our opinion direct 
measurements of an impaired mitochondrial function in the 
affected tissue are needed to make such a link. 
2.4 Biochemical targets of the antibiotics in mammalian 
cells, not related to mitochondrial protein synthesis 
A brief survey of literature data concerning inhibi-
tory actions of CAP and tetracyclines on cellular pro-
cesses other than mitochondrial protein synthesis is given 
in Table 2.1. At serum levels of CAP above 35 1Jg/ml (vir-
tually uniformly accompanied by bone marrow suppression 
in man) there is an additional risk for direct inhibitory 
effects on haem synthesis 31 and RNA synthesis 32 . These 
effects could have played a role in the morphological 
damage 
of CAP 
of the intestinal mucosa 
21 pretreatment . In these 
in two rats after 120 h 
animals plasma levels, 
however, were not registrated at this time. Extremely 
high concentrations of the drug are needed for a direct 
inhibition of mitochondrial respiration4 , 29 or sugar 
transport33 . An interference of these effects in our 
studies is highly unlikely. 
Tetracyclines may exert a broad spectrum of action 
at high concentrations (Table 2.1). Possible inhibitory 
effects on cytoplasmic protein synthesis, respiration and 
oxidative phosphorylation in small intestinal epithelium 
and liver are extensively discussed in Paper 2. The sug-
gestion made in this paper that the decrease of ATP level 
in the liver would be the result of tissue damage follow-
ing the accumulation of lipid droplets {"fatty liver 11 ) is 
19 
46 probably erroneous, because a recent report has made 
clear that most of the lipid accumulates outside the cell, 
in the space of Disse, after discharge from the sinusoidal 
surface of the cell. If the extremely high levels of tetra-
cycline in the liver reported in this study (800 ~g/g at 
300 mg TC/kg/day) had also been reached in our studies 
where a similar OTC-regime was applied, the tissue damage 
and ATP depression may be simply explained by large inhi-
bitory effects on overall protein synthesis or mitochon-
drial functions. Moreover, small amounts of OTC-degradation 
products may be formed in the tissue which might have a 
much stronger inhibitory effect on cytoplasmic protein 
synthesis than OTC itsel£ 40 (Table 2.1). 
A depression of adenylate cyclase activity by tetra-
. 43 44 
cycl1nes ' could not interfere in our studies because 
OTC is inactive in this respect (Table 2.1 and unpublished 
experiments). 
2.5 Concluding remarks 
Extrapolating the results of our study to man, inhibi-
tion of mitochondrial protein synthesis is likely to occur 
at normal serum levels of the antibiotics (~10 ~g/ml) and 
will result in a rapid decrease of cytochrome levels in 
proliferating tissues. However, if the excess of these 
essential components in the respiratory chain in human 
tissues would be comparable to that found in most tissues 
of the rat, an impairment of mitochondrial function cannot 
be expected before at least 60-70 per cent of the normal 
cytochrome content has been lost. A drop of the cytochrome 
levels beneath this critical value will be an extremely 
rare phenomenon in clinical situations because the inhibi-
tion of mitochondrial protein synthesis is reversible and 
incomplete, even at high dosages. In human small intestinal 
epithelium, the chance that the antibiotics will induce 
such a critical depletion of cytochromes is even less than 
20 
in the rat, because the crypt cell division time in man 
(appr. 2 days) exceeds that in rats about four times 47 . 
This may explain why an impairment of gastrointestinal func-
tions during clinical use of CAP and OTC in normal thera-
peutical dosages has hardly ever been reported, except in 
case of superinfections of the alimentary tract. 
The antibiotics sometimes evoke severe complications 
in case of overdosage, an impaired conjugation system for 
CAP in the liver or renal insufficiency. These complica-
tions are not necessarily the consequence of a mitochon-
drial cytochrome depletion, but may result from the many 
side effects of CAP and tetracyclines mentioned in the 
preceeding Section. 
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CHAPTER III CYCLIC AMP AND FLUID TRANSPORT 
3.1 Introduction 
In the course of their investigations of the hyper-
glycemic effects of glucagon and epinephrine on liver, 
Rall and Sutherland discovered a small, heat stable corn-
pound capable of stimulating glycogenolysis in broken cell 
48 preparations . In 1958 this compound was identified as 
adenosine 3',5'-rnonophosphate (cyclic AMP) 49 . Since then 
cyclic AMP has been detected in almost all prokaryotic and 
enkaryotic cell types where it fulfills an important and 
often essential role as an intracellular regulator 
("second messenger") of biological functions. Its implica-
tion in entirely different processes like glycogenolysis 
and gluconeogenesis, lipolysis, muscle cell contraction 
and relaxation, sensory and neural excitation, cellular 
permeability and secretion, lymphocyte activation, cell 
adhesiveness and motility, growth inhibition (Chapter V) 
and hormone synthesis, illustrates the almost universal 
character of its function. 
One of the earliest recognized actions of cyclic AMP 
was on membrane permeability of epithelial tissues. The 
discovery of its key-role as a mediator of the action of 
n-eurohypophyseal hormones on toad bladder 50 (1962) and 
mammalian kidney 51 (1966) was followed by a burst of in-
vestigations of cyclic AMP control in other transport 
processes, including gastric secretion, pancreatic secre-
tion and fluid secretion by insect salivary glands. In 
1968 Field and coworkers published their first report 
about an active secretion of both chloride and bicarbonate 
by rabbit ileum in response to cyclic AMP and theophylline 
52 
. These effects were clearly different from those in 
other epithelial tissues where cyclic AMP increased the 
permeability to water and urea (hydro-osmotic response of 
toad bladder 50 and kidney 51 ) or the active transport of 
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sodium from mucosal to serosal side (toad bladder50 ). The 
first step in the recognition of cholera as a disorder of 
cyclic nucleotide metabolism was set by Schafer and co-
workers (1970) who measured significantly elevated levels 
of cyclic AMP in canine small intestine after luminal 
contact to choleratoxin53 . This enterotoxin, produced by 
Vibrio cholerae, is responsible for the massive secretion 
of water and electrolytes in the cholera syndrome. This 
discovery led to gigantic efforts to clarify further the 
mechanism of action of choleratoxin in the small intes-
tinal epithelium. It was hoped that the knowledge gained 
from these studies would lead to new pharmacological tools 
in the prevention and treatment of cholera and other 
diarrhoeal diseases. 
Thus far, the results of this research have contri-
buted much to our present understanding of the mechanism 
of hormone action and ion transport. However, because 
choleratoxin acts by activating an enzyme system of funda-
mental importance for the functioning of all living cells, 
the chances for a chemotherapy, based on the administra-
tion of inhibitors of these systems must not be assessed 
too high. 
The bacteriological, immunological and toxicological 
aspects of enterotoxin-induceddiarrhoeaand the charac-
teristics of the cyclic AMP-mediated intestinal secretion 
have been extensively revie1.ved in articles of Banwell and 
54 . 55 . 56 Sherr , F1eld and K1mberg . Moreover, a lot of recent 
literature data is summarized in the Papers 3 and 4. There-
fore, this chapter will be restricted to a brief revie\v of 
the latest literature in this field and a discussion of 
some unpublished results. 
3.2 The mechanism of action of choleratoxin 
An indispensable role of choleratoxin (choleragen) in 
producing the cholera diarrhoea has been genetically proven 
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by the recent isolation of non-reverting tax-mutants that 
are totally avirulent57 . In clinical cholera, other bac-
terial factors may contribute to the virulence, e.g. the 
production of rnucinase 58 , phospholipase and neuraminidase 
59
. The latter enzyme may drastically increase the number 
of choleragen receptors at the mucosal surface of the 
epithelial cells60 . 
Choleratoxin is an antigenic, neutral protein with a 
molecular weight of 84.000 constituting a rnultichain 
aggregate of at least two type of subunits61 . The light 
(L) subunit (M ~ 8.000} is responsible for the binding of 
the toxin to GM
1 
ganglioside receptors in the plasma mem-
brane and also for most of its antigenicity61 - 63 . The 
heavy (H) subunit (M ~ 28.000-36.000) is important for the 
b . l . l . f th . 61 - 64 h" h b 10 og1ca act1on o e tox1n , w 1c appears to e 
associated with an activation of adenylate cyclase in the 
plasma membrane. This stimulation is preceeded by a charac-
teristic lag phase of at least 30 min63 - 65 (see Paper 4). 
Adenylate cyclase in broken cell preparations has lost its 
sensitivity to the choleragen (Paper 3 and unpublished 
results) although it still responds to prostaglandins and 
hormones (compare Paper 3). Both aspects of choleratoxin 
action can be adequately explained with the mobile recep-
tor theory proposed by Cuatrecasas and coworkers63 . In this 
scheme the binding of toxin to GM
1 
receptors is followed 
by a lateral movement of the toxin-receptor complex in the 
plane of the membrane, which ultimately leads to a direct 
and persistent interaction of the strongly hydrophobic H-
subunit of the complex with adenylate cyclase. Disruption 
of the plasma membrane should disturb this process and 
make the target-enzyme insensitive to the toxin65 . This 
mode of action of choleragen is essentially different from 
that of a number of other toxic proteins (e.g. the bac-
teriocins colicin E3
66 
or cloacin DF 13
67 
and diphteria 
toxin68 ) where a hydrophylic part of the molecule moves 
into the cytoplasma prior to its interaction with the 
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target. 
The mobile receptor theory is based on the new con-
cept of a relatively fluid state of biological mernbranes 69 
A similar mechanism is proposed for hormone-receptor-
adenylate cyclase interactions 63 . Several recently detec-
ted properties of adenylate cyclase may be easily fitted 
in this frame work: first the increase in its affinity for 
63 70 71 . hormones in the choleragen-affected state 1 1 • Thls 
may reflect stabilization by choleragen of the complex be-
tween hormone-receptors and the cyclase. The regulation of 
adenylate cyclase by guanyl and inosylnucleotides 72 may be 
explained on a similar basis. In this scheme it seemed 
also quite possible that choleratoxin, prostaglandins or 
hormones should simultaneously affect several membrane 
+ + functions or enzymes (cyclases, (Na -K )-ATPase, phospho-
diesterases) by interaction with a single receptor. This 
has actually been shown for 
lysates of erythrocytes and 
prostaglandin 
73 platelets 
in 
The possible interaction of choleratoxin with membrane-
bound enzymes in intestinal epithelial cells was tested 
during our study by measuring (Na+-K+)-ATPase (according to 
Ferard74 , Ca2+-ATPase (Na+ and K+ replaced by 0.5 rnM ca2+) 
and alkaline phosphatase (as described by Iemhoff et al. 
7 ) in brushborders and villous cell homogenates f~on­
trol and choleragen-treated rats isolated 15 min, 1 h and 
4 h after the luminal application of purified choleragen. 
Although at this time the adenylate cyclase response has 
nearly reached its maximum (Paper 4 and Chapter V), no 
significant changes were found in any of the other enzyme 
activities measured (results not shown). Thus, at least in 
the intestinal cell membrane, the action of choleratoxin 
seemed to be entirely confined to the adenylate cyclase 
system and the changes in ion transport could not be 
explained by a direct or indirect effect of the toxin on 
other membrane-bound en?.ymes. The inhibition of small in-
. + + 58 75 76 testlnal (Na -K )-ATPase, reported by other authors ·' ' 
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is probably due to the presence of mucinase in their crude 
preparations of choleragen58 , 75 or during clinical cholera 
76 
3.3 Cyclic AMP and the mechanism of fluid secretion 
Our knowledge about the steps lying between cyclic 
AMP accumulation and fluid secretion is still very poor. In 
analogy to studies in other epithelial tissues (toad blad-
der77, kidney 78 ) it may be assumed that cyclic AMP should 
act by changing the level of phosphorylation of some spe-
cific proteins in the plasma membrane, presumably at the 
luminal side of the enterocyte. This should ultimately 
lead to a change in the properties of the ion-transport 
system. Indeed it has been shown that the phosphorylated 
state of intestinal proteins particularly in the core of 
the microvilli, is increased during cholera79 . A charac-
terization of cyclic AMP-dependent protein kinases and 
their substrates in the epithelium is needed to substanti-
ate this model. Cycloheximide, an inhibitor of protein syn-
thesis, blocks the secretory response of the cell without 
inhibiting the cyclic AMP accumulation80 . This means that 
protein synthesis is essential for a certain step in the 
secretory mechanism or that cycloheximide itself exerts a 
direct effect on the secretion processBO. 
Much work has been done on the localization and cha-
racterization of the ion-transport system controlled by 
cyclic AMP. The stripped mucosa of rabbit ileum is the 
commonly used model system. According to the most recent 
scheme for cyclic AMP action, proposed by Powell and co-
workers81,82, cyclic AMP mainly stimulates the transcellu-
lar, active secretion of NaCl and/or NaHC0 3 from serosa to 
mucosa and reduces the electrical conductance, determined 
by a passive ionflux through a transepithelial shunt path-
way. The latter phenomenon may be ascribed to a swelling 
of the cell in response to choleratoxin, probably reducing 
the width of the intracellular space82 . The 
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existence of an active neutral NaCl absorptive mechanism 
in the brushborder of rabbit intestinal epithelial cells 
has been shown earlier by Frizze1 83 and Nellan~4 . Accor-
ding to these authors, cyclic AMP should inhibit this 
neutral influx rather than stimulate a reversal of this 
process. The model of Powell is more in agreement with our 
in vivo measurements of unidirectional flux rates of Na+ 
and Cl-, indicating a stimulation of the neutral efflux 
of NaCl from serosa to mucosa in the absence of a signifi-
cant change of the opposite flux (Paper 4). The flux 
studies performed in vitro with stripped mucosa give no 
information about the individual role of the different 
cell types of the epithelium in active secretion. Our main 
contribution to this field is the finding that both 
villous and crypt regions are involved in fluid secretion 
after prolonged exposure to choleragen. Independently, 
85 Schwartz et al. measured adenylate cyclase activation 
by choleratoxin in villous as well as in crypt cells from 
rat and rabbit intestine but did not solve the question of 
a possible cell type specificity of the secretory response. 
The involvement of the goblet cells in the electro-
lyte secretion is not entirely clear so far. Some indica-
tion that this process is confined to the absorptive cells 
may be derived from a combination of the following data: 
(1) Goblet cells react after exposure to choleratoxin with 
a rapid outpouring of mucus, probably stimulated by 
cyclic AMP86 . In rat small intestine, the mucus secre-
tion is completely compensated by an increased rate of 
mucus synthesis (Chapter V). Therefore, mucus syn-
thesis is probably also controlled by cyclic AMP. 
(2) High concentrations of isoproterenol and epinephrine 
(0.05-0.1 rnM) cause a stimulation of mucus synthesis 
87 in intestinal slices of the rat and a moderate ele-
vation of cyclic AMP levels in isolated villous and 
crypt cell populations {S-adrenergic response, Paper 
3) • 
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enhancement of active transport of NaCl and fluid from 
88 
mucosa to serosa . 
These facts may be easily fitted into the following hypo-
thesis: epinephrine and isoproterenol stimulate a cyclic 
AMP-mediated mucus production in the goblet cell by inter-
action with a S-receptor. In absorptive cells, however, 
the a-adrenergic response predominates resulting in an in-
creased rate of fluid and electrolyte absorption. Cholera-
toxin elevates cyclic AMP in both cell types resulting in 
a combined secretion of mucus and electrolytes. This situ-
ation is schematically represented in Fig. 3.1. It remains 
to be established whether epinephrine (or isoproterenol) 
indeed possesses the ability to stimulate mucus secretion 
from the goblet cells of an intact tissue. The observation 
of fluid secretion in the absence of mucus secretion in 
studies with shigella enterotoxin89 provides a second ar-
gument against the involvement of the goblet cell in fluid 
secretion, if the shigella toxin should indeed share a 
common secretory mechanism with choleratoxin, as has been 
89 
recently suggested 
3.4 Intestinal secretion evoked by other secretagogues 
A number of hormones, prostaglandins, enterotoxins 
and other, unrelated agents have been reported to inhibit 
absorption or to cause net secretion of water and electro-
lytes in the small intestine. A list of these compounds is 
given in Table 3.1. The involvement of cyclic AMP as a 
mediator of the secretion is clearly established in the 
case of the prostaglandins (Paper 6), E-coli enterotoxi~ 
VIP {vasoactive intestinal peptide, related in structure 
to secretin, glucagon and gastric inhibitory peptide), 
bile salts, and the phosphodiesterase inhibitors theo-
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Table 3.1 CONTROL OF FLUID AND ELECTROLYTE SECRETION IN THE SMALL INTESTINE 
Agent Secretin (+) or 
absorption (-) 
Cyclic AMP increase 
(+) or decrease (-) 
Clinical 
syndrome 
Choleratoxin53 • 56 
E.coli enterotoxin 54 • 56 
C.perfringens enterotoxin90 
Shigella enterotoxin89 ' 91 
Prostaglandins E1 , E2 , F2a
56 
VIP92,93 
++ 
+ 
+ 
+ no 
+ 
++ 
+ no 
++ 
+ 
? 
effect 
+a 
++ 
effect a 
GIP, secretLn
56
•
92
•
93 l 
(penta)gastrLn, glucagon, 
gastrin + glucagon, 
cholecystokinin, calcLtonLn 
Acetylcholine94 
Angiotensin95 
+ no effect 
+ {high doses) ? 
- (low doses) 
Vasopress~n51 • 96 • 97 + (man) no effect 
- (dog, rat) 
Epinephrine88 
Isoproterenol no effect 
Epinephrine/isoproterenol88 
+ propranalol 
{Hydroxyl fatty acids98-100 
{oleate, rincinoleate) 
Bile acidsl01,102 
(desoxycholate, taurocheno-
desoxycholate) 
-/no effect 
+ 
+ (colon) 
Theophylline52 •54 - 56 caffeinJ 03+ 
Aspirin104 
Enterovirus10 5 + 
a) See also Paper 6 
b) H.R. de Jonge, unpublished results. 
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no effectb 
no effectb 
+ 
+ 
no effect 
? 
Cholera 
Neonatal diarrhea, 
traveller's 
Bacillary dysentery 
? 
Pancreatic choler~" 
Diarrhea in fat 
malabsorption 
Transmissible 
gastroenteritis 
phylline and caffeine. As discussed in the preceeding 
section, the stimulation of cyclic AMP levels by epine-
phrine and isoproterenol {Paper 3, Table 3.1) is probably 
a specific response of the goblet cells. DL-propranalol 
(l mM) inhibited this response (unpublished results), con-
firming its S-adrenergic character. 
The other hormones tested were not able to change 
cyclic AMP levels in isolated villous and crypt cells from 
the rat {Paper 6, Table 2) nor in stripped mucosa from the 
rabbit 92 . They were likewise unable to stimulate adenylate 
cyclase activity in human jejunal mucosa 93 . Guanylnucleo-
tides increased the basal activity of the intestinal en-
zyme but did not change its horrnone-responsiveness 93 (com-
3 2) . d b . b 1 106 pare Section . . As polnte out y Blrn aumer ~-
guanyl and inosyl nucleotides may increase or decrease the 
apparent affinity of the adenylate cyclase system for 
hormones, dependent on the type of tissue or hormone 
studied. The effect of hormones on intestinal adenylate 
cyclase, preactivated with choleragen, has not been inves-
tigated thus far. Such a study could be interesting because 
choleratoxin strongly increased the affinity of the enzyme 
for hormones in a number of other tissues 63 ' 70 ' 71 (compare 
section 3.2). If a similar phenomenon could be reproduced 
in intestinal epithelium, the increased hormone sensitivi-
ty during cholera might be a complicating factor in the 
tissue response to the choleragen. 
The inhibition of ileal and jejunal fluid absorption 
by fatty 
noleate, 
acids (C10-c18 ) and hydroxy fatty acids (rici-
. 98 99 the active component of castor Oll) ' cannot 
be explained on the basis of a change in cyclic AMP levels. 
Even very high concentrations of ricinoleate (up to 5.0 mM) 
were unable to affect the cyclic AMP content of isolated 
villous cells (unpublished results). It has been suggested 
that these fatty acids may accumulate as acyl-CoA esters 
in the mucosa which, by inhibiting adenine nucleotide 
translocase, could alter mu~osal transport functions by 
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limiting the ATP-supply of the cells 100 
Recent studies comparing the action of choleratoxin 
and shigella toxin (an enterotoxin of Shigella dysenteriae) 
on rabbit ileum and jejunum indicated that both toxins 
probably stimulate the same ion transport system but in an 
entirely different way, for the cyclic AMP response was 
totally absent in the case of shigella toxin 89 , 91 . The in-
ability of this toxin and many hormones to change cyclic 
AMP levels despite their reported interaction with fluid 
transport indicates the existence of alternative, hitherto 
unknown, mechanisms to affect intestinal secretion. 
Several of these hormones have been reported to change the 
leveJ.s of the nucleotide cyclic GMP in other tissues. A 
possible role of this compound in intestinal transport 
processes is discussed in Chapter IV. 
3.5 Concluding remarks 
It is a general conclusion from our own work as well 
as that of others that even a slight increase of cyclic 
AMP levels in the intestinal epithelium leads to a drastic 
reduction of its absorptive capacity for water and electro-
lytes and may ultimately convert it into a secretory organ. 
The apparent insensitivity of the adenylate cyclase system 
of the enterocyte to a number of hormones {glucagon, in-
sulin, secretin, catecholamines in a physiological concen-
tration range) may therefore protect the absorptive func-
tion of the cell against large fluctuations in the levels 
of these hormones. At present, the only naturally occur-
ring extracellular regulator of intestinal adenylate cy-
clase is believed to be VIP, produced in the gastrointes-
tinal tract and in the pancreas. This protein may possibly 
play a physiological role in a fine regulation of the ab-
sorptive mechanism. 
Cyclic AMP control of metabolic pathways in the small 
intestine, comparable to that in other tissues (liver, 
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muscle, fat cells) might offer important risks for a con-
tinuous functioning of the absorptive system. It may be 
suggested that the lack of glycoger. 107 , the absence of 
gluconeogenesis 108 and a possible absence of a hormone-
sensitive lipase109 , at least in rat small intestine, is 
related to the need to hold its cyclic nucleotides at 
constant intracellular levels. 
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CHAPTER IV. FORMATION AND FUNCTION OF CYCLIC GMP IN 
SMALL INTESTINAL EPITHELIUM 
4.1 Introduction 
Besides cyclic AMP, the only other 3' ,5'-cyclic nucle-
otide ubiquitous present in living cells is guanosine 
3',5'-rnonophosphate (cyclic GMP). This compound was dis-
covered in 1963 by Ashman and coworker~ 10 1n urine and sub-
sequently detected in a variety of mammalian tissues and 
111 . 
other phylogenetic forms including prokaryotes .T1ssue 
levels of cyclic GMP are usually ten- to hundred fold low-
h h f l . 111 . l . l .f. er t an t ose o eye 1c AM~ .The phys10 og1ca sign1 1-
cance of the agent is not fully understood yet. However, a 
number of studies suggest a role of cyclic GMP in the cel-
lular response to cholinergic and a-adrenergic agents 
111, 112 113 . 114 (neurotransmitters) - _,insulin ,prostagland1n F 2 , estro-US 116 117 a 
gens ,plant lectins and growth factors (Chapter V). 
According to the "Yin-Yang" hypothesis proposed by 
Goldberg (1973) 11\cyclic GMP is involved in promoting cel-
lular events that are antagonistic to those mediated by 
cyclic AM.P. This "dualism" should only apply to bidirec-
tional control systems (e.g. muscle contraction and relaxa-
tion). In a monodirectional controlled system (e.g. stimu-
lation of steroidogenesis by ACTH) the two cyclic nucleo-
tides might promote similar events rather than opposing 
ones. This concept of biological control has now proven its 
value in several model systems, e.g. lysosomal enzyme re-
lease by human neutrophils 1 ;8 chemotaxis or cell motility of 
119 . 120 human monocytes , the platelet release react1on , muscle 
. 112 117 
contraction and relaxat1on and growth control . The mole-
cular basis of these apparent antagonistic actions of both 
nucleotides is not yet elucidated. Applying this hypothesis 
to the ion-transport system in the small intestine (possibly 
bidirectionally controlled; see Chapter III), cyclic GMP 
would antagonize the ion secretion stimulated by cyclic AMP. 
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In that case, a better knowledge of the factors that deter-
mine cyclic GMP formation and degradation in the epithelium 
could have important therapeutic implications. In the op-
posite case, assuming a similar action of both nucleotides 
on ion transport, this study would possibly provide an al-
ternative basis to explain the stimulatory effects of cer-
tain hormones or toxins on intestinal fluid secretion in 
the absence of any change in cyclic AMP levels (Chapter 
III). 
4.2 Formation of cyclic GMP in a number of tissues other 
than small intestinal epithelium 
Cyclic GMP is formed by the enzyme guanylate cyclase 
(GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2) in the 
following reaction: 
GTP 
M 2+ 
n ) 3' , 5 '-cyclic GHP + PP i 
dGTP and ITP can be used as alternative (non-physiological?) 
substrates . The enzyme exists in a soluble and a parti-
culate form, showing different kinetic and physical proper-
ties12~ Their relative activities are strongly tissue-
dependent and may vary with the stage of development122. The 
t . l t . t . . h . 123 par lCU a e enzyme 1s mas act1ve 1n sea urc 1n sperm and 
glomerular membranes124. Human platelets125 and rat lung 126 
are the richest sources for the soluble enzyme. The guany-
late cyclase from sea urchin sperm is largely confined to 
the flagellar membranes12~ Reliable subcellular distribu-
tion studies for the particulate enzyme in other non-epi-
thelial tissues with the use of marker enzymes have not 
been reported thus far. In rat heart12 ~ calf uteruJ 28 and 
bovine rod outer segments12 ~ most particulate activity re-
sides in the nuclear pellet. In Table 4.1, the main diffe-
rences and similarities of soluble and particulate enzymes 
are summarized and compared to those of adenylate cyclase. 
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"' Table 4.1 COMPARISON OF SOME PROPERTIES OF THE SOLUBLE AND PARTICULATE FORMS OF GUANYLATE 
AND ADENYLATE CYCLASE 
Guanylate cyclase Adenylate cyclase 
Soluble 
121 126 (rat lung , heart ) 
Substrate MnGTP (dGTP, ITP) 
Cofactor Mn 2+ (M 2+ g ' ca2+) 
Substrate- Classic (=Michaelis-
kinetics 
Cofactor-
kinetics 
Activator 
Inhibitor 
Men ten) 
Negative cooperativity 
(Mnf2+ <0. 2mH) 
ree 
Classic (Mnf2+ >0.2mM) 
ree 
2+ 2+ Ca ( > 0. lmM at low Mn ) 
PEP (1-10m!-!), oxal-
acetate (0.1-0.SmM) 
ATP (nucleotidesi 
0.5-2mM) 
Molecular ~450.000 
weight 
Particulate 
(sea urchin sperm12 ~ 
rat lung1 2 1 ) 
MnGTP 
Mn 2+ 
Positive cooperativity 
(classic in presence 
of CaGTP) 
Classic 
Particulate 
(liver) 
MgATP (dATP) 
Mg 2+ (Mn 2+) 
7 
7 
Detergent (Triton X-lOO)F-, GTP 
MnATP, ADP (<SO~M) (SOnM-0 .1mM), 
hormones 
MnATP, ADP (>SO~M) ca2+ (0.1-1mM) 
+ ' Li , alloxan, 
detergent 
'V800.000 7 
Soluble 
(bacteria) 
MgATP 
Mg2+ 
7 
7 
a.-Ketoacids 
Oxalacetate 
7 
Despite their different kinetic properties and mole-
cular weights, both forms of guanylate cyclase possibly 
represent different physical states of the same mole-
cule(s). This is strongly suggested by the recently re-
ported apparent redistribution of both forms during growth 
and development of regenerating liver, fetal liver and 
1112 2 . hepatoma ce 1n the absence of any change in total en-
zyme content. 
The current state of knowledge concerning the physic-
logical regulation of guanylate cyclase activity is still 
very poor. If the "second messenger" concept for cyclic 
AMP is translated in terms of cyclic GMP, it might be 
anticipated that hormonal stimulation of cyclic GMP levels 
would have its basis in a direct interaction of hormone 
receptors with a particulate guanylate cyclase localized 
in the plasma membranes. Evidence for this derives from at 
least two model systems: the stimulation of guanylate cy-
117 
clase in fibroblast membranes by a specific growth factor 
130 (Chapter V) and in liver plasma membranes by 1nsul1n 
The parallel with the adenylate cyclase system has even 
led to the suggestion that the guanylate cyclase activity 
in plasma membranes reflects a change in substrate speci-
ficity of the catalytic subunit of adenylate cyclase from 
ATP to GTP 113• Efforts to show a direct hormonal stimula-
tion of particulate guanylate cyclase in heart muscle 
failed thus far 126 ' 13.1 However, such effects could have been 
masked by the apparent high contamination of these crude 
preparations with nuclear enzyme (possibly insensitive to 
hormone action) . Several reports describing stimulatory 
effects of secretin 132, cholecystokinin133 and acetylcholine 
134
on soluble guanylate cyclase in vitro could not be 
confirmed in other laboratories {ref .126 and Hardman, per-
sonal communication) . Because stimulation of cyclic GMP 
levels by cholinergic or depolarizing agents generally 
requires the presence of ca2+ in the medium it has been 
suggested that these agents may rise cyclic GMP by promo-
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2+ 118,135. Indeed, 
ting Ca -uptake through the plasma membrane 
it has been demonstrated repeatedly that the ca2+-ionophore 
A-23187 can mimic their action and raise cyclic GMP levels 
. 1 . 118,136,137 . 4 1n sever a t1ssues . .As shOW'n m Table .1, a stimu-
2+ . latory effect of Ca on soluble guanylate cyclase 1n 
vitro requires high ca2+- and low Mn2+ levels. Whether 
these high levels of free ca2+ will actually be reached 
during cholinergic stimulation is uncertain. As has been 
shown earlier for adenylate cyclase138, also guanylate cy-
clase activity can be regulated by a number of cellular 
metabolites. Especially the strong inhibition by nucleo-
tides {ATP, ADP, etc.) may be of physiological importance. 
4.3 Formation of cyclic GMP in small intestinal epithelium 
The presence of a distinct guanylate cyclase in muco-
sal scrapings of the rat has first been described by 
139 Ishikawa et al . (1969). They noted an exceptionally high 
activity of the particulate enzyme and a relatively low 
amount of soluble enzyme in this tissue. Despite its poten-
tial usefulness as a model for studying function and regu-
latory properties of the particulate guanylate cyclase, no 
further research on the enzyme has been reported since 
then, probably because the small intestinal epithelium is 
generallyconsidered to be a hormone-insensitive tissue. 
New interest in the role of cyclic GMP in the small 
intestine arose by the recent observation that acetyl-
- 140 
choline may stimulate Cl -secretion also in stripped mucosa 
(in accordance with the histochemical findings of 
cholinergic nerve endings in the lamina propria) and the 
inability of a number of hormones to change cyclic AMP 
levels in the mucosa56, 92 , though markedly influencing 
fluid and ion transport (e.g. vasopressin, pentagastrin; 
see Paper 6) . 
The main results of our studies dealing with a further 
characterization of the cyclic GMP-generating system in the 
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epithelial cells are presented in Papers 5 and 6. 
The composition of the assay system described in 
Paper 5 needs some additional comment. The assay of guany-
late cyclase in relatively crude preparations requires the 
use of a GTP-regenerating system to ensure constant levels 
of GTP. The PEP-PK system applied in the original publica-
tion of Ishikawa et al: 39 was replaced by CP-CK in view of 
the marked inhibition of guanylate cyclase by high concen-
trations of PEP (Paper 6, Table 1). Moreover, CP-consurnp-
tion and product degradation could be kept low (<15 per 
cent) by the addition of theophylline (a strong inhibitor 
of alkaline phosphatase 14l and phosphodiesterases) and by 
using low amounts of protein and a short .incubation time. 
Limitation of CP-degradation is essential to obtain reliable 
kinetic data, because otherw~se deviations from linearity 
arise due to a change in [Mn 2+ J resulting from de-
2+ free 
creased amounts of Mn complexed to CP. MnC1 2 must be 
added just prior to assay, to avoid the formation of Mn2+-
Tris precipitates and Hn 2+ oxidation. 
The results of our studies (Papers 5 and 6) can be 
summarized as follows: 
(1) The soluble form of guanylate cyclase is nearly absent 
as well in villous- as in crypt cells. 
(2) Most of the guanylate cyclase is incorporated into micro-
villous membranes of the brushborder during an early 
stage of development. The distribution study, according 
to Douglas, did not eliminate a possible nuclear loca-
lization but the large increase of specific enzyme 
activity after brushborder purification according to 
Harrison and Webster, in which adherent nuclear mate-
rial is adsorbed to glass wool, indicated that most 
(but possibly not all) of the guanylate cyclase in 
these preparations was confined to the microvilli. 
(3) The residual part of the guanylate cyclase is most 
probably localized in the basal-lateral plasma mem-
branes. An accurate determination of its contribution 
39 
to the total enzyme activity in the cell is impossible 
in view of the different kinetic properties of the 
luminal and anti-luminal enzyme forms. 
(4) The kinetic characteristics of the brushborder enzyme 
appeared to be very similar to those of particulate 
enzymes in other tissues. Inhibition by oxalacetate, 
PEP and nucleotides has been found earlier for the 
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soluble enzyme from rat liver and lung The strong 
inhibition by ATP sharply contrasts with its stimula-
tory action on the nuclear enzyme in ovarian tissue12 ~ 
The small stimulation by amino acids (also found in 
the absence of a regenerating system) have no parallel 
in other tissues; one can only speculate about its 
physiological significance. 
(5) The microsomal preparation, weakly contaminated with 
brushborder enzymes, showed kinetic characteristics 
that were intermediate to those of particulate and 
soluble enzymes in other tissues. 
(6) The apparent hormone-insensitivity of the brushborder 
enzyme seemed not very surprising, in view of a possible 
lack of hormone receptors at this side of the cell. 
However, also the microsomal enzyme was insensitive to 
the hormones. Possible reasons for this phenomenon are 
discussed in Paper 6. 
A relationship between cyclic GMP and intestinal trans-
port functions was considered on the basis of the following: 
(1) The presence of a highly active guanylate cyclase in the 
brushborder. (2) The essential role of the microvilli in in-
testinal transport processes. (3) The observation of 50-70 ~ 
actin-like core filaments in the microvilliM~ and of pul-
sating movements of microvilli, under the phase contrast 
microscopel 4 ~ Both data strongly suggest a contractile func-
tion of the microvilli, possibly related to its transport 
function. (4) The high levels of guanylate cyclase in other 
cell types/organelles with a contractile function (flagel-
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lar mernbranes 12~ platelets125) .(5) A possible general role 
119,145 
of cyclic nucleotides in the regulation of cytokinesis 
A search for the presence of cyclic GMP-dependent pro-
tein kinases in the microvilli and localization of their 
substrate-proteins (core proteins?) would possibly open 
the way to test this hypothesis experimentally. 
Alternatively, a role of cyclic GMP in the development 
of microvilli may be suggested, based on the recent find-
ing that cyclic AMP caused regression of microvilli in 
normal mouse fibroblasts and that a reduction of cyclic 
AMP levels by transformation led to formation of micro-
.11.146 v~ ~ . 
4.4 Levels of cyclic GMP in epithelial cells, isolated 
from rat small intestine 
Direct measurements of cyclic GMP levels in isolated 
cells to test the hormone-responsiveness of the cyclic 
GMP-system, eliminates homogenization artifacts (e.g. re-
ceptor damage) and may provide additional information 
about hormonal effects on cyclic GMP degradation. However, 
this approach has two major disadvantages: (1) The meta-
bolic changes in the cell following isolation (e.g. a 
lowered energy state) could profoundly influence the re-
sults and (2) small effects of hormones on the guanylate 
cyclase in the anti-luminal cell borders may be masked by 
a possibly large contribution of the (hormone-insensitive?) 
microvillous enzyme to the total cyclic GMP pool. 
The results of these measurements are reported in 
Paper 6. The observed lack of correlation between cyclic 
GMP content and guanylate cyclase activities in villous-and 
crypt cells is not unique for the intestinal epithelium: 
also during the development of fetal rat heart and lung, 
cyclic.GMP contents decreased and guanylate cyclase acti-
vities strongly increased 14? Both studies suggest an im-
portant role of cyclic GMP-dependent phosphodiesterases in 
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the regulation of cyclic GMP levels. 
As discussed in Paper 6, the inability to alter cy-
clic GMP levels in villous- and crypt cells by addition of 
hormones or hormone-like agents does not definitively ex-
clude a role of cyclic GMP as a mediator of hormone action. 
The negative results would be of more value if the cyclic 
GM? measurements could be directly coupled to measurements 
of ion transport rates. The silicon oil filtration tech-
nique, particularly suited for rapid transport measure-
ments in isolated epithelial cells 148(chapter V) offers 
good perspectives to accomplish such studies. 
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CHAPTER V CYCLIC NUCLEOTIDES IN RELATION TO PROLIFER-
ATION AND DIFFERENTIATION 
5.1 Introduction 
3' ,5'-Cyclic nucleotides have been implicated as 
important modulators of growth and differentiation of 
cells in culture. Cyclic GMP seems to act as an initiator 
of cell growth, probably by promoting the movement of 
149 cells out of the G0 or G1 phase of the cell cycle In 
cultured fibroblasts and lymphocytes 116 .~ 1 ggecific growth 
factors (fibroblast growth factor (FGF), bacterial lipo-
polysaccharides (LPS), lectins) may elevate intracellular 
levels of cyclic GMP, possibly by stimulating the guany-
11 7 149 late cyclase activity in the plasma membrane ~ By con-
trast, increased cyclic AMP levels may evoke the opposite 
pleiotypic response 1 ~ 1 Intracellular cyclic AMP concentra-
tions are negatively correlated with growth rates among a 
variety of fibroblast cell lines1 ~ 2 Transformed cells have 
a lower cyclic AMP content than untransformed cells 153 A 
rise of intracellular cyclic AMP, induced by exogenous 
cyclic AMP analogs, activators of adenylate cyclase 
{choleratoxin, B-adrenergic agents, prostaglandins, pep-
tide hormones) or inhibitors of cyclic phosphodiesterases 
(methylxanthines, papaverine, cytokinins15 ~ slows or stops 
growth in a great number of cell cul tures15 5. In most cell 
lines studied, cyclic AMP arrests the cell cycle speci-
fically in G1 , a common control point in growth regula-
tion156-1;9rn exceptional cases the cyclic AMP-sensitive 
Gl56,160 161 phase seemed to be 2 or s Cyclic AMP most pro-
bably acts through activation of a protein kinase, for 
kinase-deficient mutants of mouse lymphoma cells do not 
respond to dibutyryl-cyclic AMP and maintain a normal 
157 
cell cycle . The latter result also proves that cylic 
AMP fulfills a non-essential function in cell cycle regu-
lation. At which level the protein kinase regulates 
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growth is unknown thus far. 
Cyclic AMP may play a more essential role as an in-
ductor of enzymes or structural proteins 16 : In prokaryotes 
enzyme synthesis subjected to catabolite repression is 
under cyclic AMP control at the transcriptional level162 , 163 . 
In this system, cyclic AMP, bound to a receptor protein 
(no protein kinase) facilitates the attachment of RNA 
polymerase to the promotor locus of the operon. Cyclic GMP 
inhibits enzyme induction by competition with cyclic AMP 
for its receptor protein. Catabolites (glucose, tryptophan) 
act by depressing cyclic AMP levels. Many eukaryotic cell 
types respond to cyclic AMP with a rapid induction of spe-
cific enzymes (e.g. catabolic enzymes in liver) or a re-
pression of others (e.g. anabolic liver enzymes; see ref. 
162 fora review). Both transcriptional and translational 
control may exist, probably based on phosphorylation, by 
cyclic AMP-dependent protein kinases, of chromatin pro-
teins and ribosomal proteins respectively. There is 
no information about a possible role of cyclic GMP in 
enzyme induction. 
In vivo studies of the role of cyclic nucleotides in 
cell growth and differentiation in the whole animal are 
complicated by the lack of synchronicity in most physiolo-
gical cell renewal systems, the lack of tissue specificity 
of a number of agents used to alter cyclic nucleotide levels, 
the possible interference of degradation products of these 
agents (e.g. adenosine in case of cyclic AMP) and the 
difficulty to measure the nucleotide levels in situ in a 
well-defined cell type. Results obtained with epidermis 156 , 
164 61 150 160 165-169 
, human lymphocytes 1 1 : embryonal palatal shelves 
of the rat170 and rat mammary turnors171 tend to confirm the 
anti-mitotic action of cyclic AMP or the mitogenic proper-
ties of cyclic GMP. These studies led to the view that 
proliferative skin diseases, in particular psoriasis, have 
their origin in an unbalanced ratio of cyclic AMP and 
cyclic GMP in the epidermis. They also postulate an uni-
versal role of cyclic nucleotides as intracellular media-
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tors of antigen-induced activation and proliferation of 
immunocytes. However, inertia or even positive effects of 
cyclic AMP on growth rates in vivo have been suggested in 
studies of regenerating liver 1 7~ thyrnocytes 17 ~ salivary 
gland acinar cells 17 ~ Morris hepatoma cells 17 ~ human 
b 176 l . . reast tumors or me anorna tumors 1n m1ce 
159 
. In the latter model system, where cyclic AMP levels 
were elevated by daily 
ting hormone {MSH), it 
injections of melanocyte stirnula-
has been 
could escape the G1-restriction 
proposed 
point by 
that the cells 
a discontinuous 
reception of hormone signals, based on the observation that 
MSH-receptors were only available during the G2-phase
159 
A recent reinvestigation of the salivary gland model in 
vivo177 showed that the growth stimulation by isoproterenol 
and its analogs is based on an unusual elevation of cyclic 
GMP levels in the acinar cells by these 8-adrenergic agents . 
. In order to resolve further some of these discrepancies be-
tween in vivo and in vitro studies and to prove the uni-
versal character of the involvement of cyclic nucleotides 
in regulation of growth and differentiation, extension of 
these studies to a new model system of physiological im-
portance seemed highly desirable. 
5.2 Growth and differentiation in small intestinal epi-
thelium 
Despite its potential usefulness as a model for stu-
dies of growth regulation and cytodifferentiation in mam-
malian systems, the basic regulatory mechanisms for homeo-
stasis in intestinal epithelium are poorly understood. 
The existence of a feedback control by differentiated 
villous cells on the proliferative activity in the intes-
tinal crypts, possibly mediated by local growth inhibiting 
factors {chalones) is suggested but not convincingly 
proven 17 ~ Also a role for humoral factors has been advo-
cated17? In rat small intes~ine, a number of agents {e.g. 
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. . 180 181 . . . 182 b1le ac1ds , serotonin 1 ep1nephr1ne or noradrenal1n 
t . 183) d d' . ( l . 184 . d' pentagas r1n an con 1t1ons e.g. actat1on , 1rra l-
ation17~ starvatioh85 , diabete~ 86 , germ-free state18: 
188 flattened mucosa ) are known to affect crypt cell proli-
feration or differentiation. In none of these studies a 
possible involvement of cyclic nucleotides has been ex-
plored. However, it may be speculated that at least the 
growth inhibition (appr. 50-70 per cent) found during 
a-adrenergic interaction of the crypt cells with isoprote-
renol or epinephrine or the shortening of cell cycle time 
{appr. 50 per cent} after a-adrenergic stimulation by nor-
epinphrine182 is mediated by cyclic nucleotides. 
The choice of the small intestinal epithelium as an 
experimental system for studying such relation may be moti-
vated by the following considerations: 
(1) Proliferative, maturative and functional absorptive 
cells are regularly distributed along the length of 
crypts and villi. Epithelial cells in successive 
stages of development can be isolated separately due 
to this distinct localization. Also other separation 
methods are available, based on different binding 
,189,190 
characteristics to plant lectlns . By measurements 
of biochemical parameters in these cell populationsi 
changes in the developmental pattern in relation to 
cell age may be sensitively monitored. Moreover, suit-
able techniques are known to detect altered growth 
rates or a possible extension of the proliferative cell 
pool (autoradiography or biochemical analysis after 
pulse labelling with [ 3H]thymidine, mitotic counting, 
cell cloning) . 
(2) Our previous work {Chapters III and IV) showed the 
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way to alter cyclic nucleotide levels in both villous-
and crypt cells. Whereas cyclic GMP levels could only 
be raised by a non-specific agent, alloxan, cyclic AMP 
was markedly elevated by prostaglandins, epinephrine and 
phosphodiesterase inhibitors in vitro and choleratoxin 
in vivo. These agents were expected to be useful tools 
for studying a hypothetical relationship between cyclic 
nucleotides and cell development. 
The study was carried out at two levels. In a first 
approach, macromolecular synthesis was measured in isola-
ted crypt cells, exposed to some of the fore-mentioned agents. 
Side-effects on other tissues do not interfere in this 
system. However, in view of the short survival time of 
isolated crypt cells1 this method could only be used to 
detect rapid effects of cyclic nucleotides on precursor 
transport, metabolism or macromolecular synthesis. The 
consequences of cell cycle blockade or changes in enzyme 
development cannot be adequately studied in this model. In 
a subsequent study choleratoxin was administered in vivo 
and its influence on some cell-kinetic parameters was 
examined during the next two days. Purified choleratoxin 
seemed highly preferable over the other compounds for the 
following reasons: 
First, a chalone-like action of this agent has been con-
. . . 191,197 firmed 1n a number of f1broblast cell l1nes , mouse 
. 168 193 61 167,168 leukaem1a cells ,melanoma cells and T-lympnocy~es .Also 
enzyme induction by the choleragen in vivo has been repor-
ted (e.g. alkaline phosphatase in the liver194 ) ·Secondly, 
if applicated intraluminally in adult rats, side effects 
on other tissues are completely avoided since the toxin 
does not pass the intestinal wall. Moreover, in contrast 
to the other agents, choleratoxin activates the adenylate 
cyclase in an irreversible manner. High intracellular 
levels of cyclic AMP may therefore persist for a long time 
191-193 . period after short contact to choleragen . Flnally, 
its action on adenylate cyclase is very specific in all 
cell types studied so far and is not toxic to the animal 
if dehydration is prevented. 
The technique described in the following section 
allowed a study of cell migration and enzyme development 
during cholera for any time period desired without need for 
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infusion of salt solutions. The results could also be of 
clinical interest, because the duration of choleragen-
induced diarrhea probably depends on the transit time of 
the affected epithelial cells 195 . 
5.3 Methods 
Male Wistar rats, weighing 220-250 g, were maintained 
on a normal laboratory diet. Prior to the choleratoxin-
experiments, rats were fasted for two days. 
Isolation and incubation of villous-and crypt cells 
and measurements of incorporation of radioactive label in-
to TCA-insoluble material were carried out in principle as 
described in Paper 2. Concanavalin A-selected cells were 
prepared according to Paper 5. 
The method for measuring cyclic AMP levels in isola-
ted crypt cells is mentioned in Paper 6. Adenylate cyclase 
activities were measured in principle as described in 
Paper 4. In the purification procedure. Dowex columns were 
replaced by Alumina columns (Paper 5). 
Uptake of [ 3H]thymidine by isolated epithelial cells 
was followed with the 
recently published by 
silicon oil filtration technique, 
- 148 . Lamers and Hulsmann . PlastLc 
(micro-) centrifuge tubes (Eppendorf No. 3810) were filled 
with a bottom layer of 0.1 ml 0.5 M HClo 4 , an intermediate 
layer of 0.5 ml silicon oil (TegiloxanGY A.V. 100, Gold-
schmidt Ltd., Essen, W.Germany) and a top layer of 0.5 ml 
Krebs phosphate buffer (pH 7.4), containing in addition 
10 mM glucose, 1.4 mM Cacl 2 , 0.01-100 ~M [ 3H]thymidine 
(0.5 ~Ci) and I mM [u- 14 c] sorbitol (0.25 ~Ci). For mea-
surements of intracellular water space [ 3H]thymidine was 
replaced by 3H2o (0.25 ~Ci). The tubes were equilibrated at 
0° or 37° in a 957. o2 !Si. co 2 atmosphere. Samples of 50 ~1 
from a concentrated cell suspension (25-30 mg protein/ml), 
preincubated for 1 min at 0° or 37°, were rapidly trans-
ferred with an Eppendorf pipette into the top layer. 
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After 1-5 min of incubation cells were separated from the 
medium within 15 sec by sedimentation at 10.000 g for 4 
min. Samples, taken from the cell-free top layer and from 
the bottom layer were analysed for radioactivity. The per-
chloric acid pellets were washed and [ 3H]thymidine incor-
poration measured as described in Paper 2. The method for 
calculating intracellular water space and uptake rates of 
[ 3H]thymidine is given in ref.l48. 
The experiments using choleratoxin were carried out 
as follows: in anesthetized fasted rats, appr. 10 em from 
the pylorus,two adja~ent segments of small intestine, 
each 5 em in length and cleared of intestinal contents, 
were closed at both sides with ligatures. The ropes were 
tightened around the stalk of a match, in order to facili-
tate the loosening afterwards and to reduce tissue damage 
as much as possible. The distal (control) segment was 
filled with 0.5 ml saline with a needle. The proximal seg-
ment received 10 ~g purified choleragen in saline. Then 
the abdomen was closed with woundclips. Three hours later, 
the lumen of both segments was thoroughly perfused with 
80 ml saline using two needles introduced at both ends of 
each segment. Residual amounts of unbound choleragen were 
removed by this procedure. Then the ligatures were cut 
and the abdomen again carefully closed with woundclips. 
One, six or twelve hours afterwards the animals were injec-
ted intraperitoneally with 10 ~Ci [ 3H]thymidine (20 Ci/ 
mmole) and sarcrificed at different time intervals after 
injection. Parts of the segments were fixed in neutral 
formalin and processed for autoradiography as indicated in 
Paper 2. Sections were poststained with hematoxylin-eosin 
or PAS. In at least two sections of each segment the posi-
tion of t~e highest labelled cells along 20-30 longitudi-
nally cut crypts and villous columns was determined. Resi-
dual part of the segments were used for measurements of 
[ 3H]thymidine incorporation into TCA-insoluble material, 
as described in Paper 2. 
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Radioactive materials were obtained from The Radio-
chemical Centre, Amersham. In all studies [ 3H-methyl]thymi-
dine was used. Biochemicals usually cam:from Boehringer, 
Mannheim. Theophylline (1,3-dimethylxanthine) and caffeine 
(1 ,3,7-trimethylxanthine) came from Merck, Darmstadt and 
MIX (3-isobutyl-1-methylxanthine, SC-2964) from Aldrich 
(Milwaukee, Wis. USA). RO 20-1723 (1-4-(3-butoxy-4-methoxy-
benzyl)-2-imidazolidone) was a gift from Hoffmann-La Roche, 
New York. Purified choleratoxin was kindly supplied by 
Dr. R.S. Northrup, SEATO Cholera Research Program. 
The autoradiography could be done due to the cooperation 
of Dr. N.J. de Both, Department of Experimental Pathology, 
Erasmus University, for which he is gratefully acknow-
ledged. 
5. 4 Resnl ts 
Table 5.1 summarizes the effect of cyclic nucleotide 
analogs, phosphodiesterase inhibitors, PGE 1 and epinephrine 
on the initial incorporation of thymidine, uridine and 
aminoacids into macromolecules of isolated crypt cells 
under conditions that cylic M1P levels were significantly 
elevated. The RO 20-1723 inhibitor was included because of 
its specificity for cyclic Ar,1P-dependent phosphodiester-
ases196and its inactivity as an inhibitor of alkaline phos-
phatase (in contrast to theophylline and HIX; ref.l4l and 
H.R. de Jonge, unpublished results). The results are 
strongly suggestive for a rapid inhibition of thymidine 
transport or utilization by cyclic AMP. Uridine transport 
or incorporation was affected to a minor extent or appeared 
unchanged whereas arninoacid incorporation was not affected 
at all. The inhibition by dibutyryl-cyclic AMP was pro-
bably not caused by the butyryl group for dibutyryl-
cyclic GMP was inactive. Epinephrine was likewise ineffec-
tive, despite its ability to raise cyclic AMP levels. How-
ever, this phenomenon fits well in a previous hypothesis, 
50 
ln 
~ 
Table 5.1 INCORPORATION OF THYMIDINE, URIDINE AND AMINOACIDS INTO PCA-INSOLUBLE MATERIAL 
AND LEVELS OF CYCLIC AMP IN ISOLATED CRYPT CELLS 
After preincubation for 2 min at 37° with or without the additions rnade,crypt cell sus-
pensions were supplemented with 1.0 ~M [ 3 Hjthymidine {l wCi) or 1.0 ~M [ 3 H]uridine (l wCi) 
and [ 14 C]aminoacids (10 nAtC/rnl, 0,25 wei). Incubations were stopped after 5 min by addi-
tion of perchloric acid. Net incorporation rates were measured as described in Paper 2. 
Mean values are given, obtained with n cell preparations. values for cyclic AMP levels 
are followed by the standard error. 
Additions 
Dibutyryl cyclic AMP 
Cyclic AMP 
Dibutyryl cyclic GMP 
Theophylline 
MIX (SC-2964) 
RO 20-1723 
Caffeine 
Papaverine 
Prostaqlandin E1 
Epinephrine 
Adenosine 
AMP 
ADP 
Adenine 
Hypoxanthine 
--
Final con-
centration 
(mM) 
0.5 
1.0 
1. 0 
1.0 
2.0 
0.5 
0 .1 
1. 0 
0.5 
0.05 
0.05 
0.5 
0. 5 
0.5 
1. 0 
1.0 
X: P-value <0.05 (Student t-test). 
% Inhibition 
thymidine 
(n~6) 
0 
-25 
-40 
- 5 
- 1 
-60 
-58 
-40 
-55 
-49 
-28 
- 4 
-84 
-62 
-27 
- 2 
0 
(-) or stimulation (+) 
uridine aminoacids 
(n~4) (n~6) 
0 0 
- 2 0 
+ 3 - 3 
+ 4 + 1 
0 + 3 
-21 - 8 
-20 - 4 
+ 2 - 5 
-35 - 5 
-62 - 7 
-15 + 3 
+ 1 + 4 
-37 - 2 
- 0 
- + 1 
+ 4 0 
-
- 2 
pmoles cyclic AMP 
mg protein (n 4) 
11.7 + 0.8 
23.2 + 2.5" 
32.5 + 3.6" 
20.0 + 1.9" 
- " 26.3 ± 3.1,. 
30.7 + 2.9 
- " 20.8 + 1.7 
16.2 + 1.5" 
10.2 + 0.9 
11.0 
10.9 + 1.2 
assuming a specific S-adrenergic action on the non-proli-
ferative goblet cells (Chapter III) . Adenosine and, to a 
minor extent, AMP and ADP, also inhibited thymidine in-
coporation. In astrocytoma 197andneuroblastoma cells 198 
adenosine could elevate cyclic AMP levels via interaction 
with adenosine-receptors at the plasma membrane. A simi-
lar action was not observed in the isolated crypt cells 
(Table 5.1). The inhibition seemed specific for nucleo-
sides because adenine itself was completely inactive. 
The rapid onset of the changes in thymidine incorpo-
ration rates indicated that the inhibition could take 
place at the transport level. Therefore, thymidine trans-
port in the enterocytes was characterized and the influ-
ence of the inhibitors on this process was examined. 
The uptake of thymidine by isolated crypt and upper 
villous cells increased linearly with time for about 2 
min but gradually diminished in the next period (Fig. 5.1). 
Upper villous cells contain thymidine kinase in a latent 
form 19 ~ Thymidine transported into these cells is not 
converted to TMP but instead accumulates until the intra-
cellular concentration equals the concentration in the 
medium (Fig. 5.1). No evidence was found for the existence 
of an active transport system for this nucleoside in the 
enterocyte, in accordance with conclusiOns for other cell 
types studied 2 00,20~ Due to the accumulation of phosphory-
lated intermediates, thymidine uptake by the crypt cells 
proceeded for longer periods. Here the deflection of 
linearity is most probably caused by the presence of non-
proliferative cells in the preparation and a gradual de-
toriation of the crypt cells during incubation, demonstra-
1 ted by an increased loss of soluble enzymes and a dimi-
nished oxygen uptake (unpublished observations) . For simi-
lar reasons, incorporation of thymidine into DNA also 
slightly decreased after 5 min of incubation (Fig. 5.1). 
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In subsequent studies initial transport rates were 
measured after 1 min to ensure linearity of uptake. Short-
er times were not applied because the sorbitol marker 
needed appr. 45 sec to equilibrate fully with the extra-
cellular space. 
Thymidine uptake by villous and crypt cells showed a 
hyperbolic relationship with the extracellular thymidine 
concentration at levels up to appr. 20 ~M, suggesting a 
carrier-facilitated diffusion (Fig. 5.2). At higher con-
centrations transport rates were perfectly linear and un-
saturable, indicating a simple diffusion process. Incor-
poration of label into DNl\_ likewise increased hyperbolical-
ly at thymidine levels below 5 wM as might be expected if 
thymidine transport would be rate-limiting for the incor-
poration. At 10 ~M thymidine the salvage pathway is 
saturated and a plateau value is reached(Fig. 5.2)~. 
Fig. 5.3 shows the Lineweaver-Burk plots of initial 
uptake rates, corrected for the contribution of the un-
saturable component, calculated from the slope of the 
straight lines in Fig. 5.2. Thymidine uptake in the crypt 
cells followed normal Michaelis-Menten kinetics. A K -
m 
* Under conditions that the endogenous synthesis of TMP 
from desoxyuridine monophosphate is inhibited by prein-
cubating the crypt cells for 10 min in the presence of 
30 f.JM hypoxanthine, I DO ].1M glycine and 10 ~M amethop-
terin (a folic acid antagonist) as recommended by Siegers 
et al?D 2 , the maximal incorporation rate of thymidine 
amounted to 3.2 pmoles.min-l.f.Jl-1 intracellular space~ 
equivalent to 27 pmoles.min-1.mg-1 protein or appr. 270 
pmoles .min-1 .mg-1 DNA (compare Paper 2). This accounts 
for the synthesis of appr. 16 jlg DNA. hr-1 .mg-1 DNA, 
assuming 50 per cent thymidine-adenine base pairs in 
the DNA. This leads to a mean doubling time of the 30-
50 per cent proliferative cells in the crypt cell pre-
paration of appr. 24-40 h (in vivo: 10-14 h), Although 
part of the thymidine incorporation may be involved in 
DNA repair, this calculation justifies the conclusion 
that the DNA synthesizing system in the crypt cells is 
reasonably preserved during the isolation procedure. 
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0-0 Iota I uptako,crypt cella 
•-• total uptake, upper villous cells 
D--0 incorporation into TCA pellet,crypt cella 
!II- incorporation intoTCApellet, 
upPer villous cella 
1 2 3 
Time(min) 
4 
Fig. 5.1 Total uptake of thymidine (0-0, 8-8) and incor-
poration into the TCA-insoluble fraction (o-o, m-m) by 
isolated crypt and upper villous cells as a function of 
time. Cells were incubated under a 95% 02/5% C02 atmos-
phere at 37° in the presence of 10 ~M [3Hlthymidine. Each 
point represent the mean of four experiments (+ S.E.). Rate 
of transport/incorporation were expressed as pffioles thymi-
dine per ~1 intracellular water space. Intracellular water 
volume of crypt and upper villous cells were 6.03+0.14 
(n=6) and 8.43~0.22 (n=6) ~1/mg protein respectively. 
-1 -1 
value of 5 ~Manda V equal to 3.5 pmoles.min .~1 intra-
cellular water could be calculated from the Figure. The 
apparent V decreased to 0.4 pmoles.min- 1 .~1- 1 at 0° 
(average a10 : 1.7). The uncorrected uptake rate at 100 ~M 
decreased by 2.5 fold, confirming the simple diffusion 
character of this process. An equal value for the Km and a 
-1 -1 
slightly lower value for the V (3.0 pmoles.min .~1 ) was 
measured in upper villous cells (results not shown). 
All compounds shown to inhibit thymidine incorpora-
tion into macromolecules (Table 5.1) caused a similar 
degree of transport inhibition (Figs. 5.2 and 5.3). The 
inhibition was of competitive nature for all agents tested 
(Fig. 5.3). Further experiments indicated that the trans-
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o-o total uptake,crypt cella 
e -etotal uptake, upper villous cells 
a -o incorp. TCA pellet,~rypt cells 
11- llincorp. TCA pellet,uppervillous cella 
X···XAO 2G-1724[0.5mM] 
40 80 80 100 
Fig. 5.2 Initial rates of thymidine uptake (0-0, 0-8} and 
incorporation (o-o, •-•) by isolated upper villous cells 
and crypt cells as a function of the thymidine concentra-
~!o~7~nu~~:rm;~!u~;;~~c~~::i~~~hw~~~n~a~~~~~s~~~sf~~elm:!~ 
of three experiments (~ S.E.). 
port inhibition was the cause, and not the consequence, of 
the decreased rate of thymidine incorporation into DNA: 
similar inhibitory effects on transport were measured at 
0°, where the DNA synthesis is negligible. Moreover, in-
hibition could be reproduced in upper villous cells, where 
thymidine-phosphorylation is lacking {results not shown). 
The inhibition at 0°, found for all inhibitors tested, may 
also be taken as a strong argument against the involvement 
of intracellular cyclic AMP that did not increase signi-
ficantly under these conditions (not shown) . Therefore, a 
competitive inhibition of carrier-mediated transport of 
thymidine in the plasma membrane seemed the best explana-
tion for the effects of PGE1 , phosphodiesterase inhibitors 
and nucleosides on thymidine incorporation into crypt cell 
DNA in vitro. The inhibition of transport, and concomitant-
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Fig. 5.3 Lineweaver-Burk plots of the initial rate of 
carrier-mediated thymidine transport into isolated crypt 
cells as a function of the extracellular thymidine concen-
tration. Transport rates, calculated from the total amount 
of [3H]thyrnidine taken up by crypt cells during incubation 
for 1 min at 37° in a 95% 02/S% C02 atmosphere in the pre-
sence or absence of inhibitors were corrected for the con-
tribution of simple diffusion. 
ly of incorporation, could be overcome at high thymidine 
levels (compare Fig. 5.2) indicating that simple diffusion 
was unaffected by the compounds. 
In an alternative approach,cyclic AMP levels in the 
crypt region were elevated appr. two times by in vivo 
treatment of an intestinal segment with choleragen, and 
[ 3H]thyrnidine incorporation and cell migration in the seg-
ment were compared to an adjacent control segment. It 
follows from Figs. 5.4-5.6 that both parameters of cell 
proliferation did not appreciably differ in control and 
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Fig. 5.4 Incorporation of I3H]thyrnidine 
into PCA-insoluble material of control 
and CT-treated whole segments and crypt 
cells isolated from the segments. Mean 
values of three animals are given. 
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Fig. 5.5 Cell migration in duodenal rat 
epithelium at different time points after 
CT exposure. C=control, CT=choleragen seg-
ment. Ordinate: average distance of migra-
tion (arbitrary units + S.E.) of labelled 
cells (shaded). 
0 = crypt bottom 
100 = main villus length in control seg-
ments 1 h after [3H]thymidine pulse. 
Table 5.2 ADENYLATE CYCLASE ACTIVITIES IN TOTAL CRYPT 
CELLS AND ConA-SELECTED CRYPT CELLS FROM CONTROL 
AND CHOLERAGEN-TREATED SEGMENTS OF RAT DUODENUM 
Enzyme activities were measure 4 h after luminal admini-
stration of CT. n = number of experiments. 
Whole crypt population 
(n=4) 
ConA-selected crypt 
cells (n=2) 
Adenylate cyclase activity _ 1 (pmoles cyclic AMP X 10 min X 
mg-1 protein) 
Control segments Choleragen segment~ 
Basal Fluoride Basal Fluoride 
42 310 91 334 
48 330 64 339 
choleragen segments during a period of 35 h following ex-
posure to choleragen. In agreement with a supposed non-
toxic action of the choleragen in the epithelium, intesti-
nal morphology in experimental sections appeared to be per-
fectly normal. In sharp contrast to the findings in the 
rabbit 89 the mucus content of the goblet cells of the rat 
did not change during the whole period, including the acute 
phase of water-secretion {3-17 h) when the luminal fluid 
contained large amounts of mucus (Fig. 5.7) .Therefore 
glycoprotein synthesis must be stimulated to a similar 
extent as mucus release during experimental cholera in the 
rat. 
Finally, Fig. 5.8 illustrates the parallel changes of 
adenylate cyclase activities and net fluid movement found 
in the cholera segments. Both parameters returned to nor-
mal within 32 h. Because the total transit-time of the 
epithelial cells in control and cholera segments was appr. 
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Fig. 5.6 Autoradio~ra~hy in rat 
A and B: 1 h after L3Hjthymidine 
C and 0:32 h after [ 3H]thymidine 
A,C~ Control segment 
B,D: choleragen segment 
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Fig. 5.7 Histological appearance of duodenal epithelium 
after PAS staining. 
A control segment 
B = choleragen segment, 4 h after CT-administration. 
48 h, the short duration of the choleratoxin action was 
rather surprising in view of its long term effects on 
other cell types. A gradual desensitization of the intes-
tinal adenylate cyclase for the toxin, possible due to 
enzyme turnover, or a negligible stimulation of adenylate 
cyclase in the basal cell layers of the crypt during ex-
posure to choleragen would explain the results. The latter 
possibility could be verified by measuring adenylate 
cyclase activities in conA-selected crypt 
ting a subpopulation of the proliferative 
cells, represen-
189 
cell pool 
As shown in Table 5.2, the response of the enzyme in this 
cell type to the choleratoxin was indeed much lower than 
expected on the basis of its stimulatory effect on the 
total crypt population. 
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Fig. 5.8 Ratio of adenylate cyclase activities from upper 
villous cells in choleragen and control segments and net 
fluid transport in both segments. 
Fluid transport was measured according to Paper 4. Mean 
values of three experiments are given. 
5.5 Conclusions and discussion 
The strong inhibitory effects of dibu.tyryl-cyclic AMP, 
several phosphodiesterase inhibitors and PGE1 on the rates 
of thymidine incorporation into isolated crypt cells could 
be traced back to a competitive inhibition of thymidine 
transport at the plasma membrane level. Similar effects of 
theophylline, dibutyryl-cyclic AMP or prostaglandins on 
nucleoside transport have been reported earlier in serurn-
t . l t d b l. 205 f d s 1rnu a e mouse ern ryo ce Ls , virus-trans orrne mouse 
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fibroblast~ 5 Anct rat hepatoma cells 20 ~ In these reports a 
role of cyclic AMP in this inhibition is suggested or at 
least not excluded. Because changes in the cellular uptake 
of nutritients 
altered growth 
may belong to the 
155 
rates , transport 
earliest symptoms of 
inhibition might consti-
tute an important basis to explain growth regulation by 
cyclic nucleotides 1 : 1However, an involvement of cyclic AMP 
was not very likely in the epithelial cells, for a similar 
degree of transport inhibition was found at 37° and 0°, 
despite the absence of changes in cyclic AMP levels at 0°. 
The phenomenon is better explained by assuming a competi-
tion by the heterologous compounds for thymidine-binding 
sites in the plasma membrane or a non-specific interaction 
with the membrane structure which would be overcome by 
increasing the thymidine concentration. The high Ki ratios 
(10-150) indicate a much lower affinity of the ~ 
transport system for the inhibitors than for thymidine. The 
inhibitory effects on uridine incorporation were much less 
pronounced (Table 5.1). If this inhibition would also be 
based on a competitive inhibition of uridine transport 
(compare refs.204 and 205), the K.-values would largely 
l 
exceed the Ki for thymidine transport. RO 20-1723, a speci-
fic inhibitor of cyclic AMP-dependent phosphodiesterase196 
and structurally unrelated to the methylxanthines, also 
showed a high specificity toward the thymidine transport 
system for incorporation of uridine was not affected by 
this compound (Table 5.1). 
Another interesting feature of the thymidine trans-
port system in the intestine is the conservation of its 
full capacity during the whole lifetime of the epithelial 
cell, despite the complete loss of thymidine-phosphorylating 
activity in an early stage of development. In other cell 
types studied the maximal velocity of thymidine transport 
200 
appeared strongly dependent on growth rate 
The in vitro experiments learned that studies invol-
ving the use of labelled precursors to establish the 
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effects of phosphodiesterase inhibitors, prostaglandins or 
cyclic AMP analogs on metabolism or macromolecular syn-
thesis must be interpreted very carefully. By using cholera-
toxin for activation of the intestinal adenylate cyclase, 
inhibitory effects at the transport level, not related to 
cyclic AMP, may be excluded. Initially the use of cholera-
toxin to assess a possible relationship between cyclic AMP 
and crypt cell proliferation seemed justified by the obser-
vations that 3 h after luminal application of the cholera-
gen, toxin molecules were uniformly distributed along 
206 
crypts and villi in rabbit intestine while the adenylate 
cyclase activity in total crypt populations from rabbit 85 
and rat (Paper 4) was increased appr. twofold over the 
basal level. Therefore it was expected that choleragen-
affected cells at the bottom of the crypt would be exposed 
to increased intracellular levels of cyclic AMP for at 
least one generation time (10-14 h). This time, normally 
needed to pass the proliferation zone of the crypt, would 
be enough to detect an effect of cyclic AMP elevation on 
the cell cycle. 
However, in the experimental cholera model, no indica-
tion was found for a change in cell kinetics resulting from 
choleratoxin-treatment. This led to a reinvestigation of the 
extent of adenylate cyclase activation in the proliferating 
cell layers, permitted by the availability of a new isola-
tion technique (Table 5.2). Indeed, the response of this 
cell population in vivo appeared to be small as compared to 
the total crypt population isolated by the vibration tech-
nique. These preparations contain both proliferative and 
maturative cells and are contaminated to a variable degree 
with basal villous cells. Presumably the increase of adeny-
late cyclase activity is localized preferentially in the 
non-dividing cell types. The low sensitivity of the proli-
ferative cells for the toxin may find its crigin in a 
limited accessibility of the deeper crypt layers for lumi-
nal choleragen or a possible lack of ganglioside receptors 
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in the undeveloped luminal membranes; also in other tissues 
the responsiveness to growth inhibition and adenylate cy-
clase activation was governed by the availability of GM1 
receptors, and markedly reduced amounts of ganglioside GI,n, 
GM2 and GDia as well as UDP-GalNAc: GM3-N-acetylgalactos-
arninyltransferase activity (involved in glycolipid syn-
thesis) have been found in mouse and hamster cells after 
transformation19 '7 The first explanation seemed rather un-· 
likely in view of the uniform distribution pattern of the 
toxin examined in rabbit intestine. A direct proof of the 
second hypothesis by incubation of CcnA-selected crypt 
cells with choleragen followed by measurements of cyclic 
AMP levels or adenylate cyclase activity could not be 
eas1.1.:y given in view of the short survival time of crypt 
cells at 37° and the characteristic lag time of appr. 30 
min in cyclase activation. A direct determination of the 
number of ganglioside receptors in the proliferative cells 
using [ 125 rJ-labelled choleragen191 might elucidate the 
question. A proposed low sensitivity of the proliferating 
cells towards choleratoxin seems hard to reconcile with 
the threefold rise of adenylate cyclase activity in 
foetal rabbit intestine after in vitro exposure to cholera-
20 7 
gen This response was found in a period of active cell 
proliferation before the appearance of villi and microvilli. 
However, these enzyme determinations were done in stripped 
mucosa containing appr. one half the thickness of the mus-
cularis, raising the possibility that mainly the effect of 
toxin on the non-proliferative tissue was measured. This 
is even more likely in the light of an enhanced permeabili-
ty of foetal intestine for macromolecules as compared to 
the adult state. Therefore, a low response of foetal in-
testinal epithelium to choleragen due to a lack of recep-
tors for this toxin is not definitely excluded by this 
study. The short duration of the choleragen effects on the 
intestine (Fig. 5.8) may be totally explained by the in-
ability of choleragen to affect the proliferative cell pool. 
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If only the non-proliferative cells in crypt and villus 
should be affected by luminally administrated toxin, re-
covery from cholera was expected to be finished at appr. 
34-38 h, the time needed for the maturative crypt cells to 
reach the villous tip (compare Fig. 5.5). This corresponds 
reasonably well with the period of adenylate cyclase acti-
vation in the upper villous region and a diminished rate 
of fluid absorption (Fig. 5.8). The data shown in Fig. 
5.8 adds new evidence for an active role of the villous 
cells in cholera-induced secretion (Paper 3): a clearly 
diminished absorption rate could also be demonstrated in 
the period within 20-32 h, when the choleragen-affected 
population must be replaced by new unaffected cells (Fig. 
5.5). The recovery of cholera patients is reported to take 
appr. 3 days following the first administration of anti-
biotics20~ This period is also markedly less than the total 
cellular transit-time of human epitheli~m (appr. 5 days) 209 . 
Here the absence of net water secretion was used as a 
criterium for recovery. However, this situation appeared 
as soon as sufficient new cells have been formed to com-
pensate fluid secretion by the choleragen-contacted cells. 
A considerably longer time may be required for complete 
recovery of the whole cell population (compare Fig. 5.8) 
In summary, although the experimental cholera model 
failed to establish an effect of cyclic AMP on cell growth 
it ensured initially high levels of cyclic AMP in matura-
tive crypt and absorptive villous cells. These levels are 
sustained for a sufficiently long period to enable a study 
of the possible role of cyclic AMP in the intestinal dif-
ferentiation process in the intact animal. Interpretation 
of the results will be facilitated by the present demon-
stration of normal crypt cell kinetics during cholera. Pre-
liminary results of a similar study in vitro with cultured 
rabbit intestine have revealed a marked depression of the 
glycolytic enzyme pryuvate kinase and a twofold stimulation 
of the gluconeogenic enzyme fructose-1,6-diphosphatase 
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210 
after 6 h of exposure to choleragen It would be in-
teresting to see whether the same phenomenon occurs in 
vivo, particularly because both enzymes, extensively 
--h-- . d . . d' f l b 211,212 c aracter1ze 1n prev1ous stu 1es rom our a oratory , 
may play an important role in glycolytic regulation21 ~ 
66 
REFERENCES 
1. Hlilsmann, W.C., van den Berg, J.W.O. and de Jonge, H. 
R. (1974) Methods in Enzym. (ed. Fleischer, S. and 
Packer, L.) Academic Press, New York, Vol. XXXII, pp. 
665-673 
2. de Vries, H. and Kroon, A.M. (1974) in The Biogenesis 
of Mitochondria (ed. Kroon, A.M. and Saccone, C.) 
Academic Press, New York, pp. 357-365 
3. Kroon, A.M., Arendzen, A.J. and de Vries, H. (1974) 
in Ti1e Biogenesis of Mitochondria (ed. Kroon, A.M. 
and Saccone, C.) Academic Press, New York, pp. 395-
402 
4. Firkin, F.C. 
Res. Commun. 
5. Firkin, F.C. 
55, 68-76 
and 
32, 
and 
Linnane, 
398-402 
Linnane, 
A.W. (1968) Biochem. Biophys. 
A.W. (1969) Exp. Cell Res. 
6. de Vries, H. and Kroon, A.M. (1970) Biochim. Biophys. 
Acta 204, 531-541 
7. Iemhoff, W.G., van den Berg, J.W.O., de Pijper, A.M. 
and Hlilsmann, W.C. (1970) Biochim. Biophys. Acta 215, 
229-241 
8. Dickens, F. and Weil-Malherbe, H. (1941) Biochem. J. 
35, 7-15 
9. Wilson, T.H. (1956) J. Biol. Chern. 222, 751-763 
10. Lohman, K., Graetz, H. and Langen, P. (1966) in Cur-
rent Aspects of Biochemical Energetics (ed. Kaplan, 
N.O. and Kennedy, E.P.) Academic Press, New York, pp. 
I II -I 26 
II. i\l'enner,C.E. (1967) Adv. Enzymol. 29,321-390. 
12. Detheridge, J.F., Matthews, J. and Smyth, D.H. (1966) 
J. Physiol. 183, 369-377 
13. Lamers, J.M.J. and Hiilsmann, W.C. (1972) Biochim. 
Biophys. Acta 275, 491-495 
14. Pietra, P. and Cappelli. V. (1970) Experientia 26, 
514-515 
15. Frizzel, R.A., Markscheid-Kaspi, L. and Schultz, S.G. 
(1974) Am. J. Physiol. 226, 1142-1148 
16. Hersey, S.J. (1974) Biochim. Biophys. Acta 344, 157-
203 
17. Gijzel, W.P., Strating, M. and Kroon, A.M. (1972) 
Cell Differentiation 1, 191-198 
18. Hiilsmann, W.C., Iemhoff, W.G., van den Berg, J.W.O. 
and de Pijper, A.M. (1970) Biochim. Biophys. Acta 
215, 553-555 
19. Ferguson, S.M.F. and Williams, G.R. (1971) J, Biol. 
Chern. 241, 3696-3700 
20. Windmueller, H.G. and Spaeth, A.E. (1974) J. Biol. 
Chern. 249, 5070-5079 
21. de Pijper, A.M. and Hiilsmann, W.C. (1972) Histochemie 
33, 181-190 
22. Schatz, G, and Mason, T.L. (1974) Ann. Rev. Bioch. 43, 
5!-88 
67 
23. Hallman, M. (1971) Biochem. Pharmac. 20, 1797-1809 
24. Dale, E., Baxley, J.B. and Scatchfield, F.D. (1967) 
Experientia 24, 164-166 
25. Levi, A.J., Gatmaian, Z. and Arias, I.M. (1969) J. 
Clin. Invest. 48, 2156-2167 
26. Yeh, S.D.J. and Shils, M.E. (1966) Proc. Soc. Exp. 
Biol. Med. 123, 367-370 
27. Pik6, L. and Chase, D.G. (1973) J. Cell. Biol. 58, 
357-378 
2 8. 
29. 
30. 
3 I . 
3 2. 
33. 
34. 
35. 
36. 
3 7. 
3 8. 
39. 
40. 
41 . 
4 2. 
43. 
44. 
45. 
46. 
4 7. 
4 8. 
49. 
so. 
5 I 
68 
Oerter, D. and Bass, R. (1972) Naunyn-Schmiedeberg's 
Arch. Pharmacal. 272, 239-242 
Martelo, O.J., Manyan, D.R., Smith, U.S. and Yunis, 
A.A. (1969) J. Lab. Clin. Med. 74, 927-940 
Smith, U., Smith, D.S. and Yunis, A.A. (1970) J. Cell 
Sci. 7, 501-521 
Becker, D., Metz, J, and Katz, J. (1974) Postgraduate 
Med. J. 50, 88-94 
Ringrose, P.S. and Lambert, R.W. (1973) Biochim. 
Biophys. Acta 299, 374-384 
Hamberger, A. and Isaksson, 0. (1973) Exp. Cell Res. 
76, 207-217 
Brody, T.M., Hurwitz, R. and Bain, J.A. (1954) Anti-
biot. Chemother. 4, 864-870 
Franklin, T.J. (1963) Biochem. J. 87, 449-453 
Bottaner, E. and Vazques, D. (1971) Biochim. Biophys. 
Acta 254, 316-330 
Greenberger, N.J. (1967) Nature, Lond. 214, 702-703 
Ling, V. and Morin, C.L. (1971) Biochim. Biophys. 
Acta 249, 252-259 
Tacker, P.C. and Webster, P.D. (1972) Am. J. Dig. 
Diseases 17, 675-681 
Fuska, J., Podojil, M., Fuskova, A. and Van~k, z. 
(1974) Experientia 30, 403-404 
Mukherjee, D., Ghosh, R.N. and Mukherjee, S. (1971) 
J. Antibiotics 24, 263-265 
Guiti, N. and Abtahi, F. (1973) Chemotherapy 19, 65-
74 
Counis, R., Koumanov, K., Raulin, J. and Infante, R. 
(1973) Eur. J. Biochem. 37, 244-247 
Feldman, H.A. and Singel, I. (1974) J. Pharm. Exp. 
Ther. 190, 358-364 
Forsgren, A. and Gnarpe, H. (1973) Antimicrob. Ag. 
Chemother. 3, 711-715 
Gray, J.E., Weaver, R.N., Skinner, P., Mathews, J. 
Day, C.E. and Stern, K. (1974) Toxicol. and Appl. 
Pharmacal. 30, 317-332 
Shorter, R.G., Moertel, C.G., Titus, J.L. and Reite-
meiter (1964) Am. J. Dig. Diseases 9, 760-763 
Rall, T.W., Sutherland, E.W. and Berthet, J. (1957) 
J. Biol. Chern. 224, 463-475 
Rall, T.W. and Sutherland, E.W. (1958) J. Biol. Chern. 
232, 1065-1076 
Orloff, J. and Handler, J.S. (1962) J. Clin. Invest. 
41' 702-709 
Grantham, J.J. and Burg, M.B. (1966) Am. J. Physiol. 
21 I, 255-259 
52. Field, M., Plotkin, G.R. and Silen, W. (1968) Nature 
217' 469-471 
53. Schafer, D.E., Lust, W.D., Sircar, B. and Goldberg, 
N.D. (1970) Proc. Natl. Acad. Sci. USA 67, 851-856 
54. Banwell, J.G. and Sherr, H. (1973) Gastroenterology 
65, 467-497 
55. Field, M. (1974) Gastroenterology 66, 1063-1084 
56. Kimberg, D.V. (1974) Gastroenterology 67, !023-1064 
57. Holmes, R.K., Vasil, M.L. and Finkelstein, R.A. 
(1975) J. Clin. Invest. 55, 551-560 
58. Richardson, S.H. (1968) Biochim. Biophys. Acta ISO, 
572-577 
59. Leitch, G.J. (1972) Exp. and Mol. Path. 17, 187-197 
60. van Heyningen, W.E. (1973) Naunyn-Schmiedeberg's 
Arch. Pharmacal. 276, 289-295 
61. Holmgren, J., Lindholm, L. and LOnnroth, I, (1974) 
J. Exp. Hed. 139, 801-819 
62. Holmgren, J,, LOnnroth, I. and Svennerholm, L. (1973) 
Infect. Immun. 8, 208-214 
63. Bennet, V., O'Keefe, E. and Cuatre-::asas, P. (1975) 
Proc. Natl. Acad. Sci. USA 72, 33-37 
64. LOnnroth, I. and Holmgren, J. (1975) J, Gen. Micro-
bial., in press 
65. Cuatrecasas, P. (1973) Biochemistry 12, 3547-3581 
66. Bowman, C.M., Sidikaro, J, and Nomura, M. -(1971) 
Nature 234, 133-137 
67. de Graaf, F.K., Niekus, H.G.D. and Klootwijk, J, 
(1973) FEBS Lett. 35, 161-165 
68. Gill, D.M., Pappenheimer, A.M. and Uchida, T. (1973) 
Fed. Proc. 32, 1508-1515 
69. Edidin, M. (1974) Ann. Rev. Biophys. Bioeng. 3, 179-
20 1 
70. and Cuatrecasas, P. (1975) J. Membrane 
press 
7 1 • 
Bennet, V. 
Biol., in 
Field, M. 
3303 
(1974) Proc. Natl. Acad. Sci. USA 71, 3299-
72. Rodbell, M., Birnbaumer, L., Pohl, S.L. and Kraus, 
H.M.J. (1971) J, Bioi. Chern. 246, 1877-1882 
73. Johnson, M. and Ramwell, P.W. (1973) Prostaglandins 
3' 703-719 
74. Ferard, G., Sall, I. and Metais, P. (1975) Enzyme 19, 
38-47 
75. Parkinson, D.K., Ebel, H., Dibona, D.R. and Sharp, 
G.W.G. (1972) J. Clin. Invest. 51, 2292-2298 
76. Hirschhorn, N. and Rosenberg, I. (1968) J. Lab. Clin. 
Med. 72, 28-39 
77. Walton, K.G. LeLorenzo, R.J., Curran, P.F. and Green-
gard, P. (1975) J. Gen. Physiol. 65, 153-177 
78. Schwarz, I.V., Shlatz, L.J-., Kinne-Safran, E. and 
Kinne, R. (1974) Proc. Natl. Acad. Sci. USA 71, 
2592-2599 
79. Lucid, S.W. and Cox, A.C. (1972) Biochem. Biophys. 
Res. Commun. 49, 1183-1186 
69 
80. Kimberg, D.V., Field, H., Gershan, E., Schooley, R.T. 
and Henderson, A. (1973) J. Clin. Invest. 52, 1376-
1383 
81. Powell, D.H., Farris, R.K. and Carbonetto, S.T. (1974) 
Am. J. Physiol. 227, 1428-1435 
82. Powell, D.W. (1974) Am. J. Physiol. 227, 1436-1443 
83. Frizzel, R.A., Nellans, R.N., Rose, R.C., Harkscheid-
Kapsi, L. and Schultz, S.G. (1973) Am. J. Physiol. 
224, 328-337 
84. Nellans, R.N., Frizzel, R.A. and Schultz, S.G. (1973) 
Am. J. Physiol. 225, 467-475 
85. Schwartz, C.J., Kimberg, D.V. and Ware, P. (1975) 
Gastroenterology 68, 94-104 
86. Yardley, J.H., Bayless, T.H., Luebbers, E.H., Halsted, 
C.H. and Hendrix, T.R. (1972) Hopkins Med. J. 131, J-
10 
87. Forstner, G., Shih, M. and Lukie, B. (1973) Can. J. 
Physiol. Pharmacol. 51, 122-129 
88. Field, M. and McColl, I. (1973) Am. J. Physiol. 225, 
852-857 
89. Steinberg, S.E., Banwell, J.G., Yardley, .J.H., Keusch, 
G.T. and Hendrix, T.R.(1975) Gastroenterology 68, 
309--3 I 7 
90. Mc.Donel, J.L. (1974) Infection and Immunity 10, 1156-
1 162 
91. Flores, J., Grady, G.F., Mciver, J., Witkum, P., 
Beckman, B. and Sharp, G.W.G. (1974) J. Infect. Dis. 
130, 374-379 
92. Schwartz, C.J., Kimberg, D.V., Sheerin, H.E., Field, 
M. and Said, S.I. (1974) J. Clin. Invest. 54, 536-544 
93. Klaeveman, H.L., Conlon, T.P., Levy, A. G., Gardner, 
J.D. (1975) Gastroenterology 68, 667-675 
94. Tidball, C.S. (1961) Am. J. Physiol. 200, 309-312 
95. Bolton, J.E., Munday, K.A. and Parsons, B.J. (1974) 
J. Physiol. (Lond.) 27P 
96. Soergel, K.H., Whalen, G.E., Harris, J.A. and Greenen, 
J.E. (1968) J. Clin. Invest. 47, 1071-1082 
97. Kimberg, D.V., Field, M., Johnson, J., Henderson, A. 
and Gershon, E. (1971) J. Clin. Invest. 50, 1218-1230 
98. Ammon, H.V. and Philips, S.F. (1974) J, Clin. Invest. 
53, 205-210 
99. Ammon, H.V., Thomas, P.J. and Philips, S.F. (1974) J. 
Clin. Invest. 53, 374-379 
100. Gaginella, T., Bass, P., Olsen, W. and Shug, A. (1975) 
FEBS Lett. 53, 347-350 
101. Binder, H.J., Filburn, C., Volpe, B.T. (1975) Gastro-
enterology 68, 503-508 
102. Conley, D.R., Coyne, M.J., Chung, A., Bonorris, G.G. 
and Schoenfield, L.J. (1975) Abstr. Gastroenterology 
68, 877 
103. Wald, A. and Bayless, T.M. (1975) Abstr. Gastro-
enterology 68, 1008 
104. Powell, D.W. and Farris, R.K. (1975) Abstr. Gastro-
enterology 68, 968 
70 
105. Kerzner, B., Mc.Clung, J,, Kelly, M. and Butler, D. 
(1975) Abstr. Gastroenterology 68, 909 
106. Birnbaumer, L. and Yang, P.C. (1974) J. Biol. Chern. 
24, 7867-7873 
107. Anderson, J.H. and Jones, A.L. (1974) Proc. Soc. Exp. 
Biol. Med. 145, 268-272 
108. Lamers, J.M.J., Kurpershoek-Davidov, R. and Hi.i.lsmann, 
H.C. (1974) Biochim. Biophys. Acta 343, 427-430 
109. Gangl, A. and Ockner, R.K. (1975) Gastroenterology 
68, 167-186 
110. Asllman, D.F., Lipton, R., Melicow, M.M. and Price, 
T.D. (1963) Biochem. Biophys. Res. Commun. 11, 330-
334 
Ill. Goldberg, N.D., O'Dea, R.F. and Haddox, H.K. (1973) 
in Advances in Cyclic Nucleotide Research (ed. Green-
gard, P. and Robison, G.A.) Raven Press, New York, 
Vol. 3, pp. 155-222 
112. Tee-Ping Lee, Kuo, J .F. and Greengard, P. (1972) Pro c. 
Natl. Acad. Sci. USA 69, 3287-3291 
113. Illiano, G., Tell, G.P.E., Siegel, N.I. and Cuatre-
casas, P. (1973) Proc. Natl. Acad. Sci. USA 70, 2443-
2447 
114. Dunham, E.W., Haddox, M.K. and Goldberg, N.D. (1974) 
Proc. Natl. Acad. Sci. USA 71, 815-819 
115. Kuehl, F.A., Ham, E.A., Zanetti, M.E., Sanford, C.H. 
Nicol, S.E. and Goldberg, N.D. (1974) Proc. Natl. 
Acad. Sci. USA 71, 1866-1870 
116. Hadden, J.W., Hadden, E.M., Haddox, M.K. and Goldberg, 
N.D. (1972) Proc. Natl. Acad. Sci. USA 69, 3024-3027 
117. Rudland, P.S., Gospodarowicz, D. and Seifert, 1\f, 
(1974) Nature 250, 741-742, 773 
118. Smith, R.J. and Ignarro, L.J. (1975) Proc. Natl. Acad. 
Sci. USA 72, 108-112 
119. Sandler, J.A., Clyman, R.I., Hanganiello, V.C. and 
Vaughan, H. (1975) J. Clin. Invest. 55, 431-435 
120. Chiang, T.M.H. and Kang, A.H. (1975) Abstr. Fed. Proc. 
34' 6 9 5 
121. Chrisman, T.D., Garbers, D.L., Parks, M.A. and Hard-
man, J.G. (1975) J. Biol. Chern. 250, 374-381 
122. Murad, F. and Kimura, X. (1975) Abstr. Fed. Proc. 34, 
232 
123. Garbers, D.L., Hardman, J.G. and Rudolph, F.B. (1974) 
Biochemistry 13, 4166-4171 
124. Helwig, J.J., Bollack, C., Mandel, P. and Goridis, C. 
(1975) Biochim. Biophys. Acta 377, 463-473 
125. B0hme, E., Jang, R. and Meckler, I. (1974) in Methods 
in Enzym. (ed. Hardman, J.G. and O'Malley, B.W.) 
Academic Press, New York, Vol. XXXVIII, pp. 199-202 
126. Kimura, H. and Murad, F. (1974) J. Biol. Chern. 249, 
6910-6916 
127. Gray, J.P. and Drummond, G.I. (1973) Proc. Can. Fed. 
Biol. Soc. 16, 79 
71 
128. Siegel, M.I., Fuca, G.A. and Cuatrecasas, P. (1975) 
Abstr. Fed. Proc. 34, 232 
129. Bensinger, R.E., Fletcher, R.T. and Chader, G.J. 
(1974) Science 183, 86-87 
130. Cuatrecasas, P. (1974) Ann. Rev. Bioch. 43, 169-214 
131. Limbird, L.E. and Lefkowitz, R.J. (1975) Biochim. 
Biophys. Acta 377, 186-196 
132. Thompson, W.J., Williams, R.H. and Little, S.A. 
(1973) Biochim. Biophys. Acta 302, 329-337 
133. Amer, M.S. and McKinney, G. (1973) The Pharmacologist 
1 5, 1 57 
134. White, L.E., Ignarro, L.H. and George, W.J. (1973) 
The Pharmacologist 15, 157 
135. Schultz, G., Hardman, J.G., Schultz, K., Davis, J.W. 
and Sutherland, E.W. (1973) Proc. Natl. Acad. Sci. 
USA 70, 1721-1725 
136. Van Sande, J., Decoster, C. and Dumont, J.E. (1975) 
Biochem. Biophys. Res. Commun. 62, 168-175 
137. Ferrendelli, J.A., Rubin, E.H. and Kinscherf, D.A. 
(1975) Abstr. Fed. Proc. 34, 231 
138. Birnbaumer, L., Pohl, S.L., Rodbell, M. (1972) J. 
Biol. Chern. 247, 2038-2043 
139. Ishikawa, E., Ishikawa, S., Davis, J.W. and Suther-
land, E.W. (1969) J. Biol. Chern. 244, 6371-6376 
140. Corbett, C.L., Isaacs, P.E.T., Rilet, A. and Turn-
berg, L.A. (1975) Abstr. 9th Meet. Eur. Soc. Clin. 
Invest. 14 
141. Fawaz, E.N. and Tejirian, A. (1972) Hoppe-Seyler's 
Z. Physiol. Chern. 353, 1779-1783 
142. Hardman, J.G. and Sutherland, E.W. (1969) J. Biol. 
Chern. 244, 6363-6370 
143. Tilney, L.G. and Mooseker, M. (1971) Proc. Natl. Acad. 
Sci. USA 68, 2611-2615 
144. Thuneberg, L. and Rostgaard, J. (1969) Abst. Commun. 
6th Meet. Fed. Eur. Biochem. Soc. 864 
145. Rasmussen, H. (1970) Science 170, 404-412 
146. Willingham, M.C. and Pastan, I. (1975) Proc. Natl. 
Acad. Sci. USA 72, 1263-1267 
147. Kim, G. and Silverstein, E. (1975) Abstr. Fed. Proc. 
34, 231 
148. Lamers, J.M.J. and H~lsmann, W.C. (1975) Biochim. 
Biophys. Acta 376, 561-572 
149. Seifert, W. and Rudland, P.S.(1974) Proc. Natl. Acad. 
Sci. USA 71, 4920-4924 
150. Watson, J. (1975) J. Exp. Med. 141, 97-111 
151. Kram, R., Mamont, P. and Tomkins, G.M. (1973) Proc. 
Natl. Acad. Sci. USA 70, 1432-1436 
152. Otten, J., Johnson, G.S. and Pastan, I. (1971) 
Biochem. Biophys. Res. Commun. 44, 1192-1198 
153. Sheppard, J.R. (1972) Nature (New Biol.) 236, 14-16 
154. Hecht, S.M., Faulkner, R.D. and Hawrelak, S.D. (1974) 
Proc. Natl. Acad. Sci. USA 71, 4670-4674 
72 
ISS. Ryan, W.L. and Heidrick, H.L. (1974) in Advances in 
Cyclic Nucleotide Research (ed. Greengard, P. and 
Robison, G.A.) Raven Press, New York, Vol. 4, pp. 81-
1 16 
!S6. Voorhees, J.J., Duell, E.A., Stawiski, M. and Harrell, 
E.R. (1974) ibidem, pp. 117-162 
157. Coffino, P., Gray, J.W. and Tomkins, G.M. (197S) Proc. 
Natl. Acad. Sci. USA 72, 878-882 
IS8. Froehlich, J.E. and Rachmeler, M. (1972) J. Cell Biol. 
55, 19-31 
159. Pawelek, J., Sansone, M., Koch, N., Christie, G., 
Halaban, R., Hendee, J., Lerner, A.B. and Varga, J.M. 
(1975) Proc. Natl. Acad. Sci. USA 72, 95!-955 
160. Luckasen, J.R., White, J.G. and Kersey, J.H. (1974) 
Proc. Natl. Acad. Sci. USA 71, S088-5090 
161. van Wijk, R., Wicks, W.D., Bevers, M.M. and van Rijn, 
J. (1973) Cancer Res. 33, 1331-!338 
162. Wicks, W.D. (1974) in Advances in Cyclic Nucleotide 
Research (ed. Greengard, P. and Robison, G.A.) Raven 
Press, New York, Vol. 4, pp. 335-438 
163. Pastan, I. and Perlman, R.L. (1970) Science 169, 339-
344 
!64. Williams, J.P.G. (1972) Cell Differentiation I, 317-
323 
165. Henney, C.S., Lichtenstein, L.M., Gillespie, I. and 
Rolley, R.I. (1973) J, Clin. Invest. 52, 2853-2857 
166. Plescia, O.J., Yamamoto, I. and Shimamura, T. (1975) 
Pro c . Nat 1 . Ac ad . S c i , US A 7 2 , 8 8 8- 8 9 I 
167. DeRubertis, F.R., Zenser, T.V., Adler, W.H. and 
Hudson, T. (1974) J. Immun. 113, 151-161 
168. Sultzer, B.M. and Craig, J.P. (1973) Nature (New Biol.) 
244, 178-180 
169. Kateley, J.R. and Friedman, H. (1975) Ann. N.Y. Acad. 
Sci. 249, 413-423 
170. Pratt, R.M. and Martin, G.R. (1975) Proc. Natl. Acad. 
Sci. USA 72, 874-877 
171. Cho-Chung, Y.S. and Gullino, P.M. (1973) Science 183, 
87-88 
172. MacManus, J.P. and Whitfield, J.F. (1974) Prostaglan-
dins 6, 475-487 
173. MacManus, J.P. and Whitfield, J.F. (1969) Exp. Cell 
Res. 58, 188-191 
174. Guidotti, A., Weiss, B. and Costa, E. (1972) Mol. 
Pharmacal. 8, 521-530 
175. Thomas, E.W.,Murad, F. and Looney, W.B. (1973) 
Biochim. Biophys. Acta 297, 564-567 
176. Minton, J.P., Wisenbaugh, T. and Matthews, R.H. (1974) 
J, Nat. Cane. Inst. 53, 283-284 
177. Durham, J.P., Baserga, R. and Butcher, F.R. (1974) 
Biochim. Biophys. Acta 372, 196-217 
178. Galjaard, H. and Bootsma, D. (1969) Exp. Cell Res. 58, 
79-9'2 
73 
179. Loran, M.R. and Carbone, J.V. (1966) in Gastrointes-
tinal Radiation Injury (ed. Sullivan, M.F.) Excerpta 
Medica Foundation, pp. 127-139 
180. Raicht, R.F., Deschner, E. and Salen, G. (1975) Abstr. 
Gastroenterology 68, 979 
181. Tutton, P.J.M. (1974) Virchows Arch. B Cell Path. 16, 
79-87 
182. Tutton, P.J.M. and Helme, R.D. (1974) Cell Tissue 
Kinet. 7, 125-136 
183. Johnson, L.R. (1975) Abstr. Gastroenterology 68, 920 
184. Cairnie, A.B. and Bentley, R.E. (1967) Exp. Cell Res. 
46, 428-440 
185. Brown, H.O., Levine, H. and Lipkin, H. (1963) Am. J. 
Physiol. 205, 868-872 
186. Jervis, E.L. and Levin, R.J. (1966) Nature 210, 391-
393 
187. Khovry, K.A., Floch, H.H. and Hersh, T. (1969) J, Exp. 
Med. 130, 659-665 
188. Wright, N., Watson, A., Morley, A., Appleton, D., 
Earks, J. and Douglas, A. (1974) Virchows Arch. A 
Path. Anat. and Histol. 364, 311-323 
189. Podolsky. D.K. and Weiser, M.H. (1973) J, Cell Biol. 
58, 497-500 
190. Etzler, M.E. and Branstrator, M.L. (1974) J. Cell. 
Biol. 62, 329-343 
191. Hollenberg, H.D. and Cuatrecasas, P. (1973) Proc. 
Natl. Acad. Sci. USA 70, 2964-2968 
192. Hollenberg, M.D., Fishman, P.R., Bennet, V. and 
Cuatrecasa, P. (1974) Proc. Natl. Acad. Sci. USA 71, 
4224-4228 
193. O'Keefe, E. and Cuatrecasas, P. (1974) Proc. Natl. 
Acad. Sci. USA 71, 2500-2504 
194. Baker, A., Kaplan, M. and Kimberg, D.V. (1973) J. 
Clin. Invest. 52, 2928-2930 
195. Guerrant, R.L., Chen, L.C. and Sharp, G.W.G. (1972) 
J. Infect. Dis. 125, 377-381 
196. Pasternak, T. (1974) Ann. Rev. Pharmacal. 14, 23-33 
197. Clark, R.B., Gross, R., Su, Y.F. and Perkins, J.P. 
(1974) J. Biol. Chern. 249, 5296-5303 
198. Blume, A.J., Dalton, C. and Sheppard, H. (1973) Proc. 
Natl. Acad. Sci. USA 70, 3099-3102 
199. Salser, J.S. and Balis, H.E. (1973) Cancer Res. 33, 
1889-1897 
200. Cunningham, D.D. and Remo, R.A. (1973) J. Biol. Chern. 
248, 6282-6288 
201. Plagernann, P.G.W. and Erbe, J. (1972) J. Cell Biol. 
55, 161-178 
202. Siegers, M.P., Schaer, J.C. Hirsiger, H. and Schindler, 
R. (1974) J. Cell Biol. 62, 305-315 
203. Rozengurt, E. and de Asua, L.J. (1973) Proc. Natl. 
Acad. Sci. USA 70, 3609-3612 
204. Plagemann, P.G.W. and Sheppard, J.R. (1974) Biochem. 
Biophys. Res. Commun. 56, 86 9-8 7 5 
74 
205. Plagemann, P.G.W. (1971) Biochim. Biophys. Acta 233, 
688-701 
206. Peterson, J.W., Lo-Spalluto, J.J., Finkelstein, R.A. 
(1972) J. Infect. Dis. 126, 617-628 
207. Grand, R.J., Torti, F.M. and Jaksina, S. (1973) J. 
Clin. Invest. 52, 2053-2059 
208. Francis, T.I., Lewis, E.A., Oyediran, A.B.O.O. et al. 
(1971) J. Trop. Med. Hyg. 74, 172-176 
209. HacDonald, w.c., Trier, J.S. and Everett, N.B. (1965) 
Gastroenterology 46, 405-417 
210. Sherr, H.R., Stifel, F.B. and Herman, R.H. (1975) 
Abstr. Gastroenterology 68, 984 
211. van Berkel, Th.J.C., de Jonge, H.R., Koster, J.F. and 
Hlllsmann, W.C. (1974) Biochem. Biophys. Res. Commun. 
60. 39 8-405 
212. van Tal, A. (1974) Hoppe-Seyler's z. Physiol. Chern. 
355, 1261-1262. 
75 
SUMMARY 
The first part of this thesis (Chapter II, Papers 1 
and 2) describes the consequences of a prolonged treatment 
of rats with inhibitors of mitochondrial protein synthesis 
(chloramphenicol and oxytetracycline) for mitochondrial 
biogenesis and function in the small intestinal epithelium. 
This tissue is extremely sensitive to the action of these 
antibiotics due to its unequalled high cellular turnover 
rate, implying a rapid formation of intestinal mitochon-
dria. At serum levels of both antibiotics above 10 ~g/ml 
the content of the cytochrornes aa3 , b and c 1 in villous 
and cry?t cells decreased to about 25-35 per cent of the 
control value within two days. The activity of numerous 
other mitochondrial enzymes did not change in this period. 
It is concluded that these proteins are made on cyto-
plasmic ribosomes prior to their integration into the 
mitochondrial structure. These processes are apparently 
not disturbed by a partial loss of mitochondrial trans-
lation products. Also the energy stores in the epithelium 
in vivo and the rate of oxidative phosphorylation in 
isolated mitochondria appeared to be unaffected, indica-
ting an intact mitochondrial energetic function. 
Prolonged treatment with oxytetracycline (but not 
with chloramphenicol) caused a severe structural damage of 
the villous epithelium and accumulation of lipid droplets 
in the liver ("fatty liver"). The crypt cell proliferation 
rate was not appreciably affected, suggesting again the 
preservation of a normal energy metabolism in this cell 
type. Because chloramphenicol, producing a similar degree 
of cytochrome depletion, was non-toxic under similar con-
ditions, the toxicity of oxytetracycline in intestine and 
liver was ascribed to side effects on other cellular pro-
cesses, arising after drug accumulation in blood and tis-
sues. An investigation of several other potential targets 
for tetracyclines in the cell (not affected by chloram-
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phenicol) suggested that a partial inhibition of cytoplas-
mic protein synthesis was responsible for most of the 
toxic effects. Although the degree of inhibition caused by 
oxytetracycline during short incubations of isolated epi-
thelial cells appeared to be small, a gradual accumulation 
of the antibiotic in the microsomes or formation of highly 
active degradation products might have amplified its 
action in vivo. 
During prolonged clinical application serum levels of 
the antibiotics seldom raise above 20 ~g/ml, allowing 
little chance for toxic side-effects. On the basis of the 
present study a decrease of the level of some mitochondrial 
cytochromes in the intestinal mucosa of patients subjected 
to antibiotic therapy may be expected, although this change 
will probably occur much more slowly than in rat intestine 
in view of the considerably lower dividing activity of 
human crypt cells. However, the reversibility of the anti-
biotic action and the apparent excess of mitochondrial 
cytochromes in mammalian intestine will guarantee the pre-
servation of a normal mitochondrial function under nearly 
all circumstances, even in this rapidly proliferating and 
differentiating tissue. 
Chapter IIL(Papers 3 and 4) is devoted to a study of 
the adenylate cyclase system and cyclic AMP levels in iso-
lated villous and crypt cells from rat small intestine. 
The major part of the adenylate cyclase activity appeared 
to be localized in the basal-lateral plasmamembranes of 
the enterocyte. The enzyme of both villous and crypt cells 
was stimulated by NaF, PGE 1 and high levels of epine-
phrine but did not respond to a number of other hormones, 
reported to affect the transport function of the epithelium 
in vivo. A similar hormone-insensitivity was observed in 
measurements of intracellular cyclic AMP levels. The 
stimulation by epinephrine was interpreted as a a-adrener-
gic effect on the mucus-secreting goblet cells. Prolonged 
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luminal contact of the epithelium in vivo to purified 
choleratoxin led to an irreversible activation of adenylate 
cyclase in villous and crypt compartments. Short exposure 
(1-2 min) to choleragen was followed by a maximal activa-
tion of this enzyme exclusively in the upper villus and 
not in the crypt. By comparing the effects of short and 
prolonged contact with choleratoxin on the unidirectional 
and net fluxes of ions and water in vivo, it could be 
established that both villous and crypt cells contribute 
to the choleragen-induced secretion. Choleragen stimulated 
+ - -the serosal to mucosal fluxes of Na , Cl and HC0 3 with-
out impairing the opposite flux. These results imply that 
absorptive and secretory processes may occur within the 
same epithelial compartment and conflict with the view 
that fluid secretion is a specific function of the crypt. 
The cholera studies clearly showed that even a slight 
increase of cyclic AMP levels in the intestinal mucosa 
leads to a drastic reduction of its absorptive capacity 
for water and electrolytes. The apparent insensitivity of 
the adenylate cyclase system in the enterocyte to hormones 
{e.g. insulin, glucagon, catecholamines) is interpreted as 
a protection of the absorptive function against large 
fluctuations of hormones levels under physiological con-
ditions. 
Chapter IV (Papers 5 and 6) deals with some aspects 
of cyclic GMP formation and regulation in the enterocyte. 
Appr. 65-75 per cent of the total guanylate cyclase acti-
vity in the villous cell was found in the brushborder 
region, the other part was mainly localized in the basal-
lateral plasma membranes. Crypt cell activities were much 
lower, probably due to the immature state of their luminal 
membranes. Whereas the kinetic properties of the brush-
border enzyme were comparable to those of the particulate 
form of guanylate cyclase in rat heart and lung, the 
kinetics of the enzyme in the anti-luminal membranes 
showed more resemblance to the soluble form in other 
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tissues. Both types of guanylate cyclase were completely 
insensitive in vitro to a great number of hormones, neuro-
transmitters, prostaglandins and plant lectins but could 
be inhibited to an appreciable extent by physiological 
concentrations of ATP and ADP. L-arninoacids had a small 
stimulatory effect. 
The levels of cyclic GMP in isolated villous and 
crypt cells were appr. 4-6 times lower than the cyclic 
AMP levels and decreased slightly from crypt to villus. 
Because the guanylate cyclase activity strongly increased 
in the same direction, it is suggested that cyclic GMP-
degrading enzymes {phosphodiesterases) may play an impor-
tant role in the physiological regulation of cyclic GMP 
levels. Also the cyclic GMP concentration could not be 
changed by incubation with hormones, hormone-like agents 
or the divalent cation-ionophore A-23187. Possible reasons 
for this insensitivity are discussed. It is concluded that 
the function of cyclic GMP in the intestinal epithelium is 
difficult to assess because of a lack of suitable and 
specific agents that could regulate its intracellular con-
centration. The preponderance of guanylate cyclase in the 
brushborder is suggestive for a relationship between cyclic 
GMP and transport processes. The existence of pulsating 
movements of the microvilli and the high activity of guany-
late cyclase in some other organs with a contractile func-
tion {e.g. flagellae from sea urchin sperm) lend some sup-
port to the hypothesis that cyclic GMP plays a role in the 
assembly or action of intestinal microfilarnents. 
In Chapter V the relationship between cyclic AMP and 
crypt cell proliferation was investigated. Isolated crypt 
cells were used to measure direct effects of cyclic AMP 
on thymidine incorporation rates. All agents capable to 
elevate intracellular cyclic AMP levels {PGE 1 , dibutyryl-
cyclic· AMP, phosphodiesterase inhibitors) caused a profound 
inhibition of this incorporation process. By measurements 
of thymidine transport rates in isolated villous and crypt 
79 
cells, using the silicon oil filtration technique, the 
effects on incorporation could be traced back to a direct 
competitive inhibition of thymidine transport at the plas-
ma membrane level not related to a change in cyclic AMP-
content. This result warns against thymidine incorporation 
measurements as a tool to investigate a relationship be-
tween cyclic AMP and rates of DNA synthesis. 
In an alternative approach, cyclic AMP levels in 
crypt and villous cells were elevated by pretreatment of 
short segments of rat small intestine with choleragen to 
explore the influence of the cholera-state on cell proli-
feration and migration in vivo. It was found that cholera-
toxin treatment did not lead to a retardation or accelera-
tion of epithelial cell turnover and had no influence on 
cell morphology at the light-microscopal level. This 
result could not be used to deny a possible role of cyclic 
AMP in intestinal cell proliferation because application of 
a new selection technique for the proliferative cell types 
in the crypt showed that the cyclic AMP levels in these 
cells did not change during cholera. Although the experi-
mental cholera model failed to establish an effect of cy-
clic AMP on cell growth, it ensured high levels of cyclic 
AMP in maturative crypt and absorptive villous cells for a 
sufficiently long period to enable a future study of the 
possible role of cyclic AMP in intestinal differentiation 
processes in the intact animal. 
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SAMENVATTING 
In het eerste deel van dit proefschrift (Hoofdstuk 
II, Publicaties 1 en 2) worden de gevolgen beschreven van 
een langdurige behandeling van ratten met remmers van de 
mitochondriele eiwitsynthese (chlooramphenicol en oxyte-
tracycline) voor de biogenese en functie van de rnitochon-
drien in het dunnedarrn epitheel. Dit weefsel is buitenge-
woon gevoelig voor deze antibiotica wegens de hoge proli-
feratiesnelheid van de stamcellen in de crypt, die gepaard 
gaat met een snelle vorming van darrncel rnitochondrien. Bij 
plasma concentraties van beide antibiotica tussen 10 en 
30 ~g/ml narn het gehalte aan cytochroorn aa3 , b en c 1 in 
de villus en crypt cellen binnen twee dagen af tot onge-
veer 25-35 procent van de normale waarde. Activiteitsver-
anderingen van andere mitochondriele enzymen werden niet 
waargenornen. Hieruit volgt dat deze eiwitten op ribosomen 
in het cytoplasrna worden vervaardigd v66r hun integratie 
in de mitochondriele structuur. Beide processen worden 
blijkbaar niet gestoord door een gedeeltelijk verlies van 
mitochondriele translatieprodukten. Oak het gehalte aan 
energierijke verbindingen in het epitheel in vivo was on-
veranderd, evenals het proces van de oxydatieve fosfory-
lering in gelsoleerde rnitochondrien, hetgeen duidt op een 
intact gebleven energielevering door deze organellen. 
Een langdurige behandeling met oxytetracycline (maar 
niet met chloorarnphenicol) veroorzaakte een ernstige 
structurele beschadiging van het villus epitheel en de op-
hoping van vet in de lever. De delingssnelheid van de 
cryptcellen was vrijwel onveranderd, hetgeen opnieuw 
wijst op een ongestoorde energiehuishouding in dit eel-
type. De chloorarnphenicol behandeling leidde niet tot 
toxische effecten op het epitheel hoewel het cytochroorn 
niveau in dezelfde mate was verlaagd. De toxiciteit van 
oxytetracycline in darrn en lever werd daarorn toegeschre-
ven aan neveneffecten op andere cellulaire processen die 
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kunnen optreden na ophoping van dit antibioticurn in bloed 
en weefsels. Een nader onderzoek van verscheidene andere 
potenti8le aangrijpingspunten van de tetracyclines in de 
eel (niet gestoord door chloorarnphenicol) leidde tot de 
suggestie dat een partiele rernrning van de cytoplasrnatische 
eiwitsynthese verantwoordelijk was voor de rneeste toxische 
effecten. 
Hoewel de door oxytetracyline veroorzaakte rernrning tijdens 
kortstondige incubaties van gelsoleerde darrncellen slechts 
gering was, zou een geleidelijke ophoping van het antibio-
ticurn in de rnicrosornen van de eel of de vorming van zeer 
toxische afbraakprodukten deze remrning in vivo kunnen ver-
sterken. 
In de klinische situatie zullen serumconcentraties van de 
antibiotica zelden boven de 20 ~g/ml uitstijgen, zodat 
ontplooiing van de besproken neveneffecten weinig waar-
schijnlijk is. Op basis van deze studie kan verwacht wor-
den dat het niveau van enkele mitochondriele cytochrornen 
in de darmmucosa van patienten die een antibioticurnkuur 
ondergaan zal dalen hoewel dit proces veel langzarner zal 
verlopen dan in de rat wegens de aanzienlijk lagere de-
lingscapaciteit van menselijke crypt cellen. De reversibi-
liteit van de rernming door deze antibiotica en de klaar-
blijkelijke overmaat aan cytochrornen in darrnmitochondrien 
van zoogdieren zal echter onder vrijwel alle ornstandigheden 
een normaal functioneren van de rnitochondrien garanderen 
zelfs in dit sneldelende en differentierende weefsel. 
Hoofdstuk III(Publicaties 3 en 4) is gewijd aan een 
studie van het adenylcyclase systeern en de cyclisch AMP 
niveau's in gelsoleerde villus en crypt cellen van de 
dunnedarm van de rat. Een aanzienlijk deel van de adenyl 
cyclase activiteit kon worden gelocaliseerd in de baso-
laterale plasmarnernbranen van de enterocyt. Zowel het villus 
als het crypt enzyrn werd gestirnuleerd door fluoride, pros-
taglandine E1 en hoge concentraties epinephrine, maar re-
ageerde niet op een aantal andere horrnonen, waarvan bekend 
82 
is dat zij de transport functie van het epitheel in vivo 
beinvloeden. Dezelfde hormoonongevoeligheid werd gevonden 
voor de intracellulaire cyclisch AMP niveau's. De stimu-
lering door epinephrine werd geinterpreteerd als een s-
adrenergisch effect op de slijmbekercellen. Een langdurig 
luminaal contact van het epitheel met gezuiverd cholera-
toxine in vivo veroorzaakte een irreversibele activering 
van het adenylcyclase in villus en crypt. Door een kort-
stondige expositie (1-2 min) kon het adenylcyclase in de 
bovenste helft van het villus epitheel maximaal gestimu-
leerd worden, terwijl het crypt enzym zijn basale activi-
teit behield. Door de effecten van kort- en langdurig 
contact met het choleratoxine op de eenrichtings- en 
netto flux van ionen en water in vivo te vergelijken, kon 
worden vastgesteld dat zowel crypt als villus cellen bij-
dragen tot de door choleratoxine-geinduceerde secretie. 
Choleratoxine stimuleerde de flux van Na , Cl en HC0 3 
van serosa naar mucosa zonder de flux in orngekeerde rich-
ting te beinvloeden. Hieruit werd geconcludeerd dat ab-
sorptie-en secretieprocessen kunnen plaatsvinden binnen 
hetzelfde epitheliale cornpartirnent. De resultaten zijn 
duidelijk in strijd met de opvatting dat vloeistofsecretie 
een specifieke functie van de crypt zou zijn. 
De cholera studies toonden aan dat zelfs een geringe toe-
name van de cyclische AMP niveau's in het darrnslijrnvlies 
een drastische verlaging teweegbrengt van de absorptie-
capaciteit voor water en electrolyten. De ongevoeligheid 
van het adenylcyclase systeern in de enterocyt voor hor-
rnonen (bijv. insuline, glucagon, catecholarnines) kan wor-
den opgevat als een bescherming van de absorptieve darrn-
functie tegen de aanzienlijke fluctuaties van hormoon-
spiegels die kunnen optreden onder physiologische condi-
ties. 
Hoofdstuk I'' (Publicaties 5 en 6) behandelt enkele 
aspecten van de cyclisch GMP productie en regulatie in de 
enterocyt. Ongeveer 65-75 procent van de totale guanyl-
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cyclase activiteit in de villus eel werd aangetroffen in 
de borstelzoorn, de overige activiteit was hoofdzakelijk 
gelocaliseerd in de baso-laterale plasrnamernbranen. De 
activiteit in de crypt cellen was veel lager, verrnoede-
lijk als een gevolg van de onvolgroeide toestand van 
hun luminale rnembraan. De kinetische eigenschappen van het 
borstelzoorn enzyrn bleken vergelijkbaar met die van de 
rnernbraangebonden vorrn van het guanylcyclase in rattehart 
en -long. De kinetica van het enzyrn in de baso-laterale 
rnembraan kwarn daarentegen meer overeen met die van het op-
losbare guanylcyclase in andere weefsels. Beide types 
guanylcyclase getest in vitro bleken volledig ongevoelig 
voor een groat aantal horrnonen, neurotransmitters, prosta-
glandines en plant lectines maar konden aanzienlijk worden 
geremd door physiologischeconcentraties van ATP en ADP. 
L-arninozuren bezaten een geringe stirnulerende werking. 
De cyclisch GMP niveau's in geisoleerde villus en crypt 
aellen waren ongeveer 4-6 rnaal lager dan de cyclisch AMP 
niveau's en narnen enigszins a£ van crypt naar villus. Orn-
dat de guanylcyclase activiteit juist toenam in deze rich-
ting, wordt verondersteld dat cyclisch GMP-afbrekende en-
zyrnen (fosfodiesterases) een belangrijke rol zouden kunnen 
spelen in de physiologische regulatie van het intracellu-
laire cyclisch GMP gehalte. Ook de concentraties van cy-
clisch GMP konden niet worden gewijzigd door incubatie van 
de cellen met hormonen of daarmee vergelijkbare agentia en 
de ionofoor A-23187, specifiek voor divalente kationen 
(Ca2+, Mg 2+). Mogelijke oorzaken voor deze ongevoeligheid 
worden aangegeven. De negatieve resultaten betekenden dat 
de functie van het cyclische GMP in het darrnepitheel 
rnoeilijk was vast te stellen wegens een gebrek aan ge-
schikte en specifieke middelen om de intracellulaire con-
centratie van cyclisch GMP te reguleren. De verrijking 
van guanylcyclase activiteit in de borstelzoom suggereert 
een rnogelijke relatie tussen cyclisch GMP en transport 
processen. Het bestaan van pulserende bewegingen van de 
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microvilli en de hoge activiteit van guanylcyclase in en-
kele andere organen met een contractiele functie (bijv. de 
flagellen van zeeegel sperma) werden gebruikt als argu-
menten voor de hypothese dat cyclisch GMP een rol speelt 
in de aanleg of activiteit van microfilamenten in de bor-
stelzoom van de eel. 
In Hoofdstuk v werd de relatie onderzocht tussen cy-
clisch AMP en de prolifererende activiteit van de crypt 
cellen. Gelsoleerde crypt cellen werden gebruikt om recht-
streekse effecten te meten van cyclisch AMP op de incor-
poratiesnelheid van thymidine in het DNA. Alle stoffen die 
in staat bleken intracellulaire cyclische AMP niveau's te 
verhogen (PGE1 , dibutyryl-cyclisch AMP, rernrners van fosfo-
diesterases) veroorzaakten een aanzienlijke rernrning van 
dit inbouw proces. Door metingen van thymidinetransport-
snelheden in gelsoleerde villus en crypt cellen met behulp 
van de siliconenoliefiltratie techniek kon worden vastge-
steld dat de incorporatie rernrningen waren terug te voeren 
op een rechtstreekse competitieve remrning van het thymi-
dine transport door het plasmamembraan die onafhankelijk 
was van de veranderingen in cyclisch AMP gehalte. Op 
grand van dit resultaat moet worden gewaarschuwd tegen de 
toepassing van thymidine incorporatie metingen als een 
middel om een relatie te onderzoeken tussen cyclisch AMP 
en DNA-synthese snelheden. 
In een paging deze problemen te omzeilen werd het cyclisch 
AMP gehalte in crypt en villus cellen verhoogd door pre-
incubatie van korte darm segmentjes met choleratoxine ten-
einde de invloed van de cholera-toestand op celdeling en 
migratie in vivo te onderzoeken. De choleratoxine-behande-
ling bleek niet van invloed op de "turnover"-snelheid van 
de epitheelcellen en ook de celmorfologie op lichtmicros-
copisch niveau was niet verschillend van controle seg-
menten. Dit resultaat kan echter niet dienen om een moge-
lijke rol van cyclisch AMP in het darm eel proliferatie 
proces uit te sluiten: door toepassing van een nieuwe 
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techniek voor de selectie van prolifererende cellen uit 
de totale crypt eel populatie kan worden aangetoond dat 
het peil van cyclisch AMP in dit celtype niet verhoogd was 
in de cholera periode. Terwijl dit experimentele cholera-
model dus ongeschikt bleek om een mogelijke invloed van 
cyclisch AMP op de celgroei aan te tonen, opent het goede 
perspectieven voor een toekomstig onderzoek naar een ~oge­
lijke rol van cyclisch AMP in het differentiatieproces van 
dunnedarm epitheelcellen in vivo omdat sterk verhoogde cy-
clisch AMP niveau•s in absorptieve villus cellen en matu-
rerende crypt cellen konden worden gegarandeerd gedurende 
een lange periode zonder enige schade aan de normale li-
chaamsfuncties van de rat. 
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NASCHRIFT 
In dit naschrift wil ik graag iedereen dank betuigen 
die op de een of andere wijze het tot stand komen van dit 
proefschrift mogelijk hebben gemaakt. 
In de eerste plaats ben ik veel dank verschuldigd 
aan rnijn ouders voor de geestelijke en materiele steun 
die zij mij tijdens mijn scheikundestudie geboden hebben. 
Willem Hlilsmann, aan jou heb ik het te danken dat 
deze studie niet werd bekroond met een tweejarig verblijf 
in een militaire inrichting. Je brede kennis en groat as-
sociatief vermogen (zowel biochernisch als taalkundig) zijn 
de werkbesprekingen van de Darrngroep vaak ten goede ge-
komen en hebben het plezier in het onderzoek sterk gesti-
rnuleerd. De vrijheid die je me gelaten hebt in de bepaling 
van de richting van onderzoek heeft wellicht het werk (en 
dit proefschrift) een enigszins heterogeen karakter ge-
geven en het invullen van het FUNGO-projectforrnulier tot 
een jaarlijks bezoeking gemaakt. Deze flexibiliteit gaf 
echter ook de gelegenheid tot een verbreding van inzicht 
in de darmbiochemie binnen onze werkgroep en tot een tij-
dige aanpassing van het onderzoek aan de actuele ontwik-
kelingen in dit specialisme. 
Prof. Dr. A.M. Kroon, beste Ab, ondanks je gastro-
intestinale complicaties (enterovirus?) heb je de energie 
opgebracht het manuscript van dit proefschrift kritisch 
en nauwgezet door te nernen. Aangezien je een van de pio-
niers bent geweest in het onderzoek van de rnitochondriele 
eiwitsynthese, heb ik in het bijzonder je oordeel over 
het eerste deel van het proefs.chrift op hoge prijs gesteld. 
Ook Prof. Dr. M. Frenkel dank ik voor de bereidwil-
ligheid waarrnee hij als coreferent van dit proefschrift 
wilde fungeren. De belangstelling die hij als clinicus 
bezit voor biochernische vraagstellingen zoals ook bleek 
uit gezarnenlijke werkbesprekingen is een stimulans voor 
een rneer op de klinische problernen afgestemde instelling 
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van de onderzoeker. 
Leo Scheek, het optimisme en de energie waarmee je in 
vrijwel alle fasen van het experimentele werk hebt geassis-
teerd is voor dit onderzoek van buitengewone waarde ge-
weest. Het isoleren van darmcellen werd door jou tot een 
ongeevenaarde graad van perfectionisme opgevoerd. 
Cecile Hanson ben ik bijzonder dankbaar voor het uit-
typen van diverse artikelen en dit proefschrift in een 
adernbenemend tempo en op een zeer accurate wijze. De fout-
loze ontcijfering van mijn handschrift heeft steeds rnijn 
grootste respect afgedwongen. Ook Mieke d'Hamecourt dank 
ik voor de voortreffelijke uitvoering van het typewerk in 
de eerste periode van het onderzoek. 
De vele discussies met Wirn van den Berg, Jos Lamers 
en (in de beginfase) met Willem Iernhoff, zijn voor mij 
zeer waardevol geweest. Van de door hen ingevoerde tech-
nieken heb ik meerdere malen dankbaar gebruik gemaakt. 
Anna Maria Leeflang-de Pijper ben ik erkentelijk voor de 
informatie verkregen uit het histologisch onderzoek van 
het darmepitheel. 
Frans Angenent dank ik voor de snelheid en bekwaam-
heid waarmee hij onverwachte technische storingen wist op 
te heffen en Rinus Machielse voor de efficiente verwerking 
van spoedbestellingen en het op peil houden van een schier 
onuitputtelijke chernicalienvoorraad in het magazijn. 
Oak alle andere, niet met name genoernde rnedewerkers 
dank ik hartelijk voor hun bijdrage tot een aangenaam werk-
klirnaat binnen de afdeling en voor hun belangstelling tij-
dens het onderzoek. 
Bijzonder erkentelijk ben ik tenslotte voor de goede 
contacten met medewerkers van andere afdelingen, in het 
bijzonder met Dr. N.J. de Both (Pathologische Anatomie) en 
Drs. J.M. van Dongen (Celbiologie) die een vraagbaak vorm-
den voor problemen van morfologische of enzymhistochemische 
aard; Nice wil ik speciaal danken voor zijn rnedewerking aan 
de autoradiografische experimenten beschreven in het laat-
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ste hoofdstuk. Hun directe bijdrage aan dit proefschrift 
is zichtbaar op de ornslag (een scanning-electronenmicros-
copische opnarne van het dunnedarrn oppervlak gemaakt door 
Han van Dongen) en in de eerste figuur (Fig. l.l), een 
lichtrnicroscopisch beeld van een dunnedarrncoupe vervaar-
digd door Nico. De autoradiografische bijdrage aan het 
antibioticurnonderzoek was rnogelijk dankzij de rnedewerking 
van Prof. Dr. H. Galjaard (Celbiologie) en werd met vak-
rnanschap uitgevoerd door Pim Visser. 
Dr. B.A. Cooke, beste Brian, je adviezen bij het op-
zetten van de eerste cyclische AMP bepalingen hebben het 
onderzoek zeer bespoedigd. Ik hoop dat onze gezarnenlijke 
belangstelling voor cyclische nucleotiden, zij het in een 
qua functie totaal verschillend weefsel, ook in de toe-
kornst een sarnenwerking op methodologisch gebied zal blij-
ven verzekeren. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren in 
1944 te Eindhoven en behaalde in 1962 het diploma Gymna-
sium-S aan het Protestants Lyceum ter stede. In hetzelfde 
jaar werd de cherniestudie begonnen aan de Vrije Universi-
teit te Amsterdam. Het kandidaatsexamen in de wiskunde 
en natuurwetenschappen (richting e) werd in 1967 afgelegd. 
Als hoofdrichting werd vervolgens biochemie gekozen, als 
bijvak microbiologie. Van de volgende periode werden vier 
rnaanden doorgebracht in Groningen voor het opdoen van 
electronenmicroscopische kennis (Rijksuniversiteit, Labo-
ratorium voor Structuurchernie). In 1970 werd het docto-
raalexamen scheikunde afgelegd . Sinds decem-
ber 1970 is hij als wetenschappelijk medewerker verbonden 
aan de afdeling Biochemie I van de Erasmus Universiteit 
te Rotterdam waar het hier beschreven onderzoek werd ver-
richt. 
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Eur. J. Biochem. 32, 356-364 (1973) 
Inhibition of Mitochondrial-Protein Synthesis 
in Rat Small-Intestinal Epithelium 
Hugo R. DEJoNGE and Willem C. Hii'LSllANN 
Afdeling Biochemie I, Medische Faculteit Rotterdam 
(Received June 16/0ctober 18, 1972) 
Because of its very fast turnover, implying a rapiJ biogenesis of intestinal mitochondria, rat-
small-intestinal epithelium was regarded as an excellent target for the action of chloramphenicol 
and oxytetracycline, specific inhibitors of mitochondrial protein synthesis. ·with constant blood 
levels of chloramphenicol and ox.ytetracycline above 1.0 !J.g/ml the levels of the mitochondrial 
cytochromes aa3 , b and c1 in villous and crypt cells decreased gradually until a minimum level was 
reached after about 48 h of treatment. Thera pid onset of the fall in cytochrome aa3 content "1-\ithin 
the villous cells indicated a further synthesis of this enzyme outside the proliferative compartment 
of the crypt . .:-.ro significant change was observed in the cellular contents of numerous other mito-
chondrial and extramitochondrial enzymes, confirming the restricted function of the mitochon-
drial protein-synthesizing machinery for the biosynthesis of mammalian mitochondria. Prolonged 
t-reatment with oxytetracycline, but not with chloramphenicol, caused a sevel"e damage of the 
>'illou~ epithelium. This t.oxic effect was probably not related to the lowered cytochrome content 
of the mitochondria. 
The small intestinal epithelium of the rat was 
regarded as an excellent target for inhibitors of mito-
chondrial protein synthesis, ~uch as chloramphenicol 
or oxytetracycline, since the turnover of the cells is 
extremely rapid. In the intestinal crypts the ceil 
cycle of the principal cells is about 10-14 h [1], 
implying rapid formation of mitochondrial enzymes. 
In the transitional zone between crypt and villus, 
differentiation may require extra synthesis of some 
mitochondrial proteins [2,3) and in the villous cell 
mitochondrial protein synthesis may be continued 
to compensate for possible breakdown. Since the 
lifet-ime of the small intestinal cells is only about 
2 days, antibiotic trcatn1ent of short duration might· 
be expected to result in a selective influence on the 
constituents of these cells, without disturbing the 
vital functions of other organs in the rat. 
Enzymes. Succinate: (acceptor) oxidoreductase or succin-
ate dehydrogenase (EC 1.3.99.1); L-glycerol-3-phosphate: 
(acceptor) oxidoreductase or glye<lrol-3-phosphate dehydro· 
genase (EC 1.1.99.5); D·3-hydroxybutyrate: NAD oxido-
reductase of D·3·hydroxybutyrate dehydrogenase (EC 1.1.1. 
30); L-aspartate: 2-oxoglutarate aminotransferase or aspar-
tate aminotransferase (EC 2.6.1.1); L-glutamate: NAD{P) 
oxidoreductase (deaminating) or glutamate dehydrogenase 
(EC 1.4.1.3); Ferrocytochrome c: oxygen oxidoreductase or 
cytochrome c oxidase or cytochrome aa, {EC 1.9.3.1); 
Monoamine: oxygen oxidoreductase (deaminatmg) or mono-
amine oxidase (EC 1.4.3.4); L-malate hydro-lyase or fumarate 
hydratase or fumarase (EC 4.2.1.2); L-lnctate: NAD oxide· 
reductase or lactate dehydrogenase (EC 1.1.1.27). 
This report, dealing with the changes in enzymic 
composition of the mitochondria in villous and crypt. 
cells during antibiotic treatment., provides information 
concerning the participation of mitochondrial protein 
synthesis in the biogenesis of intestinal mitochondria 
and the site of synthesis of :mitochondrial enzymes 
in the intestinal epithelium. Studies on the energy 
metabolism of the epithelial cells and mitochondria 
during long-term treatment w:ith chloramphenicol 
or oxytet-racycline and histochemical observations 
w:ill be published elsewhere (4,5]. 
MATERIALS AND METHODS 
Animals 
In all experiments male, ~pecific-pathogen-free. 
\Vistar rats, weighing 200-2:l0 g were utilized in 
order to eliminate the contamination of villous and 
crypt cell preparations with protozoa (cf. [6]). Normal 
laboratory chow and drinking water were prO\'ided. 
Rats were sacrificed by cervical fracture and ~ub. 
sequent bleeding. 
Chemicals 
Enzymes and cofactors were purchased from 
Boehringer and Sons (Mannheim, Federal Republic of 
Germany), antimycin A, phenazine methosulphate 
and rotenone were from the Sigma Chemical Co. 
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(St. Louis, Missouri U.S.A.), fatty-acid-poor bovine 
serum albumin was from Pentex (Kankakee, illinois, 
U.S.A.), chloramphenicol succinate was from 
Nogepha (Amsterdam, Holland) and oxytetracycline 
(terramycin) was from Chas. Pfizer & Co. (New York, 
U.S.A.). All other chemicals were A. R. Grade. 
Preparation of Cell Suspen.sions 
and Homogena.tM 
Removal of the small intestine and harvesting of 
villous and crypt cells were performed according to 
the method of Harrison and Webster [7], as described 
in detail in previous reports [6, 8]. For histochemical 
assays, small pieces of duodenum, jejunum and ileum 
were frozen immediately after flushing the intestinal 
lumen with cold saline (cf. [5] for histochemical data). 
The remaining parts of the intestine, with a total 
length of about 60 em, were used as starting mate. 
rial for the isolation procedure. The isolation medium 
for the epithelial cells contained 0.01 :M Tris-HCl 
buffer, 0.13 M KaCl and 5 mM EDTA (final pH 7.6). 
The cells, collected by centrifugation at 800 X gma" 
for 15 s, were suspended in 10 ml of a medium con-
taining0.25M sucrose, 20mM Tris-HCJ buffer, 1 mM 
EDTA, 5 mM MgCl2 and 1 mg/ml bovine serum albu-
min (final pH 7.4) and homogenized for 60s with a 
small Polytron homogenizer (type PT10, Kinematica 
Luzern, Switzerland) set at position 4.5 (8000 rev./ 
min). 
Administra.tion of the Antibiotics 
Oxytetracycline was injected int-ramuscularly 
every 8 h in a total dose of 300 mg/kg body weight 
in 24h. Chloramphenicol succinate was administered 
every 4 h intramuscularly to a total amount of 1680 
mgjkg body weight in 24 h. Control animals received 
corresponding volumes of saline by a similar route. 
As8ays 
Determination of concentrations of the anti-
biotics in serum samples was performed by the micro-
biological method of Hoette and Struyk [0] in colla-
boration with the Department of Clinical Micro-
biology of the Rotterdam Medical School. 
Protein wa.<l determined according to Lowry 
et al. [10] in sonicated samples, using bovine serum 
albumin as standard. 
Except when indicated all enzyme assays were 
carried out at 30 °C in sonicated preparations (for 
sonicat-ion method see [3]). In order to avoid auto-
lytic damage as much as possible, the enzyme solu-
tions were sonicated just before the start of the assays 
and labile enzymes (for instance cytochrome c oxid-
ase) were tested first. 
All data concerning the assays of the following 
enzymes are given in [3]: glycerol-3-phosphate de-
hydrogenase; succinate dehydrogenase; glutamate 
dehydrogenase; D-3-hydroxybutyrate dehydrogenase 
and aspartate aminotransferase. 
Cytochrome c oxidase was estimated spectro-
photometrically according to Smith et al. [11]. Puri-
fied cytochrome c was reduced with a few grains of 
dithionite. Excess of dithionite could be effectively 
removed by gassing the solution wit-h oxygen. The 
cuvette contained 0.04 rru."\'1 cytochrome c (reduced), 
75 roM: potassium phosphate buffer (pH 7.4) and 1 m}.1 
EDTA (total volume 2.07 ml). In the blank cuvett-e 
cytochrome c was omitted. During the first 10 min 
the oxidation of cytochrome c followed first· order 
kinetics. The activity is expressed as the value of the 
first-order rate-constant (s-l) per mg protein. 
For the measurement of monoamine oxidaHe two 
different substrates were used. The oxidation of 
kynuramine was determined according to a slight 
modification of the method ofKraml [12] as described 
by Blokhuis [13]. The production of 4-hydroxy<juino-
lin aE mea-sured fluorimetrically at 20 "C (excitation 
318 nm and emission 386 nm) increased linearly 
with time and proportionally to enzyme concentra-
tions during an incubation of the test solution for 
30 min at 37 "C and was expressed quantitively wit.h 
the aid of known product concentrations added to a 
blank without kynuramine. The monoamine oxidase 
activity with benzylamine as substrate was measnrcJ 
spectrophotometrically according to Tabor el al. [14], 
following the rate of benzaldehyde production at 
250 nm. 
Fumarase was determined in a cuvette contain. 
ing 125 1-Lmol sodium phosphate and 150 1-Lmol 
potassium-L-malate. Total volume 3.0 ml, final pH 
7.3. The formation of fumarate was followed at. 
240 nm. The molar absorption coefficient used wa::~ 
1740M-1 cm-1• 
Rotenone-insensitive NADH- and NADPH-cyto-
chromc c reductase were tested. according to Hoge-
boom [15] by following the reduct-ion of cytochrome c 
at 550 nm. The assay mixture contained 75 mM 
potassium phosphate (pH 7.4), 1 m:Vf EDTA, 0.1 m~l 
NADH or KADPH, 0.05 ml\-1 cytochrome c(oxidizcd), 
1 mM KCN and 1.5~J-~1 rotenone. Total \'Olume: 
2.11 ml. 
Lactate dehydrogenase was measured at 340 nm 
in a cuvette containing 150 mM potassium phosphate 
buffer (pH 7.4), 0.3 mM KADH and 1 mM KCN. 
Final volume: 2.07 ml. The reaction, except the 
blank, was started with 1 mM sodium pyruvate. 
Cytochrome contents were calculated from the 
difference spectra of the reduced minus the oxidized 
pigments of a sonicated villous cell suspension in 
CaH-free Krebs-Ringer-phosphate buffer, containing 
4-10 mg proteinfml. Registration was performed 
with an Aminco-Chance wavelength scanning spectro-
photometer in the split-beam mode at room tempera-
ture. After dividing the homogenate into two cuvettes 
and correcting for deviations of the baseline, the 
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~ample cuvette was retluccd with a few grains of 
clithionitc while 1 [Ll H 20 2 (5°/0) was added to the 
reference cuvette. The clifference ~pcctrum of cyto-
chrome bin homogenates of villou~ cell suspensions, 
containing 2.50 mM sucrose, 20M 'l'ris-HCl (pH 7.4), 
f) ruM IlfgC12 and 5 [LII1 rotenone, was recorded after 
reduction of cytochrome b in the sample cuvette by 
the adclition of succinate (10 mM) and antimycin A 
(4/).g/ml). The contents of both cuvettes were saturat-
ed with oxygen. The data from the~c spectra were 
used for the calculation of a corrected value of the 
cytochrome b content. 
The following absorption coefficient.s were used: 
Cytochrome aa3 : r (605-630 nm) = 24.0 mM-1 cm-1 
(cf. [16]); r {445-455 nm) = 164 mM-1 cm-1 (cf. 
[l6J); Cytochrome b: r(562-575nm) = 20.0mM-1 
cm-1 (cj. [17]); Cytochrome c + c1 : r (.'551-540 nm) 
= 19.1 mM-1 cm-l(cj. [17]); Cytochrome b5 : r (424 to 
405 nm) = 160 mM .. ' cm-1 (i'f. [18]). 
HESULTS AND J)lSCLSSIO::>i 
Administration and Blood-Level;; 
of Chloramphenicol and Oxytetracycline 
D(- )-rhreo Chloramphenicol and oxyt.etraeycline 
al'e C!m.~idcred as effective and selective inhibitors 
of protein synthc~is in mitochondria of a number of 
cucaryotic cell types [19]. 
To obtain optimal inhibition conditions, a level 
of 10-501J.g/ml chloramphenicol has been applied in 
the medium of cultivated mammalian cells [20, 21 J 
as we\! as in blood during experiments with regenerat-
ing rat liver in t'ivo [22,2:3). After injection the blood 
concentration of biologically active chloramphenicol 
in adult rats dcerea~cN extremely rapidly because of 
partial inactivation, resulting from glucuronic aeill 
conjugation, and a rapid secretion of free and conju. 
gated forms in the mine [24]. In ordet· to maintnin 
sufficiently l1igh levels during the cow·se of our 
experiments, it appeared necessary to inject. the rat~ 
intramuscularly 1,vcry 4 h with a t.ot.a! dosage of 
1680 mg chloramphenicol succinate est.er per kg 
body weight in 24 h. Under these conditions t.he 
so>rum levels fluduat.ed between 10 and 30 [Lg/ml 
(see Fig.l). Even after longet· periods of treatment 
(7 day~) t.hese levels never exceeded 50 [Lg/ml or 
dcrrcased below 8/).g/ml, indicating that t.he drug 
int.ake bal<tnced t.\lc clea1·ance. 
Oxytdracyclinc has bC'('n reported to exhibit. a 
~imilat· .'lct·ion as chlor·.'lmphonicol in yoa~t. [25], 
eultut·rd heart ct'll~ ]201 and liver [22] at about the 
same concentrations. The biological half-life of this 
compouml in rats apprarcd to be much higher than 
that of chloramphenicol (Fig.!). Comtant serum 
levels Let ween 10 and 40 j.Lf;/ml were obtained by 
mean~ of intrnmllHOillrtr injection~ of terramycin 
(Pfizer) every 8 h at a Jo~age of 300 mg per kg body 
50 
" ~ 30 
5 
T11M after rnJedion (h) 
l<'ig.1. Concentrations of chloravtphenicol a11d OJ:!fltlmcycline 
in the serum of specific-pa.IM!Jen-free rats. Serum l~vels of 
oxytetracycline(--) and chloramphenicol{----) in adult 
specific-pathogen-free rats were measured after a single 
intramuscular injection of 100 mg/kg body weight tcrram,ycin 
;md 280 mg chlornmphenicol succinate/kg body weight 
respectively 
weight in 24 h. Long trrm administration (more than 
2 days) led to temporary concentration rises of the 
drug up to 120 1-lgfml. Trtraoyclines are concentratctl 
in the bile and excreted by the liver in the gut where 
they probably enter an enterolwpatic circulation [27]. 
Berause penetration of these antibiotics into small 
intestinal mucosa has been established [27,28], o:>::y'-
tetracyclinc was expected to be an useful inhibitor for 
our purpose, although high tissue concentrations 
(above 50 [Lg/ml) might give rise to a disturbance of 
other cellular processes (see [29,30,4]). 
Influence of Chloramphenicol a.nd Oxyletmcycline 
on Various Enzyme Activitie.~ in Homogenale8 
of Isolated Fillous Cells 
The rather large range of values found fol' the 
specific activities in cell homogenate~ of the cont.rol 
rats may be caused by individual difference~ in the 
animals used, the variation in cross contamination 
of villous and cr_ypt cells and a fluctuating degree 
of leakage of soluble enzymes from the intestinal 
cells during the isolation procedure (cf. [8]). It is 
notewortllV that treatment of the .'lnimal~ with either 
of the two· ant-ibiotics for 48 h did not result in a sig-
nificant body weight or mucosal-protein loss, anorexia. 
or diarrhea. 'l'herefore poS3ible influence of greatly 
diminished food uptake on the enzyme activities 
can be ruled out (cf. [:ll]). furthermore, it is unlikely 
that reduction of the bacterial population during the 
treatment coulcl explain some of the differences 
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Table 1. Anlibiolic lrealment and the. yield of viUoU8- and crypl·cell protein 
VillollS and crypt cell yield {expressed as mg protein ± standard error isolated from 60 em of the small intestine) after various 
times of antibiotic treatment. The number of determinations is given in parenthesis. P-values were calculated from the Student 
I-test 
l'rotoin yield "ftcr lroll.tmcnt for 
Tt!"alu\out Cell lrao\intt 6 ,, 
'"" 
72h 
""" 
"'' Control villus 128 ::.i: s (19) 
crypt· 30±3(11} 
Chloramphenicol villus 130 ± 15 (5) 120 ± U:l ,,, 
crypt 25 ± 5 (5) 28 ± 6 (3) 
Oxytetracycline villus 121 ± 17 (6) 71) ± 12a (4} 4,., ± w~ (4) 
crypt 26 ± 6 (6) ;)1 ± 5 ,,, :!:i:); 6 (3) 
•J' .; O.UI. 
Tllble 2. Specific a.cliuilie$ of enzyme-s in soniwled lu.rmogenates of villous cells isolated from the small intc.'lline of control and anti-
biolic-lnated rats 
Control anima.\s were injected intramuscularly with 0.3 ml saline every 8 h for 2-3 days n =number of experiments. P prob-
ability value, calculated from the Student l·te.~t 
l>ll1.)"n\C Cont-rol 15-h ~4-h oxytetm- oxytetra-
oyolin~ cyclino 
(11- 4) ("- 4) 
Cytochrome c oxidase 0.112 0.075b o.ossa 
±0.010 +0.011 ±0.009 
Succinate dehydrogenase 15.9 15.4 16.3 
:::1.6 ±1.1 ±1.0 
Glutamate dehydrogenase 78.5 81.2 71.1 
±7.9 ±6.6 ±5.0 
Monoamine oxidase 
{kynuramine as substrate) 0.3S 0.32 
±0.04 =':;0,05 
1\:ADPH-~ytQchrome c 
'·' 
4.0 
reductase (rotenone- ::i.:O.:J ±0.2 
insen~ith·e) 
Lactate dehydrogenase 3200 2810 
±68 ±90 
• p < 0.01. 
b I'~ 0.01. 
between treated and control rats because no signif-
icant difference in specific activity of the enzymes 
tested had been detected between specific-pathogen-
free and germ-free rats (unpublished observations). 
After prolonged treatment only the oxytetracycline-
injected rats showed symptoms of lethargy, weight 
loss and loosening of villous cells {see also [5]). The 
villous-cell protein yield after isolation appeared to 
be markedly reduced whereas the amount of crypt~ 
cell protein remained relatively constant (Table 1). 
Table 2 shows the effect of treatment of rats with 
oxytetracycline or chloramphenicol on the specific 
Spcoillc activity ~fter 
20-h 48·h 48·h 130·h 140-h 
chlorant- oxytctra· ohlor~m· oxyletm- "hlomm· 
phcniool online t>hcnioul eyclino phonicnl 
(n.- 3) ("- 8) ("- 5) (n- ~) (n- 2) 
'xn>g ' 
0.046 0.033~ 0.035~ 0.029 0.030 
±0.008 ±0.007 
nmol x min-• x n>r' 
13.9 13.9 13.4 14.1 13.9 
;!;;Ll ±1.3 
67.0 73.7 82.4 95.6 84.1 
::;5.ij ±4.8 
0.30 0.35 0.37 0.37 o.:l7 
:';;0.04 ±0.06 
'·' 
4.3 4.1 4.S 4.3 
±0.3 ±0.2 
3250 2210 ~ 3180 ll.lGO 2500 
±135 ±85 
activities of a variety of enzymes tested in sonicated 
homogenat-es of villous cells. 
The mitochondrial inner-membrane enzyme 
cytochrome c oxidase clearly has a lower specific 
activity after treatment with either of the anti-
biotics. The activity level decreases gradually with 
time and reaches a minimum. after about 48 h, 
equal to about 300/0 of the control value. Prolonged 
treatment did not result in a further lowering of this 
value. On the other hand, succinate dehydrogen!l$e, 
also a mitochondrial inner-membrane marker, is not 
influenced by the antibiotic treatment to a significant 
3ijl) J nhihition of illitodJOmlrial-l'rotein .':lynihcois in lbt t:imall-Intcst-imtl Epithelium 
551 
l c( t c ! r, 
0.09 
0.0~ 
0.03 
·0.03 
·C .G~ 
·0.0~.: ·0.015 -1--,_,-,-.~~~r+~~~~ ~~--+ A B 
L.OO 500 50.0 
W•v~lengtn (nm) 
l<"ig.2. Reduced-minus-oxidi::ed spectra of villous-cell lwm.o-
yenale.s from control (A) and o:rytetraoycline-trealed (B) rats. 
Experimental detaiiH are shown in the legend of Table 3. 
Protein concentration, 4.6 mg/ml. (--) Dithionite-reduced 
minus Hp,-oxidized difference spectra obtained with control 
extent. The same (not shown in Table 2) hollis for 
mitochondrial glyeerol-3-phosphate dehydrogenase 
(specific activity 11.6 ± 1.1 nmolxmin-1 Xmg pro-
tein-1; n = 12) and D-3-hydroxybutyratc dehydro-
genase (specific activity 11.4 ± 0.6nmolxmin-1 
:ong protein-1 ; n = 12). Tho specific activities of 
glutamate dehydrogenase, fumara8e and aspartatl' 
a!llinotransfcrase, generally considered as mito-
chondrial mat-rix enzymes [32,33] (the lat.tcr two 
also occurring in the cytosol), appear unchanged in 
the treated rats. The control values for fumnrase 
and aspartate aminotrunsfemse in sonicated homo-
genat-es (not pre~entcd in Table 2) were 370 :1: 21 
and 189 ± 9.4 nmol substrate X min-1 x mg prot.oin-1 
respectively (n = 12). Neither the mitochondrial 
outer-membrane markers, monoamine oxidase, h•stell 
with kynuramine as substrate (Table 2), or b<:nzy]. 
amine (specific activity 0.62 :::: 0.09 nmol X min-1 
X mg-1 ), and rotcnonc-inscnsit.i~-e NADH-cyt.o-
chrome c reductasP (specific activity 2.3.1 ± 1.2 nmol 
X min-1 X mg-1), nor the microsoma.l marker enzyme, 
rot-enone-insensitive NADl'H-c,vtochrome c rednctase 
(Table 2) are affected by the antibiotics. 
The activity of lactate dehydrogenase (a cytosol 
marker) decreases by abottt 30°(0 after 48 h treatment· 
with oxytetracycline whereas aft-er 130 h only about 
30°(0 of the normal activity remained. On the contra-
ry, chloramphenicol-treated animals did not. sho1r 
such a decrease even after a 140-h injection period. 
Because we observed no rlifferencc in specific activity 
of lactate dehydrogenase in wl1ole pieces of intest-ine 
rats.(·· ·····)Analogous spect-ra obtained with rats, treated 
for 48 h with ox,vtetracydin~. (-·-·-) Cytochrome b in 
sample cuvette reduced wit-h succioate and antimycin A; 
control experiment8; (----) Comparable curves obtainetl 
with rats after 48 h of antibiot-ic treatment 
between controlrat.s and rats, tre<tted with oxyi-etrn· 
cvcline for 48 h, in accordance with the histochemical 
r~sults [5], we must assume that the severe damage of 
intestinal villous cells caused by oxytet.racyeline 
aft.cr prolonged t-reatment is proceeded by an in-
creased lability of cell membranes which resu]t5 in an 
enlarged pcrmeabilit._y for ~olublc protein molecuk~ 
during the yibration procedure. The lability could 
not be induced with chl<Jr;lmphcnicol ant! s('ems 
tlwreforc not· to be related to the cytochmme dcti-
ciency evoked by bot-h of the ant.ibi;Jt.ics. 
Cytochrome Content of Villo/J .. ~·Ccll llomoynwtes 
of Control and Chloramphenicol- or O.<yletracychne-
'l'realed Rat8 
In order to obtain further in,cight into the eon~c­
quences of the inhibit-ion of mitochondrial protein 
:>,yntbesis for the compo8ition of int.c~tinal mit.o-
chondria, difference spectra of \'illons-cell homogena· 
tes were measured. 
Fig.2 illustrates the re"'ults obtained with control 
rats and rats treated for 48 h with oxyt-etracycline. 
About. the same picture was found after treatment of 
rats for two days with chloramphenicol (Table 3). 
Antibiotic treatment causes a significant. decrease 
of the peak at 445 nm (y-maximu!ll of cytochrome 
aa3), a disappearance of the shoulder at 562 nm 
(::<-band of cytochrome b) and a strong reduction of 
the maximum at 605 nm (a-band of cytochrome aa3). 
A slight. decrease is observed at 551 nm (a-bands of 
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Table :l. C'!flocflromc conlent of vi/lou.~ cell homogen.ales from control and dliorrPII)Jhrnirol- or OX1JiflraC!jcline·lreated rals 
Details ofth~ cxpcrimPntal procedure and calculation of cytochrome content-s ar<' p;iYCtl in Motlwds. n = number of experiments, 
]>.values were calculated according to the S1udent 1-tf';;( 
Cl·tochron~<· 
a+l1, «+a, r +r, .. 
(~(),-;-~~,"> lllH) (H5-455mn) (56~-570 mn) (oorrc•oll•d mlae) (.">:Ol-540!llU) (4~4-405 nrn) 
Control (no.--. .S) 
24-h oxyt<·tra~ycline 
(n = :l) 
0.061 ± O.OOi 
0.036 
1).0-!IJ -':li.IJ(4 o.1a;; 
O.n:-10 0.110 
tmoul.'mg 
:L: 0.020 (1.102'' + 0.012 0.201) ± 0.022 0.209 ± 11.1122 
1!.210 0.210 
4S-h oxytetracycline 
{n =• :)) (1,1)11)~ :!:: n.nn4 (1.(111" :::: 0.005 0.079• ± O.lJlO 0.044" 0.111!/ 11.1(;7 :I: 0.112() 0.198 :1: 0.023 
48-h chloramphenicol 
(n =5) 0.014" == ll.llll:l 0.1110• + 0.004 0.081• ± 0.007 0.04fi• +11.11()[) 11.178 :~ 0.021 11.220 :': O.OHI 
120-h oxytetro,c.vcline 
{11 = 2) 0.014 
120-h chloramphenicol 
(n = 2) 0.014 
• {J ·- 11.111. 
' 
0.011 0.107 
0.010 0.085 
cytochromes c and c1) and in the Soret region at 
424 nm (y· band of cytochrome b5 with contributions 
of they-bands of cytochrome b and c; hemoglobin is 
ah~ent in the preparations). 
Table 3 shows that the amount (per mg protein) 
of cytochrome aa3 decreases after a 48 h period of 
antibiotic treatment by about 75°/0, in good agree-
ment with the data shown in Table 2 for cyto-
duumc c oxidase. The levels of the cytochromes a 
and a3 are equally affected since the absorption peak 
at 443 anti 605 nm are lowered to the same degree. 
For the calculation of the cytochrome aa3 contents, 
ba.-Jcd on the height of the y-maximum at 445 nm, 
no corrections were made for the absorption difference 
due to cytoclwome b at this wavelength. This may 
e:-.:plain the Uifferent absolute values for the cyto-
chrome aa 3 content measured at the wavelength 
pairs 605-630 and 445-455 nm respectively. Again, 
a new steady-state level of cytochrome c oxidase is 
reached after about 48 h, indicating an incomplete 
inhibition of mitochondrial protein synthesis under 
the conditions in vivo or a. strong reduction of the 
turnover rate of the intestinal cell population. The 
latter possibility could be excluded by further 
e.»:periments [ 4]. 
The decrease of cytochrome b, determined from 
the dithionite-reduced minus H 20 2-oxidized differ-
ence spectra (Table 3, uncorrected value), is small as 
('ompared to cytochrome aa~. However, this deter-
mination is int-erfered with by the spectral contri-
butions of the .x-bands of cytochrome c, c1 and b5• 
Better values could be derived from the difference 
spectra obtained after reduction of cytochrome b in 
the sample cuvette with succinate in the presence of 
antimycin A (Fig.2 and Table 3, corrected value~:~), 
11.1RO 0.230 
0.192 0.200 
It can be seen that the maximal decrease of cyto-
chrome b content {about 60°/0) is still slightly lower 
than the drop of cytochrome ua3• 
The decrease of the 424 nm maximum is not 
significant and can be easily explained by the dimin-
ished contribution of the y·bands of the cytochromes b 
and c + c1 at this wavelength (Fig.2). Therefore we 
conclude that the antibiotics do not influence the 
level of cytochrome b5 , occurring in microsomes and 
the outer membrane of mitochondria, in agreement 
with the results of ot.hcl' microsomal and outer 
membrane markers already mentioned (Table 2). If 
it is assumed that the inhibitors of mitochondrial 
protein synthesis do not block the synthesis of cyto-
chrome c, which, at least in other tissues, is synthesiz-
ed in the microsomes [34], and that. the contribution 
of cytochrome b5 at 551 nm does not change during 
the treatment, it i~:~ likely that the slight decrease 
observed in the cytochrome c + c1 peak at 551 nm 
is caused by a drop in cytochrome c1 content (cf. 
[23]). In liver this cytochrome accounts for about one 
third of the absorption maximum at. 551 nm at room 
temperature [35]. In HeLa cells [36] and regenerating 
liver [23], chloramphenicol-treatment led to a signif-
icant increase in the amount of cytochrome c. If a 
similar increase has occurred in the intestinal cells, it 
is obscured in the difference spectra by the fall of 
cytochrome c1 content. 
Finally, no significant change in flavoprotein 
content, measured at 463 nm, was observed (Fig.2). 
The results, obtained so far, confirm and replenish 
~the work of other investigators who reported a similar 
specific action of chloramphenicol in vivo on the 
cytochromes aa3 , b and c, in regenerating liver [23] 
and during the rapid biogenesis of mitochondria in 
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Table 4. Comparison of specific a.cUrilies of 8eoera~ enzyme.! in villrnu- and crypt-cell hornoyenates jro1n control and t,.ea.ted rats 
Separate vill01.1s- and crypt-cell fractions were obtained D.B described in Methods. The Table shows the specific activity of some 
enzymes in sonicated homogcnateH of villous cells (expressed aa nmol substrate metabolized x min-1 X rug protein-1), di;·idcd by 
their specific activity in crypt-eel! homogenatcs, originating from the same animal, followed by the standard <:'!Tors of the ratios. 
n = number of experiments 
Ratio of activity vHii/crypto 
i';,,_,·me 15-h 15-h i8-lt ~8-h C'oJ>tl'<•l chlorum- ox:rtetm· ciLloram· 
'" 
-~ l Ul pheniool C)'OJllle ]>henicol 
(11 ~ ~) (n-
" 
(11 ~ 3) (I<= 3) 
Cytochrome c oxidase 0.97 ::::: 0.09 0.90 ± 0.1:3 0.90 ± 0.11 0.76 0.92 
Succinate dehydrogenase 1.:l5 ± 0.12 t.3:l :l: O.lli 1.27 ± 0.09 1.46 1.34 
nlycerol-:3-phosplmte dehydro-
genase 1.61 ± 0.14 l.61 ± 0.14 Ul:; :f: 0.10 2.:l0 UlO 
p-:l-HydroxybutyratD dehydro· 
genase 0Ji7 ::: 0.04 11.72 :~ 11.12 0.61 
Glntanmte dehydrogenase 0.87 ±0.06 n.s4 
.:.!:: {).It 0.81 J: 0.18 0.71 0.84 
Lactate dehydrogenase 2.8 :::o.n 
liver, heart, kidney and brain of neonatal rat~ [37]. 
Hcccnt studies of Cooke and Work [:38] indicate 
t-hat only about 70/o of the total protein content of 
liver mitochondria, comprising at lea~t 10 distinct 
protein.~. is synthesized in vivo and in vitro on mito-
rillosomcs. The major part of these products, wit.h 
molecular weights in the range from 14000 t.o 50000, 
i.~ (•onsidered to consist of "organizer" proteins whieh 
promote the insertion of the insoluble cytochrome~ 
oft he mitochondrial inner-membrane into their active 
('onfif,!:uration in the cristae [38,1t!J. \Vhereas cadier 
invesl.i~ations with the "petite" mutant of yeast 
I HJJ and mitoehondria from rat liver [39) and Neuro-
.-pora crassa [40] indicated that the protein moiet.v 
of the chlommphcnicol-inhiblicd cytochrome aa 3 is 
l'ntirely synthc~izcd outside the mitochondria, very 
n•ecnt reports of \Veisd el al. [41-4:~] suggest t.hat 
in Neurospora cras.,·a at least one of the precursor poly-
Jll'ptidcs of the functional cytochrome aa3 complex 
i.q synthesizer\ on mitochondrial ribo~omes. 
The Influence of Antibiotic Treatment 
on En::yme Activ'ili~s in Intestinal-Crypt Crfls 
ns Compared to t'illous Cells 
As shown in Table 4, we found different value.~ 
liJr' the villous/cr.ypt ratios of homogenate actidties 
(on a protein baHl') of several mitochondrial cnz~·nw~ 
in the ~ont.rol rat~. in agreement with the ~onccpt of 
a ditl'ercntial devclopnwnt of mitochondl'iul enzymL'H 
during the short life of t.hc cpit.hdial cells (cf. t:m. 
However, the homogenate~ ~howed appreciably lower 
ratios of glutamate dehydrogenase (Table 4), exclu~i­
vdy localized in the matrix mitoehondrialis, and of 
aspartate aminotran~fera~c (villous/erypt rat.io: 0.8:5 
± O.U. n = 10). a~ compur~d to the mitochondrial 
preparations used in earlier ~tudies [2,3]. ln those 
3.0 ±0.\i 2.'J 7"~ 0.7 2.40 
expct'imc·nt~. a more vigorou~ homogenization proce· 
dure {75 s with a type-20 Polytron homogenizer) was 
applied, which improved the yield but. impaired the 
quality of the intestinal mitochondria. The latter 
could !.Je inferrc·cl from a considerable leakage of 
mitoehondriul matrix enzymes to the 14000xg 
!;llpt•ma-tant (see f_2]) especially from crypt mit.o-
chrondria. The higher fragility of crypt mitochondda, 
may rd1cct an inherent property of these particleK 
or may be due to an artifaet, caused by homogeniza-
t.ion of a more dilute and less intact crypt-cell suspen. 
sion [SJ a~ compared to villous-cell preparations. By 
u~in:; the present homogenization proccdure, no 
discrepancy of Yillu.'J/cr·ypt ratios of matrix enzyme~ 
wa~ founcl between mitochondrial preparations u.nd 
cell homogenate~ {unpublished rc~ults). 
According- to llarrisun and 'Vcbster [7] and in 
agrwnwnt. with our results {Table4), the antibiotic. 
sensitive enzyme, cytochrome c oxidase, display~ a 
constant activity (expressed per mg protein) from 
the crypt. to the top of the villus. Since the amount of 
protein }Jef crypt cell seems to be significantly lower 
than the amount per villous cell [7,44], t.\w equal 
value found for the specific activity of c,ytocluome (' 
oxidase in villous and cr,ypt cells probably cOI'rc-
sponds with an increase of the cellula1· content· of 
thi~ eyt.ochrome in the maturating compartment of 
the crypt. An extra synthesis of cytochrome ua, in 
t.he Cl'.vpt is also suggested by the lower value~ of t.hc 
\'il\us/crypt. ratios for 3-hydroxybutyrate dehy(h·o-
genase and a number of matrix enzyme~. if dl'gntda. 
tion of t.hese enzymes in the villus ]$ ne-glected. 
further evidence was obtained by treatment of t)w 
rats 'With chloramphenicol or oxytetracycline during 
a very short period (15 h), corresponding wit.h about 
one mitotic cycle. After this time the cells, present 
in the proliferation zone of the crypt as the treatment 
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sta.rted, have migmlc·d not far beyond thl' junction 
of cr,ypt and villus (rf. [45 J). If the synthesis de novo 
of cyt-ochrome c oxida3e i~ limited to the proiifera.tion 
zone of the crypt, the short treatment should only 
result in a decreased activity in the crypt and not 
in the villous cells. However, after 15 h treatment the 
level of c_ytochrome c oxidase in villous. and crypt· 
Cl'll fractions arc equally affected (Tables 2 anU 4), 
indicating an extra synthesis of this cytochrome in 
the maturating wne of the crypt and/or in the villous 
cells. "l,.ccording to histochemical observations (see 
1.5]) the strongest Uecrease of cytochrome c oxiU.as<e 
occurs in the crypt and the lower part. of the villus. 
whereas a much smaller loss of activity has been shown 
at the upper half of the villus. The latter result. 
~ug;st'tit~ the c.:d~t.ence of a slow rate of synthesis of 
thi~ enzyme de novo in the villus. Since the specific 
activity of cytochrome c oxidase does not increase 
along the villus, the latter assumption seems to 
imply a. remarkably ra.pid turnover of this mito. 
ehonrll"ial inner.mC"lllbranc protein in the villous 
cpitlwlium if eompa.red wit.h other tissues [19]. The 
l"Xistcn~e of mpid degradation processes in the villous 
n·gion of small intC"st-inal epithelium is suggested by 
.James et al. [46] for bru~h-border proteins and has 
been demon~t-rated. by Imondi et al. [47] for othct· 
<·\lramitochondria.l enzymes. Howe>er, no similar 
st.udies have been done on intestinal mitochondrial 
vnzymcs. 
Al~o after a 48-h injection period, when a mi.ni-
111\l!ll level of cytochtome aa 3 in the villu~ was reached 
(Table 2 and 3, cf. [5)), \l'l" found the ~anw extent of 
inhibition in villou~ ancl crypt cells. Apparently a 
new steady state i$ obtained in whieh an equal 
dcgr~c of inhibition of protein synthesis during the 
proliferation and t.he maturutive phase of the cell 
Jjfl" OCC\Il"!"Cd. 
A~ .~lwwn in Tabk ±,the unchanged nducs ofth(· 
villous/crypt ratios for succinate d("hyrhogcnase, 
glyccrol-3-phosphat.e dehydrogenase and the matrix 
enzymes, confirm the data of Table 2 aml pt·ove that. 
the drastically lowered level of cytochrome aa3 has 
110 efl"cct on the differential de\·elupmcnt -of other 
mitochondrial enzymes. 
.Since the influence of the antibiotics on tlw crypt. 
~ell activities never exceeded the influence on the 
villus, most of our work was d.one with villous-cell 
fractions which can be harvested with a greater 
. vicld and in a more intaet state than the crypt cell,;. 
(cf. [8]). 
Long-Term Effects of the Antibiotic.~ 
on the Small-Intestinal Epithelium 
Chloramphenicol treatment for at. least 3 dayH 
did not influence inte~tina.l protein content (Tabll, 1 ), 
absorptive function (judged from the absence of 
rliarrhea and weight loss) and, most proba.bly, did 
not. alter t-he cellular ltll"llllver rate [-!]. It wa<> found. 
that this treatment, although it led to strong reduc-
tion of the cyt-ochrome content of small intestinal 
mitochondria, diU not impair the ene1·getic function 
of these organelles. The c>vidonce for t-his was based 
on measurements of oxidative phosphorylation in 
cell homogenates and of creatine phosphate and ade-
nine nucleotide levels in freeze-clamped samples of 
jejunum [4]. Lack of impairment of energetic func-
tion by chloramphenicol trc<ttment has also been 
observed in rcgencratin!,!" liver [23) and organs of 
neonatal rats [37J. 
The damage of the villou~ epithelium after long-
term treatment with oxytetracycline, mentioned 
before, occurred at the same eytochrome levels as 
measured in the chloramphenicol.treatcd animab 
[4] and was not attended by a significant recluction 
of the proliferation of crypt cells. The intestinal necro-
sis is t-herefore difficult t.o explain as the consequence 
of an impaired mitochonllrial function in crypt or 
villous cells. Several other mechanisms of action of 
oxytetracycline, which may become manifest only 
after accumulation of the Urug in blood and tissues, 
were investigated. Our present results [4] indicate 
that the inhibition of microsomal protein synthesis 
by high concentrat-ion~ of tet-racyclines (50-100 [Lg/ 
ml), also described by other author8 [:30,48-50], 
must be seriou~ly con~idcrcd as another po~sible 
base to account for the toxkity of oxyt-etracycline 
in long-term expcriml'llts. 
We gratefully acknowler.lge the skilful technical assistance 
of 11-lr L. :J-I. Scheck. 
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Abstract-Rats, treated for 3 days or longer with high concentrations of oxytetracycline 
(OTC) suffered from a severe damage of structure and function of the small intestinal 
epithelium and showed an excessive accumulation of fat in the liver. In an attempt to 
explain these toxic effects, several possible modes of action of this drug were investi-
gated. No direct correlation was found between the strong inhibitory effect on mito-
chondrial protein synthesis, leading to drastically lowered mitochondrial cytochrome 
levels in the rapidly dividing small intestinal epithelial cells, and a disturbance of mito-
chondrial energy production. After chloramphenicol treatment, producing a similar 
decrease of cytochrome contents, no epithelial cell damage was observed. At a stage of 
the OTC-treatment in which minimal cytochrome levels were reached but still no 
structural damage of the epithelium was observed, the energy-stores in the epithelial 
cells and the rate of oxidative phosphorylation in isolated intestinal mitochondria 
appeared to be unaffected. After 3-4 days, when morphological alterations of the villus 
were clearly observed histologically, the rate of proliferation of the crypt cell population 
was not appreciably affected, suggesting again a lack of influence on energy metabolism 
in the crypt cells. During short incubations of isolated villous cells, the cellular energy 
charge and the rate of aminoacid incorporation into protein was strongly decreased 
after anaerobiosis and addition of KCN, oligomycin or 2,4-DNP, conditions which 
impair the mitochondrial energetic function. However, incubation with 100-500 ,u.g/ml 
of several tetracyclines, of which doxycycline showed the strongest effect, led to a 
significant inhibition of cytoplasmic protein synthesis without affecting the rate of 
glycolysis and respiration or the energy charge in the epithelial cells. These obser-
vations tend to support the view that the toxic effects of OTC are mainly based on its 
interaction with cytoplasmic protein synthesis under conditions of drug accumulation 
in blood and tissues. The lowering of energy charge in liver and intestine after prolonged 
treatment may be interpreted as secondary effects of this action, namely of fatty 
infiltration in the liver and structural damage of the villous epithelium respectively. 
A NUMBER of antibiotics which inhibit protein synthesis in bacterial 70 S ribosomes 
also interfere with the mitochondrial protein synthesis in eucaryotic cells such as 
yeast, Neurospora crassa and mammalian systems. 1 - 3 The consequences of this in-
hibitory action for mitochondrial structure and function can be studied most success-
fully in tissues with a rapid and continuous de novo synthesis of mitochondrial com-
ponents. In our previous work, the small intestinal epithelium of adult rats had been 
used as a model system because of its unequalled high cellular turnover rate4 Treat-
ment of rats with chloramphenicol (CAP) or oxytetracycline (OTC) during about 48 
hr led to drastically decreased levels of the mitchondrial cytochromes aa3 and b 
in the intestinal villous and crypt cells without significantly affecting the contents of a 
variety of other mitochondrial- and extramitochondrial enzymes. 4 • 5 Prolongation of 
the OTC treatment beyond 2 days caused a considerable loss of body weight, lethargy, 
diarrhea and severe structural damage of the intestinal epithelium, resulting in a 
2659 
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lowered protein yield of the villous cells after isolation. No similar toxic effects were 
observed with CAP even after 96 hr of treatment although both antibiotics evoked an 
equal decrease of cytochrome levels.•-• These results suggested that the toxicity of 
OTC was not based on its interference with mitochondrial protein synthesis but that 
the antibiotic had another site of action in mammalian cells, appearing after accumu-
lation of the drug during prolonged treatment at serum concentrations above 50 l"gf 
ml. 4 High-concentration effects of CAP, e.g. a direct inhibition of cellular respira-
tion, 7 • 8 were not expected because the intramuscular administration guaranteed 
serum levels not surpassing 50 l"gfml during the whole course of the experiment• 
In the present study, more information was obtained about the energy metabolism 
of the intestinal mitochondria in vivo and in vitro under conditions of greatly depressed 
cytochrome levels (about 2 days after the start of the injection series) and after pro-
longed treatment with OTC when villous cell loss occurred. In addition, attemps were 
made to localize other targets of OTC in the intestinal cells. The villous and crypt cell 
preparations proved to be useful models for a study of the action of tetracycline anti-
biotics at subcellular levels in mammalian systems. 
EXPERIMENTAL 
Animals. Male, specific pathogen free, Wistar rats, weighing 200-230 g, were used 
throughout. They were maintained on a normal laboratory diet and water ad lib. Rats 
were sacrificed by cervical dislocation. 
Chemicals. Enzymes and cofactors were purchased from Boehringer and Sons 
(Mannheim, W. Germany), 2,4-dinitrophenol and oligomycin from the Sigma 
Chemical Co. (St. Louis, Mo., U.S.A.), fatty acid poor bovine serum albumin from 
Pentex (Kankakee, Ill., U.S.A.) and TMPD (N, N, N', N'-tetramethyll,4-phenylene-
diaminedihydrochloride) from Fluka, A. G. (Buchs, Switzerland). All other chemicals 
were analytical grade. 
Antibiotics. Chloramphenicol (sodium succinate) was obtained from Nogepha, 
Amsterdam, Holland. Oxytetracycline (Terramycin), obtained from Chas. Pfizer 
& Co., Inc., New York and Tetracycline(Achromycin), purchased from R.I.T., Genval, 
Belgium, were used in the form of their hydrochlorides. Doxycycline (Vibromycin), 
obtained from Pfizer, was used as the hyclate salt (hydrochloride, hemihydrate, 
hemi-ethanolate ). 
Administration of the antibiotics in vivo. Serum levels of D(-)-threo chloramphenicol 
(CAP) between 10 and 50 l"gfml were continuously maintained by intramuscular 
injection of 280 mg CAP-succinate/kg body wt every 4 hr. Oxytetracycline was in-
jected intramuscularly over 8 hr at a dose of 300 mgfkg body wt per 24 hr. After 48 hr 
of treatment, serum levels fluctuated between 50 and 120 l"g/ml. Further details are 
reported elsewhere. 
Assays. The conditions for the determination of protein and alkaline phosphatase 
(EC 3.1.3.1) are reported by Iemhoff et af.9 Esterase activity was measured as de-
scribed by Higgins and Lapides. 10 
Preparation of epithelial cell suspensions, lwmogenates and mitochondrial fractions. 
Villous- and crypt cells originating from the whole length of the small intestine were 
harvested separately according to the high-frequency vibration technique of Harrison 
and Webster4 • 11 in a medium containing 0·01 M Tris-HCl buffer, 0·13 M NaCl and 
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5 mM EDTA (final pH 7·6). Cells and cell sheets were collected by centrifugation 
for 15 sec at 800 g m><· Homogenates of villous cells were prepared in a medium, 
containing 0·25 M sucrose, 20 mM Tris-HCl buffer, 1 mM EDTA and I mg/ml bovine 
serum albumin (final pH 7·4), by treatment of the suspension for 60 sec with a small 
Polytron homogenizer (type PT 10, Kinematica, Luzern, Switzerland) set at position 
4·5 (8000 rev/min). Subfractionation of the homogenate was carried out according to 
the scheme, extensively described by H\ilsmann et alu The gentle homogenization 
procedure used gave a small yield of mitochondria. Their quality however, was better 
than of those obtained by earlier methods13 where higher yields were obtained. 
Preparation of rat liver mitochondria. Rat liver mitochondria were isolated according 
to Schneider14 in a medium containing 0·25 M sucrose, 0·01 M Tris-HCl and 1 mM 
EDTA (pH 7·4). After removing the fluffy layer on top of the mitochondrial pellet by 
washing with sucrose, the mitochondria were washed four times by resuspension in 
the isolation medium and resedimenting at 6500 g for 10 min. The final pellet was 
suspended in the isolation medium to a final concentration of about 30 mg 
protein/mi. 
Polarographic experiments. Oxygen uptake was recorded polarographically with a 
Clark oxygen electrode (Yellow Springs Instrument Co.) at 30° in an air-saturated 
medium in a final volume of 1·6 mi. Villous cells were incubated in a Ca 2 +-free Krebs 
Ringer bicarbonate buffer, pH = 7·4. The incubation medium for cell homogenates 
and mitochondrial preparations contained 250 mM sucrose, 20 mM Tris-HC!, 1 mg/ 
ml bovine serum albumin, 5 mM potassium phosphate and 1 mM EDTA. The final 
pH was 7·2. The measurements were started after addition of 1-4 mg of cellular or 
mitochondrial protein. For calculation of P /0 ratios and respiratory control indices 
(RCI) from the stimulation of respiration rates caused by ithe addition of 200 nmoles 
ADP, the method of Chance and Williams15 was applied, except in the experiments 
described in Table 4 with intestinal mitochondria. In that case, the basic reaction 
medium in the polarographic vessel was supplemented with 2 mM MgCl2 , 16 mM 
glucose, 10 IU of dialyzed hexokinase (EC 2.7.1.1) and 200 nmoles ADP. After 
determination of the oxygen uptake following the addition of the mitochondria in the 
presence or absence of OTC, the reaction was terminated by addition of HC104 
(final concentration 4 per cent). After deproteinization and neutralization with 
KOH, the samples were assayed for hexosemonophosphate. Further details are 
reported elsewhere. 16 
Determination of adenine nucleotides and creatine phosphate in intestinal segments, 
epithelial cells and liver. Rats were anaesthetized with Nembutal. After opening their 
abdomen through a midline incision and cannulation of the lumen at the proximal 
part of the duodenum, the terminal ileum was tied off and cut near the ligature. The 
lumen contents of the small intestine were carefully removed by rinsing with saline 
(temperature: 38°). The jejunal part of the intestine was quickly frozen by means of a 
Wollenberg clamp, precooled in liquid nitrogen. The frozen tissue was pulverized in a 
porcelain mortar, kept cold with liquid nitrogen, mixed with 5% HC!04 , thawed and 
centrifuged. The pellet was used for the determination of DNA. 1 7 After filtering the 
supernatant through "Millipore" filter (pore size 0·41-'m) it was neutralized with KOH 
and centrifuged. ATP, 18 ADP, 19 AMP19 and creatinephosphate20 (CP) were deter-
mined enzymically within 3 hr from the start of the operation. 
Freeze-clamping of the right lobe of the liver was performed after elevation by 
B.P. 22/21-B 
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means of a loose ligature conducted through the organ with a needle. Determinations 
of DNA and adenine nucleotides were carried out as described for intestine. 
Levels of adenine nucleotides and DNA in freshly isolated villous cells were deter-
mined after gentle shaking of 1·5 ml of a cell suspension (15-20 mg protein) in a Ca 2 +-
free Krebs-phosphate buffer, containing 10 mM glucose, for 20 min in polyethylene 
vials at 37". The cells were rapidly disrupted by the addition of 1·5 ml 10% HC!04 , 
immediately followed by an ultrasonic desintegration procedure. Hereafter the same 
procedure was followed as described for freeze-clamped samples. 
Glucose metabolism in isolated intestinal villous cells and human erythrocytes. 
Glucose utilization was measured in 2 rnl of a Ca' +-free Krebs Ringer-phosphate 
buffer (pH 7·4) containing I 0 mM [l-14C]glucose (20 I'Ci/m-mole). Villous cell 
suspensions were incubated in polyethylene vials for 30 min at 37', as described in the 
previous section. The cells were preincubated with the drugs for 10 min before the 
addition of glucose. Glucose consumption, lactate production and the production of 
C02 , originating from the !-position of glucose, were measured according to Iemhoff 
eta/. 9 Human erythrocytes were collected from heparinized blood samples and washed 
three times with 8 volumes of saline. The top layer and buffy coat were discarded and 
the packed cells were suspended in an equal volume of the incubation medium. For 
measurements of glucose metabolism, the same procedure was applied as described for 
viii o us cells. 
Incorporation of 14C labeled amino acids into protein of isolated villous and crypt 
cells. Isolated villous and crypt cells were suspended in a Ca 2 +-free Krebs Ringer-
phosphate buffer, pH 7·4, fortified with a mixture of L-amino acids of the same con-
centration and composition as used in the Basal Medium, described by Eagle et a/. 21 
Incubations of 1·1 ml aliquots (protein content 5-20 mg) were carried out in polyethy-
lene vials at 37" as described before. After preincubation in the presence of the anti-
biotics for 5 min, the incorporation of labeled amino acids was started by addition of 
0·25 0Ci[14C]am.ino acid mixture(sp. act. 52 mCijmAtC; code CFB.25, Radiochemical 
Centre, Amersham) and was stopped after 15 min by the addition of 6 ml ice-cold 5% 
trichloroacetic acid (TCA). The precipitate was centrifuged and resuspended in TCA 
(5% wjv) by ultrasonic homogenization. After standing at 90" for 30 min the 
suspension was centrifuged again and the pellet was washed once with TCA 
and once with 5 ml ethanol-diethyl ether (2: !, vjv). The final pellet was taken up in 
0·5 ml NCS solubilizer (Amersham, Searle) and sonified. This solution was transferred 
to counting vials, 10 ml toluene liquifluor was added and counting was performed in a 
liquid scintillation counter with automatic standardization. 
Measurement of 3H thymidine incorporation into DNA of villous and crypt cells 
after in vivo administration of the label. Control rats and rats treated for 80 and 60 hr 
with OTC, wereinjectedintraperitoneallywith ['H)-thymidine ([3H]methyl-thymidine, 
specific activity 37·8 Cijm-mole, Radiochemical Centre, Amersham). Treatment with 
OTC was continued for 20 and 40 hr respectively. The animals were then sacrificed 
and their guts were removed. A duodenal segment (5 em below the pylorus) was pro-
cessed for autoradiography. According to Harrison and Webster, 11 different villous 
cell fractions were harvested during the vibration procedure, as judged from the 
specific activity of alkaline phosphatase and esterase (Table 1). The first fraction 
(vibration time 0-10 min, amplitude 0·2 em) mainly contained cells from the apical 
areas of the villi and the third fraction (18-27 min) appeared to be rich in basal 
TABLE 1. DISTRIBUTION OF LABELED DNA IN CRYPT AND VILLOUS CELL FRACTIONS 20 AND 40 hr AFTER [3H]METHYL-THYMIDINE LABELING 
Specific incorporation 
Esterase (nmoles Alkaline phosphatase (10-
3 x dis/min X ftg- 1 DNA) 
mg protein Total protein x min- 1 X mg- 1 (nmoles x min - 1 x 
(mg) mgDNA protein) mg- 1 protein) 20 hrt 40 hrt 
Cell fraction Control OTC* Control OTC Control OTC Control OTC Control OTC Control OTC 
Villous fraction 1 29 18 16·9 16·7 2900 3110 390 175 0·4 0·6 J.4 1·2 
Villous fraction 2 37 12 16·4 1H 2600 2780 165 83 H 1·0 1·3 H 
Villous fraction 3 24 15 15·2 n9 1960 2040 141 55 1·4 H 1·0 1·2 
Crypt fraction 30 27 9·7 10·5 1020 1010 32 29 H J.4 H 1·0 
Total fractions 120 72 
* Period of OTC-treatment: 100 hr. 
t Period after pulse-labeling with [3 H]thymidine. 
For details concerning the isolation of cells, the antibiotic treatment and the determinations see Experimental. Each value represents an average of six 
animals, except for the calculations of specific incorporation, where values derived from three animals were used. 
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villous cells. After isolation of the crypt cells by means of dilatation and vibration, the 
fractions were centrifuged and the cells resuspended in isolation medium, from which 
samples were drawn for the assay of protein and enzymes. The cells were then pre-
cipitated with ice-cold TCA (5% w/v) and centrifuged again. The precipitates were 
washed four times with !Om15% TCA and twice with !Om! ethanol-diethylether 
(2: I, vjv) and were finally taken up in 5% TCA. Part of this suspension was used for 
determination of DNA. 17 The other part was centrifuged again. The final pellet was 
taken up in 0·5 ml NCS and counted, as described for the protein samples in the 
previous section. 
Autoradiography. Duodenal segments were fixed in neutral formalin. Paraffin 
sections were cut at 6 p.m and coated with Ilford K -2 emulsion. After an exposure 
time of 4 weeks the sections were poststained with hematoxylin and eosin. The average 
distance covered by labeled cells was determined from micrographs of perfect longi-
tudinal cut crypts and villi. For each animal 10-15 sections were examined and 20-25 
crypts and villi were measured. 
RESULTS AND DISCUSSION 
Turnover rate of the intestinal cell population after OTC-treatment. As shown in 
previous reports,'·' after treatment of rats for 48 hr with OTC or CAP a minimal 
value of cytochrome aa3 content in the epithelial cells was reached corresponding with 
about 25-30 per cent of the control value, whereas cytochrome b showed a residual 
activity of about 40 per cent. No further decrease was observed after prolonged treat-
ment. The residual activities of the cytochromes may be explained by an incomplete 
inhibition of mitochondrial protein synthesis by OTC or CAP under the in vivo con-
ditions or, alternatively, by a strong reduction of the turnover rate of the intestinal 
cell population. According to Firkin and Linnane, 8 long-term treatment of Hela cell 
cultures with CAP caused an 80 per cent decrease of cytochrome aa3 content resulting 
in a loss of dividing activity. Since a similar inhibition of the proliferation of in-
testinal crypt cells should provide a reasonable explanation for the structural altera-
tions of the villous epithelium after prolonged treatment with OTC, this hypothesis was 
tested by comparing the proliferative activity of crypt cells from normal rats with 
those from OTC rats during a period between 60 and 100 hr after the first injection 
of the antibiotic. For that purpose, the incorporation of [3H]thymidine in the crypt 
cells and the migration of the label from the crypt to the villous top was measured as 
described in the Experimental section. 
Table I shows that 20 and 40 hr after the injection of ['H]thymidine the specific 
activity of DNA in the three villous fractions and in the crypt of the OTC-rats does 
not differ significantly from the control. Incorporation of (3 H]thymidine into the DNA 
of the crypt cells did not seem to be impaired by the antibiotic treatment for 60 or 80 
hr. The data also suggest that the migration of label to the villus top had not been 
delayed by OTC-treatment for 100 hr. However, because of the OTC-induced morpho-
logical changes, especially of the villus, examined histologically, 6 and the incomplete 
separation of cells from different regions of the villus, indicated by the presence of 
label in villous fraction I 20 hr after the pulse, autoradiography was considered as a 
more accurate technique to trace a possible change in turnover time after prolonged 
antibiotic treatment. 
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Table 1 also shows that the protein/DNA ratio in the fractions was not significantly 
changed, indicating that the diminished yield of villous cell protein ( cf. also Ref. 4) 
was accompanied by a loss of DNA, which is most easily explained by an increased 
extrusion of villous cells during the antibiotic treatment. The loss of villous cells 
contributes to the sharp decrease in villus length, observed histologically (Fig. 1). 
Finally, the specific activity of the marker enzyme alkaline phosphatase, in contrast 
with esterase, was decreased after OTC-treatment for 100 hr (Table 1). A similar 
specific depression of this enzyme has been observed following in vivo administration 
of cycloheximide, a potent inhibitor of protein synthesis, at concentrations not in-
hibiting cell migration. 22 
100 
control control 
5 
0 
0 40 40 
FIG. 1. Abscissa: hours after (3 H]thymidine pulse. Ordinate: average distance of migration (arbitrary 
units of length) of (3 HlthymidineMlabeled cells (shaded) on the duodenal villi (open). 0 =crypt 
bottom, 100 =villus length of control rats. Period of OTC-treatment = 100 hr. 
Autoradiographic results, given in Fig. 1, show that the distance travelled by the 
label 20 hr after the [3H]thymidine pulse was not significantly changed by OTC-
treatment. In both cases, the boundary between labeled and unlabeled cells was 
located 8-12 cell positions above the villus-crypt junction. Apparently OTC-treat-
ment did not drastically alter the rate of proliferation of the crypt cells. After 
another 20 hr the label was at about the same space from the villus top in control 
and OTC rats. This means, however, that the migration rate of the villous cells was 
reduced, because the villus length had decreased markedly (Fig. 1 ). This retardation 
may be explained by a partial loss of cells during their migration to the villus top, in 
addition to a reduction of cell size, due to a general dehydration of the animal, as is 
occasionally observed during treatment with high doses of OTC. 23 
Influence of OTC and CAP administration in vivo on respiration and energy pro-
duction of intestinal mitochondria in vitro. From the lack of influence of the OTC-
administration on the proliferative activity of the crypt cells it might be concluded 
that the energy production in these cells had not been drastically reduced by the 
antibiotic. However, this does not exclude a diminished mitochondrial energy pro-
duction, because, as in beating heart cells, 24 the glycolytic capacity of the intestinal 
tissue might conpensate for such a decrease. A deficiency of oxidative phosphorylation 
may result from two factors: a lowered rate of electron transport, induced by critical 
levels of the affected cytochromes and/or a partially uncoupled state of the mito-
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chondria, as might arise under conditions of a decreased rate of synthesis of some of 
the coupling factors (cf. Refs. 8, 24, 25). These two possibilities were investigated in 
experiments with isolated villous cells, homogenates and mitochondrial fractions 
derived from 48 hr OTC- or CAP-treated rats, when minimal levels of the cytochromes 
aa3 and b were obtained. The results are presented in Table 2. 
Villous cell suspensions in Krebs-phosphate buffer maintained a high rate of 
endogenous respiration for at least 3 hr after the isolation. A KCN-sensitivity of 
9()...95 per cent was found. In most of the control preparations the Q0 , value was not 
influenced to an appreciable extent by the addition of glucose, pyruvate and cofactors 
such as ADP and NAD+. Succinate, an amino acid mixture or 2,4-dinitrophenol 
gave a slight and variable stimulation. After gentle homogenization of a cell suspension 
in sucrose medium in the presence of ADP, P, and bovine serum albumin, the respira-
tion decreased to a low level, but could be greatly enhanced by the addition of the 
substrates indicated in Table 2. No stimulation by cytochrome c or NADH was 
observed. Polarographic measurements of oxidative phosphorylation in homogenates 
and mitochondrial preparations were only successful in a Mg2 +-free sucrose-medium 
in the presence of I mM EDTA in order to suppress the hydrolysis of ATP and ADP 
by the Zn2 + -dependent enzyme alkaline phosphatase.26 Addition of 1·5-3 mM Mg2+ 
to the medium caused a similar stimulation of state 4 respiration as could be induced 
by the uncoupler 2,4-DNP (results not shown). According to preliminary experiments, 
Mg2 + stimulates the mitochondrial-bound hexokinase in the preparations. The 
glucose arises from the sucrase activity present in contaminating brushborder frag-
ments. Furthermore, the preparations contain a specific oligomycin-sensitive Mg2 +-
ATPase, which has been noticed also in mitochondrial preparations of heart- and 
skeletal muscle.27 •28 Under our conditions we obtained P:O and RCI values, which 
exceeded those measured by Clark and Sherrat'9 in mitochondrial preparations from 
guinea-pig mucosa. These authors described a defective oxidative phosphorylation in 
small intestinal mitochondria isolated from the rat. As shown in Table 2, the only 
significant differences in maximal Q0 ,, observed between control and 48 hr OTC- or 
CAP-treated rats, appeared with sonicated preparations in the presence of cytochrome 
c and TMPD plus ascorbate as substrate (sonication caused a ten-fold stimulation of 
respiration). In that case, the decrease of Q02 to about 35 per cent of the control 
value, agrees with the strongly reduced activity of cytochrome c oxidase mentioned 
before.'·' However, since the lowered level of TMPD-ascorbate oxidation always 
exceeded the respiration rates found with the other substrates, the electron transport 
process via cytochrome aa3 need not be rate-limiting for the overall oxidation with 
these compounds, neither in the control, nor in the treated rats. The results of the 
measurements of state 3 oxidation rates, P: 0 ratios and RCI values with succinate 
and NAD+ -linked substrates, summarized in Table 2, indicate that neither an in-
fluence on the rates of electron transport, nor on the phosphorylating efficiency could 
be detected in the cytochrome-depleted mitochondria. Similar results for heart 
mitochondria were obtained by Hallman' after treatment of neonatal rats for 4 days 
with CAP. Furthermore, Firkin and Linnane30 failed to detect an effect of CAP on 
the respiration and P: 0 ratios of mitochondria from regenerating liver. Apparently, 
even in isolated mitochondria lacking 6()... 70 per cent of their content of cytochrome b 
and aa3 , state 3 oxidation rates are not limited by the turnover rates of these cyto-
chromes. However, these experiments do not entirely exclude the possibility that under 
TABLE 2. RESPIRATION RATES AND OXIDATIVE PHOSPHORYLATION IN VILLOUS CELLS AND HOMOGENATES PROM CONTROL RATS AND RATS TREATED FOR 48 hr WITH 
OTCoRCAP 
Cells Total homogenates 
Substrate added Qo, Qo, p,o RCI 
Control Treated Control Treated Control Treated Control Treated 
1l = 8 1l = 16 n=8 n = 6 n = 8 n=6 ll = 8 1l = 6 
19·2 17·5 3-1 3-6 
±0·7 ±1·0 ±0·4 ±0·5 
Glucose 20·5 17·9 
(30 mM) ±1·2 ±0·9 
Succinate 24·0 20·5 31·2 27·8 2·14 2·05 2-47 2·21 
(5 mM) ±1·5 ±1·7 ±2·7 ±2·7 ±0·12 ±0·13 ±0·16 ±0·41 
Glutamate 15·2 15·7 3·20 3·09 3-15 3·03 
(5 mM) ±1·8 ±2·0 ±0·14 ±0·17 ±0·13 ±0·16 
3-DL-Hydroxybutyrate 15·3 14·1 2·84 2·80 2·24 2-16 
(5 mM) ±0·9 ±1·2 ±0·10 ±0·11 ±0·15 ot0·16 
Pyruvate (10 roM) plus 15·1 13-6 3·02 2·94 2·21 2·35 
L-malate (2 mM) ±1·3 ±1·3 ±0·13 ±0·18 ±0·12 ±0·14 
IMPD (0·5 mM) plus 106 44·6 
ascorbate (10 roM) ±6·2 ±8·1 
plus cytochrome c p < 0·01 
The Q 02 values, measured polarographically as described in Experimental, are expressed as nmoles 0 2 consumed/min/mg protein followed by their standard 
errors. P-values were calculated using the Student /-test. The Q02 of homogenates is given for state 3 respiration rates. Final substrate concentrations are 
indicated in parenthesis. All substrates were added in the form of their sodium salt. Calculations of respiration rates with TMPD plus ascorbate, measured 
with sonicated preparations, were corrected for auto-oxidation. Because the results with CAP- and OTC-rats showed no significant differences, all data 
obtained after both kinds of treatment, were pooled for the calculation of mean values and standard errors. With preparations of isolated mitochondria 
(results not shown), P: 0-ratios and RCI-values were essentially similar to those measured with total homogenates, the Q0 2-values increased about twice. 
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certain in vivo conditions higher rates of respiration are required, which cannot be 
sustained by the low levels of the affected cytochromes (cf. Ref. 31). Therefore we felt 
that additional information concerning the energy metabolism in the intestine in vivo 
was needed. 
Levels of adenine nucleotides and creatine phosphate in small intestinal tissue and 
liver of the rat in vivo after OTC- or CAP-treatment. A depression of oxidative phos-
phorylation in vivo was expected to evoke similar alterations as occur under hypoxic 
conditions, e.g. a decrease of the energy stores in the epithelial cells, concomitant with 
an increased rate of glycolysis. 32 Such changes can only be measured accurately with 
the aid of the freeze-clamping technique, because a preliminary isolation of epi-
thelial cells leads to a rapid and irreversible fall in A TP content of the tissue. 9 How-
ever, the contribution of the muscle layer to the energy reserves in the freeze-clamped 
samples cannot be measured directly. Assuming an equal nucleotide content per mg of 
dry matter in intestinal epithelial cells and muscle of control rats, about 40 per cent 
of the estimated nucleotides is derived from the muscle layer. 33 An unequal distribu-
tion of creatine phosphate (CP), between epithelial cells and muscle cells is unlikely, 
as we have found that about 60 per cent of the total activity of creatine kinase in 
small intestinal tissue was recovered in isolated villous- and crypt cells.* Therefore, a 
specific influence of the antibiotic treatment on the energy metabolism of the epi-
thelial cells should manifest itself in a significant change in the content of adenine 
nucleotides, as well as of CP in total intestinal tissue. For comparison, levels of nuc-
Ieotides were measured in liver of rats subjected to the same OTC regime. 
Table 3 shows that intramuscular treatment of the rats for 2 days with OTC or 
for 3 days with CAP had no significant influence on the levels of ATP, ADP, AMP and 
CP in intestine and liver, as compared with saline-injected rats. This indicates that, 
in accordance with the in vitro results with isolated mitochondria, the cytochrome-
poor mitochondria in intestine kept their normal ATP-generating capacity. However, 
after 3 days of OTC-treatment, the energy charge of the adenyl ate system in liver and 
intestine, proposed by Atkinson 34 as an important metabolic regulatory parameter, 
and the CP-content of intestine showed a significant decrease. Histochemical in-
vestigations showed an excessive accumulation of fat in the liver (unpublished results), 
in agreement with many earlier reports about the effects of high doses of OTC or 
tetracycline (TC) on liver, 35 - 37 and a structural damage of the intestinal villus,O 
in which no accumulation of fat was found. 
Both observations may explain the substantial fall of phosphate potential in these 
organs or, alternatively, both phenomena are the consequences of a decreased A TP-
content of the cells. In the latter case, the energy deficiency is most probably caused 
by a direct effect of OTC, accumulated in liver and intestine, on energy providing 
processes, e.g. oxidative phosphorylation or glycolysis. This hypothesis was further 
tested using isolated intestinal cells and mitochondria from intestine and liver as 
model systems. 
bifluence of OTC on glucose utilization in intestinal epithelial cells and erythrocytes. 
According to a recent report of Carevic and Cerlek, 38 erythrocytes of patients treated 
with OTC (I gjday for 2 days) and human erythrocytes incubated in the presence of 
100 ,ug/ml of this antibiotic, showed a strongly reduced rate of glucose utilization. 
However, our results apparently conflict with this result. Under similar conditions 
* H. R. de Jonge, unpublished results. 
TABLE 3. LEVELS OF ADENINE NUCLEOTIDES AND CREATINE PHOSPHATE IN JEJUNUM AND LIVER OF THE RAT bt vivo 
Metabolite concentrations (nmoles/mg DNA)* ATP' 
Number of Duration of ---ATP ADP AMP CP Energy charge*, t ADP +AMP 
Dose/injection injections treatment ~~ 
Drug (mg(kg body wt) per 24 hr (hr) I L I L I L I I L I L 
Saline - (I.M.) 3-6:j: 48-72:j: 230 1470 41 356 9 42 220 0·89 0·88 4·56 3·66 
(n ~ 5) ±9 ±52 ±2 ±18 ±2 ±5 ±15 ±0·02 ±0·01 ±0·30 ±0·20 
OTC 100 (l.M.) 3 48 223 1312 44 370 7 39 210 0·89 0·87 4·48 3·21 
(n ~ 4) ±14 ±39 ±3 ±21 ±2 ±7 ±21 ±0·03 ±0·01 ±0·25 ±0·24 
OTC 100 (l.M.) 3 72 167 810 70 758 16 86 132 0·80 0·72 2·00 0·96 
(n ~ 4) ±10 ±62 ±6 ±40 ±4 ±11 ±9 cl0·02 ,l0·02 ±0·29 ±0·17 
P<0·05 P<O·OS P<0·05 P<0·05 P<0·05 P<O·OS P<O·OS P<0·05 P<0·05 P<0·05 P<0·05 
CAP 200 (I.M.) 6 48 250 45 12 234 0·88 4-40 
(n ~ 3) ±12 ±5 ±5 ±19 ±0·03 ±0·33 
CAP 200 (I.M.) 6 72 233 38 10 250 0·89 4·85 
(n ~ 3) ±8 ±6 ±4 ±16 ±0·03 ±0·30 
*Values are given as means ±S.E. 
t The energy charge of the adenylate system is defined as the ratio (ATP + !ADP)/(ATP + ADP + AMP). 34 
~ No significant differences were found between saline-injected rats after different methods of treatment. Therefore, all values were pooled for calculation 
of mean values and standard errors. 
Abbreviations used: I = intestine, L =liver, I.M. =intramuscular, n =number of rats, P =probability value, calculated by the Student t-test. 
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in vitro, incubation with 100-300 ,ugjml of oxytetracycline, tetracycline or doxycy-
cline for 30 min did not affect glucose consumption of intestinal epithelial cells (mean 
value: 15·8 nmoles X min- 1 X mg- 1 protein glucose used) or human erythrocytes 
(2·07 ,umoles X hr- 1 x ml- 1 packed cells). Also the lactate production (27·5 and 
3·9 respectively) and the production of C02 originating from the !-position of glucose 
(2-4 nmoles x min - 1 X mg- 1 protein for villous cells) were not appreciably affected. 
If an extremely high dose of OTC (400 mg/kg body wt) was given to rats by means 
of a stomach tube or intraperitoneal injection, essentially the same results (not 
shown) were obtained with villous cells isolated 4 hr later. Since a direct action of the 
tetracyclines on glycolysis could not be confirmed by our experiments, we tend to 
believe that the changes in carbohydrate metabolism observed after tetracycline-
treatment39·40 mainly result from an impaired function of the fatty liver. 
Influence of oxytetracycline on oxidative phosphorylation in vitro. As suggested by 
Linnane et a/.,41 •42 considering mitochondrial ribosomes as an integral part of the 
mitochondrial membrane, inhibitors of mitochondrial protein synthesis may interact 
with other membrane functions, e.g. oxidative phosphorylation and electron 
transport. Indeed, it has been established that high concentrations of CAP, 7 •8 
carbomycin, oleandomycin, paromycin41 and mikamycin43 may interfere with 
respiration. Brody et a/44 described an inhibitory action of 5 x w-• M OTC (300 
,ug/ml) on oxidative phosphorylation and octanoate oxidation by isolated Mg2 +-poor 
mitochondria from rat liver and brain. This inhibition could be reversed in the 
presence of excess Mg2 + -ions. 
Reinvestigation of these effects (Table 4, Fig. 2) revealed a rather complex inter-
M 2.0 mg 
: 
• 
succ 
~ 
t,. M, 
M4.1 mg l pyr~+mol M 4.1 mg l pyr +mol 
t • 
OTC f 
OTC Mg2''" 
ADP 
ADP • 
FIG. 2. Effect of oxytetracycline on mitochondrial respiration. Oxygen uptake was determined 
polarographically at 30° in a medium containing 250 mM sucrose, 20 mM Tris-HCI, 1 mM EDTA, 
5 mM potassium phosphate buffer and 1 mg/ml BSA, pH 7·2. Additions: M =liver mitochondria 
(mg of protein); 2mM Mg>+ as MgCI2 ; 200~g/ml OTC (0·33mM); 200nmoles ADP; JO~g 
oligomycin; 10- 4 M2, 4-dinitrophenol; substrate concentrations: see Table 4. 
TABLE 4. EFFECT OF OXYTETRACYCLINE ON OXIDATIVE PHOSPHORYLATION OF MITOCHONDRIA ISOLATED FROM RAT SMALL INTESTINAL EPITHELIUM AND LIVER 
Intestinal mitochondria Liver mitochondria 
Mg2 + omitted 2mMMg2+ 2mM Mg2 + 
-
Qo, Qo, Qo, 
OTC Qo, Qo, Oo, p,Qt (state 4) (state 3) (uncoupled) p,Q 
Substrate (~g/m1) (state 4) (state 3) (uncoupled)* At B§ A B A B A B A B 
Succinate (5 mM) 0 28 70 75 2·3 21 117 124 2-1 
200 41 48 76 1·2 2·2 50~ 19 65 115 118 120 0·6 1·9 
Pyruvate (10 mM) 0 11 35 37 3·0 7 44 46 2.9 
+ L-ma1ate (2 mM) 200 13 17 26 1·4 2·6 9 7 20 39 27 40 1·4 2·4 
I 
g, 
l 
~ 
s· 
~ 
Q02 values are expressed as nmoles 0 2 consumed/minfmg of protein. The polarographic experiments were carried out six times with different mitochondrial ~ 
preparations. All results were quite reproducible. 
* The uncoupled state was induced by IQ- 4 M dinitrophenol (DNP) added to ADP supplemented mitochondria. 
t P:O ratios were determined using the glucose hexokinase assay described in Experimental. No inhibition of HKwactivity was observed under these con-
ditions (200 ~gfm1 OTC, 10 I.U. HK). 
t Columns A represent P:O or Q02 values measured if OTC was added 1 min prior to Mg2 +. 
§Columns B refer to the experiments in which preincubation with 2 mM MgCh for 1 min preceded the addition of OTC. 
~ Higher values were obtained during a transitory period immediately after the addition of succinate (Fig. 2). 
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action of the antibiotic with the respiratory chain of Mg2 +-depleted mitochondria 
from rat liver and intestine, isolated in sucrose-Tris-EDTA medium. At concentra-
tions of 150-200 fLgfmi (175-250 nmolesjmg of protein), OTC caused a stimulation of 
succinate respiration in the energy-controlled state 4, 15 but only slightly affected 
state 4 oxidation rates with NADH-Iinked substrates (glutamate, pyruvate plus mal-
ate). Furthermore, an inhibitory effect of OTC on state 3 respiration was observed 
with all substrates tested. Addition of the uncoupler DNP released the inhibition of 
succinate oxidation but only partly restored the respiration with NADH-Iinked 
substrates. Concomitantly, P:O ratios, measured with the glucose-hexokinase assay, 
showed a strong decrease if OTC was added prior to the addition of Mg2 +-ions 
(Table 4, column A). Where this influence on the phosphorylation process could not 
be released by subsequent addition of excess magnesium (2-8 mM), it could be pre-
vented to a large extent by preincubation of the mitochondria with 2-3 mM Mg2 + 
(Table 4, column B). 
The interaction of the drug with succinate respiration may be summarized as a 
uncoupling effect, resulting in a lowering of the P: 0 ratio and stimulation of controlled 
respiration, superimposed on a partial oligomycin-like inhibition of the process of 
energy transfer, implying a depression of state 3 respiration rates. The electron 
transfer between succinate and oxygen appeared unobstructed, since DNP was able 
to release this depression. If NADH-Iinked substrates are offered, the uncoupling 
effect of OTC, traced by a strong decline of the P: 0 ratio, does not manifest itself 
clearly in a stimulated rate of state 4 respiration. This may be explained by an addi-
tional influence of the antibiotic on the rate of transfer of reducing equivalents from 
these substrates to cytochrome b, suggested as well by a decrease of the Q0 , values in 
the uncoupled state. 
The behaviour of Mg2 +-poor mitochondria in the presence of OTC and other 
tetracyclines is similar, in certain aspects, to the detrimental action of 25-100 mM 
Na+ on oxidative phosphorylation, described by G6mez-Puyou et a/.45 for liver 
mitochondria, incubated in a Mg2 +-free sucrose-EDT A medium. Here too, the 
respiratory control could be restored by including Mg2+ in the incubation mixture. 
This similarity and the insensitivity of the tetracycline action to subsequent addition 
of Mg2 + suggest that tetracyclines exercise a rather aspecific and readily irreversible 
influence on the structure of the Mg2 +-depleted mitochondrial innermembrane, 
where the respiratory chain and the enzymes involved in fl-oxidation of fatty acids are 
localized. An explanation of this action, merely based on the Mg2+ -chelating pro-
perties of tetracyclines, as proposed by Brody et a/. 44 does not agree with the low 
binding constant of the Mg2 +-tetracycline complex46 and the inability of excess Mg2 + 
to cancel the action of these drugs. 
Whereas a direct inhibition of oxidative phosphorylation by high concentrations 
of tetracyclines is well established by these in vitro experiments, a similar action 
in vivo can be expected only if the concentration of Mg2 +-ions in the mitochondria 
of the cells is very low and if tetracyclines accumulate in this region. However, 
radiolabeling techniques showed that tetracycline is selectively bound to the micro-
somal fraction of liver, kidney and muscle cells of the rat 4 7 Stronger arguments 
against a disturbance of oxidative phosphorylation by these antibiotics in the intact 
cell could be derived from measurements of respiration rates and adenine nucleotide 
levels of isolated villous cells. 
Additions 
Nitrogen* 
2,4-DNP 
Oligomycin 
KCN 
OTC 
TC 
Doxy 
Concn. 
0·2mM 
35 ~g/ml 
0·7mM 
500 ~gfml 
500 ~gfml 
300 ~gfml 
TABLE 5, ADENINE NUCLEOTiDE LEVELS IN ISOLATED VILLOUS CELLS 
Adenine nucleotide levels 
(runolesfmg DNA) ATP + !ADP ATP 
~ (ATP + ADP +AMP) ATP ADP AMP ATP + ADP +AMP ADP +AMP 
260 99 83 78 0·54 0·61 
254 24 90 140 0·27 0·10 
243 12 80 !51 0·21 0·05 
258 22 100 136 0·28 0·09 
239 10 59 170 0·17 0·04 
281 105 106 70 0·56 0·60 
254 95 71 88 0·51 0·60 
268 103 98 67 0·57 0·62 
Incubations were carried out as described in Experimental. Mean values are shown, calculated from three different experiments. For further details see 
also Table 2. 
* Anaerobiosis was maintained by a stream of nitrogen gas through two needles in rubber-capped incubation vials during the whole course of the incubation. 
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The Q0 , of villous cells, incubated for 10 min in a glucose containing Krebs-Ringer-
bicarbonate buffer, did not change after addition of 100-300 l'gfml OTC, TC or 
doxycycline (results not shown). 
Table 5 shows that the total nucleotide content per mg of DNA did not differ 
significantly from the value obtained with freeze-clamped samples of jejunum (Table 
3). This confirms the intact state of the isolated villous cells (cf. also Ref. 12). The 
energy charge in these cells appeared to be highly dependent on a proper functioning of 
!he intestinal mitochondria. Incubation of villous cells in a glucose-containing medium 
under anaerobic conditions or in the presence of the uncoupler 2,4-DNP, oligomycin, 
an inhibitor of oxidative phosphorylation, or KCN, led to a remarkable lowering of 
the cellular energy charge. However, high concentrations of OTC, TC or doxycycline 
had no effect on this parameter, although penetration into the cells was indicated by 
the influence of these antibiotics, especially of doxycycline, on the amino acid incor-
poration into cellular protein under comparable experimental conditions (see 
Table 6). 
TABLE 6. INHIBITORY EFFECT OF TETRACYCLINES ON THE INCORPORATION OF [14CJ-LABELED AMINO 
ACIDS INTO PROTEIN OF ISOLATED SMALL INTESTINAL VILLOUS- AND CRYPT CELLS 
Percentage of inhibition 
Incorporation activity of extramitochondrial 
(dis/minx mg- 1protein) protein synthesis 
Time of incubation 
Additions (min) Villous cells Crypt cells Villous cells Crypt cells 
None 7·5 260 1299 
None 15 482 2575 
CAP (50 P-gfml) 15 469 2510 
Puromycin (300 p,gfrnl) 15 37 126 92 (89-96) 95 (92-98) 
OTC (I 00 P-gfml) 15 419 2270 10 ( 8-12) 11 ( 8-13) 
OTC (300 P-g/ml) 15 355 1832 24 (23-26) 27 (24-31) 
TC (I 00 P-gfml) 15 389 2083 17 (14-19) 17 (13-19) 
TC (300 P-gfml) 15 290 1581 38 (34-41) 37 (35-38) 
Doxy (100 P-gfml) 15 368 1810 21 (19-22) 28 (25-30) 
Doxy (300 P-g/ml) 15 184 890 60 (50-70) 65 (60-70) 
KCN(0·7mM) 15 45 237 90 (88-93) 90 (86-94) 
Nitrogen* 15 56 291 88 (85-91) 88 (82-93) 
Oligomycin (35 P-gfml) 15 97 529 80 (77-84) 79 (76-83) 
2,4·DNP (0·2 mM) 15 83 424 83 (80-86) 84 (79-89) 
Each value of the incorporation activity represents the average of four determinations. The in-
corporation activities after 7·5 or 15 min were diminished with the small values found at zero min 
incubation. The extent of inhibition of cytoplasmic protein synthesis was obtained after correction 
for the diminished incorporation activity, caused by the action of 50 ,ug/rnl CAP on mitochondrial-
and bacterial protein synthesis. 
* See the legend of Table 5. 
Inhibition of cytoplasmic protein synthesis by tetracyclines. Experiments with cell 
free systems from rat 1iver48 and yeast,49 with intestinal slices50 or rings51 and 
in vivo studies of incorporation of labeled amino acids into various organs of the rat 5 2 
indicate that tetracyclines at high concentrations not only inhibit bacterial or mito-
chondrial protein synthesis, but in addition act on the 80 S-ribosomes of eucaryotic 
cells. Therefore, cytoplasmic protein synthesis is also partially inhibited. The results 
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of our studies with isolated villous and crypt cells, presented in Table 6, are in agree-
ment with this concept. The incorporation of labeled aminoacids into villous aud 
crypt cell protein, followed during an incubation period of 7·5-15 min, showed a linear 
rate. The capacity of the crypt cells for protein synthesis, expressed on a protein base, 
surpassed that of the villous cells about five times, probably reflecting the in vivo 
situation. 53 During these short-term incubations with a mixture oflabeled amino acids 
the extent of inhibition of cytoplasmic protein synthesis by 100-300 i"g/ml of the anti-
biotics varied from 10-25 per cent for OTC to 28-65 per cent for doxycycline. Puro-
mycin, a strong inhibitor of cytoplasmic- and mitochondrial protein synthesis, in-
hibited the incorporation by about 95 per cent. Although it was found that the rate 
of protein synthesis in isolated intestinal cells was very sensitive to an impairment of 
oxidative phosphorylation induced by KCN or anaerobiosis (Tables 5 and 6), even 
under conditions of a high aerobic glycolysis, this could not explain the inhibitory 
effects of the tetracyclines, because the adenine nucleotide levels in the isolated 
villous cells were unaltered under similar experimental conditions (Table 5). According 
to Ling and Morin, 51 inhibition of amino acid transport by these drugs may only be 
expected as an effect, possibly secondary to the inhibition of synthesis of a transport 
protein possessing a rapid turnover rate. It is unlikely that this action interfered with 
our studies in which very short incubation periods were used. 
The much stronger inhibitory action of doxycycline as compared with OTC or TC 
may be due to its higher lipophilicity, 54 which possibly enables it to penetrate the 
intestinal cell much easier than the other tetracyclines. Despite the potential danger 
of the use of doxycycline suggested by our incorporation studies, this antibiotic is 
specially recommended for patients with renal insufficiency. However, as shown by 
the work of Schach von Wittenau et al., 54 it has little chance to become toxic because 
of the low maintenance dose and the enhanced elimination of this compound from the 
blood by diffusion into the intestinal lumen, which prevents its accumulation in 
blood and tissues. 
In the liver the action of high concentrations of OTC on cytoplasmic protein 
synthesis may be responsible for a disturbance of lipoprotein synthesis and/or trans-
port resulting in fatty infiltration, also observed after puromycin treatment" which 
might cause the decrease of the energy charge in this organ after 3 days of antibiotic 
treatment. 
In intestine, the unchanged rate of proliferation of the epithelial cells in the OTC 
rats does not necessarily conflict with a partial inhibitory action of OTC on overall 
protein synthesis, because a degree of inhibition, much less than 80 per cent, does not 
significantly affect the number of proliferating crypt cells. 56 However, in the villus 
region it may influence the synthesis of some protein components of the brushborder, 
e.g. alkaline phosphatase, 22 transport proteins 51 or glycoproteins of the glycocalix. 
The latter might increase the lability of cell membranes, suggested by the increased 
loss of soluble enzymes from the cells during the isolation procedure,' and induce a 
loosening of cells from the connective tissue. Also chelating of calcium by the tetra-
cyclines might play a role in the displacement of the villous cells (cf. Ref. II). Moreover, 
an additional effect of the drug on glycoprotein synthesis and release by the mucus-
producing Goblet cells is conceivable in the light of a recent report of Tucker and 
Webster, 57 indicating an impaired transport and secretion of pancreatic proteins 
after administration of high doses of tetracycline. In our view the decrease of energy 
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charge in the intestinal tissue might be a consequence of the structural damage of the 
epithelium, resulting from the proposed actions of OTC mentioned above. Finally, 
inhibition of protein synthesis in other organs such as liver, kidney and pancreas 
may severely impair their function and exert secundary effects on the gastrointestinal 
morphology (e.g. dehydration23) or function (e.g. decreased absorption of fat 58). 
Also, alterations of the intestinal microfiora may affect absorption of some nutritients, 
such as iron. 59 
In conclusion it may be stated that the toxicity of OTC under our experimental 
conditions is most probably based on a primary action of this antibiotic on cyto-
plasmic protein synthesis rather than on an interaction of the drug with cellular 
energy metabolism either directly, or indirectly via depletion of mitochondrial 
cytochromes in rapidly proliferating tissues. 
Acknowledgements-The author is indebted to Prof. Dr. W. C. Hiilsmann for his suggestions and 
advice and to Mr. L. M. Scheek for expert technical assistance. He also thanks Mr. W. J. Visser 
(Department of Cell Biology, Erasmus University, Rotterdam, head: Prof. Dr. H. Galjaard) for 
doing the autoradiography. 
REFERENCES 
1. M. ASHWELL and T. S. WORK, Ann. Rev. Biochem. 39, 251 (1970). 
2. A. M. KROOM, in Inhibitors in Cell Research (Eds. TH. BUcHER and H. SIES), pp. 159-166. 
Springer, Berlin (1969). 
3. M. HALLMAN, Biochem. Pharmac. 20, 1797 (1971). 
4. H. R. DE JONGE and W. C. HiiLSMANN, Eur. J. Biochem. 32, 356 (1973). 
5. H. R. DEJONGE and W. C. HDLSMANN, Abstr. Commun. Meet. Fed. Eur. Biochem. Soc. 8, No. 663, 
Amsterdam (1972). 
6. A.M. DE PDPER and W. C. HULSMANN, Histochemie 33, 181 (1973). 
7. K. B. FREEMAN and D. HALDAR, Biochem. biophys. Res. Comrnun. 28, 8 (1967). 
8. F. C. FIRKIN and A. W. LINNANE, Biochern. biophys. Res. Cornrnun. 32, 398 (1968). 
9. W. G. J. lEMHOFF, J. W. 0. VAN DEN BERG, A. M. DE PDPER and W. C. HULSMANN, Biochim. 
biophys. Acta 215, 229 (1970). 
10. C. HIGGINS and J. LAPIDES,]. bioi. Chern. 170, 467 (1947). 
11. D. D. HARRISON and H. L. WEBSTER, Exp. Cell Res. 55,257 (1969). 
12. W. C. HDLSMANN, J. W. 0. VAN DEN BERG and H. R. DEJoNGE, Methods in Enzymology, in press. 
13. W. G. J. !EMHOFF and W. C. HULSMA:I'\'N, Eur. J. Biochern. 23, 429 (1971). 
14. W. C. SCHNEIDER, J. bioi. Chern. 176,259 (1948). 
15. B. CHANCE and G. R. WILLIAMS, Adv. Enzymol. 17, 65 (1956). 
16. W. C. HOLSMANN, J. W. DEJoNG and A. VANToL, Biochern. biophys. Acta 162, 292 (1968). 
17. D. N. CROFT and M. LUBRAN, Biochem. J. 95, 612 (1965). 
18. W. LAMPRECHT and I. TRAUTSCHOLD, in Methoden der Enzymatischen Analyse (Ed. H. U. BER-
MEYER), p. 2024. Verlag Chemie, Weinheim (1970). 
19. D. JAIVOREK, W. GRUBER and H. U. BERGMEYER, in Methoden der Enzymatischen Analyse (Ed. 
H. U. BERMEYER), p. 2051. Verlag Chemie, Weinheim (1970). 
20. W. LAMPRECHT, P. STEIN, F. HEINZ and H. WEISSER, in Methoden der Enzymatschen Analyse (Ed. 
H. U. BERMEYER), p. 1729. Verlag Chernie, Weinheim (1970). 
21. H. EAGLE, V.I. OYAMA, M. LEVY and A. E. FREEMAN, J. bioi. Chern. 226, 191 (1956). 
22. A. M. SPIELVOGEL, R. D. FARLEY and A. W. NoRMAN, Exptl. Cell Res. 74, 359 (1972). 
23. M. E. SHILS, Clin. pharmac. Ther. 3, 321 (1962). 
24. A. M. KROON and R. J. JANSEN, Biochim. biophys. Acta ISS, 629 (1968). 
25. A. M. KROON, in Atti del Semenario di Studt Biologi (Ed. E. QUAGLIARIELLO), Vol. 4, pp. 9-26. 
Adriata Editrice, Bari (1969). 
26. G. HUBSCHER and G. R. WEST, Nature, Land. 205, 799 (1965). 
27. D. D. TYLER and J. GoNzE, Methods in Enzymology Vol. X, pp. 76-77. Academic Press, New 
York (1967). 
28. L. E. ERNSTER and K. NoRDENBRAND, Methods in Enzymology Vol. X, p. 93. Academic Press, 
New York (!967). 
29. B. CLARK and H. S. A. SHERRAT, Comp. Biochem. Physio!. 20, 223 (1967). 
Toxicity of tetracyclines in rats 2677 
30. F. C. FIRKIN and A. W. LINNANE, Exptl. Cell Res. 55, 68 (1969). 
31. M. HALLMAN, Scand. J. clin. Invest. 25, Suppl. 113, 80 (1970). 
32. J. M. J. LAMERS and W. C. HOLSMANN, Biochirn. Biophys. acta 275, 491 (1972). 
33. H. S. A. SHERRAT, Camp. Biochem. Physiol. 24, 745 (1968). 
34. D. E. A. ATKINSON and G. M. WALTON, 1. bioi. Chern. 242, 3239 (1967). 
35. J. T. SETO and M. H. LEPPER, Antibiot. Chernother. 4, 666 (1954). 
36. L. D. WRUBBLE, A. J. LADMAN, L. G. BRITT and A. J. CUMMINS, JAMA 192, 92 (1965). 
37. K. BREEN, S. SCHENKER and M. HEIMBERG, Biochim. biophys. Acta 270, 74 (1972). 
38. 0. CAREVIC and N. CERLEC, Enzyrnologia 41, 53 (1971). 
39. S. BANERJEE, K. S. KUM"AR and A. BA]'..'DYOPADHYAY, Proc. Soc. exp. Bioi. Med. 125, 618 (1967). 
40. V. Y. KUDRYAVTSEVA, Antibiotiki 3, 65 (1958). 
41. A. W. LINNANE andJ. M. HASLAM, Current Topics in Cellular Regulation, Vol. 2, p. 101. Academic 
Press, New York (1970). 
42. C. L. BANN, C. H. MITCHELL, H. B. LUKINS and A. W. LINNANE, Proc. natn. Acad. Sci., U.S.A. 
67, 1233 (1970). 
43. H. DIXON, G. M. KELLERMAN, C. H. MITCHELL, N. H. ToWERS and A. W. LINNANE, Biochern. 
biophys. Res. Commun. 43, 780 (1971) 
44. T. M. BRODY, R. HURWITZ and J. A. BAIN, Antibiot. Chernother. 4, 864 (1954). 
45. A. G6MEz-Puvou, F. SANDOVAL, A. PE1~A, E. CaAvEz and M. TUENA, J. biol. Chern. 244, 533 
(1969). 
46. R. H. CoNNAMACHER and H. G. MANDEL, Biochirn. biophys. Acta 166, 475 (1968). 
47. E. DALE, J. B. BAXLEY and F. D. SCUTCHFIELD, Experientia 24, 164 (1967). 
48. T. J. FRANKLIN, Biochem. J. 90, 624 (1964). 
49. E. BoTTANER and D. VAZQUES, Biochirn. biophys. Acta 254, 316 (1971). 
50. N.J. GREENBERGER, Nature, Land. 214, 702 (1967). 
51. V. LING and C. L. MoRIN, Biochim. biophys. Acta 249, 252 (1971). 
52. S.D. J. YEH and M. E. SHILS, Proc. Soc. exp. Biol. Med. 121, 729 (1966). 
53. B. C. DAs and G. M. GRAY, Biochirn. biophys. Acta 195,255 (1969). 
54. M. SCHACH VON WITTENAU, T. M. TwoMEY and A. C. SWLNDELL, Chemotherapy 17, 26 (1972). 
55. D. S. RoBINSON and A. SEAKINS, Biochim. biophys. Acta 62, 163 (1962). 
56. R. S. VERBIN, H. LIANG, L. M. SAEz, G. DILUJSO, P. J. GoLDBLATT and E. FARBER, Exptl. Cell 
Res. 65, 81 (1971). 
57. P. C. TUCKER and P. D. WEBSTER, Am. J. Dig. Diseases 17, 675 (1972). 
58. S.D. J. YEH and M. E. SHILS, Proc. Soc. exp. Biol. Med. 123, 367 (1966). 
59. B. S. REDDY, J. R. PLEASANTS, D. R. ZINlMERMAN and B.S. WosTMANN, J. Nutr. 87, 189 (1965). 
B. I?. 22/21-c 

545th MEETING, SWANSEA 
Adenylate Cyclase Activities and Adenosine 3': 5' -Cyclic Monophospllate 
Concentrations in Villus and Crypt Cells of Rat Small-Intestinal 
Epithelium: Response to Cholera Toxin, Prostaglandin E1 and Hormones 
H. R. DE JONGE and W. C. H0LSMANN 
Department of Biochemistry I, Erasmus University, P.O. Box 1738, Rotterdam, 
The Netherlands 
The regulatory function of cyclic AMP in intestinal processes, e.g. fluid and electrolyte 
secretion (Schafer et al., 1970; Pierce eta/., 1971; Chen et al., 1972; Parkinson et al., 
1972; Guerrant eta/., 1973; Grand eta/., 1973; Kim berg eta/., 1971, 1973) and glyco-
protein synthesis (Forstner et al., 1973), has commonly been studied by use of intestinal 
biopsies, mucosal scrapings or stripped mucosa. These preparations consist of a hetero-
geneous population of epithelial cells, fragments oflamina propria and (in the latter case} 
fragments of muscularis mucosae. Information more specifically related to well-defined 
cel1 types can be obtained by measuring adenylate cyclase activities and cyclic AMP 
concentrations in relatively homogeneous preparations of villus and crypt epithelial 
cells, isolated separately by the vibration technique of Harrison & Webster (1969), as 
described by lemhoff et al. (1970) and DeJonge (1973). During the isolation procedure 
only a small percentage of the cells is damaged, as judged by leakage of soluble enzymes 
and measurements of protein and DNA synthesis (Iemhoff eta/., 1970; DeJonge, 1973). 
As shown in Table I, the cyclic AMP content of crypt cells, incubated in Krebs-
Ringer phosphate buffer, pH7.4, containing glucose, expressed on a protein base, is 
about three times that of the villus cells. The cyclic AMP concentration in the isolated 
proliferative crypt cells therefore exceeds that in the differentiated villus cells about 
!.5-2-fold (see De Jonge & Hi.ilsrnano, 1973). Extrapolation of these results to the 
situation in vivo suggests that apparently no reverse relationship exists between 
cyclic AMP content and proliferative activity of intestinal epithelial cells. The mean 
concentration of cyclic AMP determined in freeze-clamped samples of rat small 
intestine (including muscle layers and lamina propria) was found to be 4.7±0.6 (n = 6) 
and showed no significant variation along the length of the intestine. Therefore this 
method leads to values resembling those obtained with isolated villus cells. 
Table 1 also shows a stimulatory effect of prostaglandin E1, theophylline and adrena-
line on cyclic AMP concentrations. No appreciable qualitative or quantitative dif-
ferences were found in the response of either type of cells to these agents. The ,8-adrenergic 
stimulation of cyclic AMP concentrations by adrenaline may explain the increased rate 
of glycoprotein synthesis measured in intestinal slices (Forstner et al., 1973). However, 
Table 1. Cyclic AMP concentrations in villus and crypt cells of rat small intestine 
Cells, transferred to plastic vials and suspended in Krebs--Ringer phosphate buffer, 
pH 7.4,containing O.lmM-CaCh and 20mM-glucose, were incubated for 15min in a 
water bath at 37°C with gentle agitation. Cyclic AMP contents were measured in tri-
chloroacetic acid-precipitated samples by a slight modification of the method of Brown 
eta/. (1971), as described by Cooke et al. (1972). The results are expressed as means 
±S.E.M., with the numbers of animals in parentheses. 
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Conditions 
Control 
Prostaglandin E1 (I I'M) 
Prostaglandin E1 (IOf'M) 
Prostaglandin E 1 (O.!mM) 
Theophylline (!OmM) 
Adrenaline (lf'M) 
Adrenaline (IOf'M) 
Adrenaline (0.1 mM) 
Insulin (20/'units/ml) 
Insulin (200/'units/ml) 
Insulin (I munit/ml) 
Prostaglandin E 1 (O.ImM)+ 
insulin (20-200/'units/ml) 
BIOCHEMICAL SOCIETY TRANSACTIONS 
Cyclic AMP content 
(pmol/mg of protein) 
Villus cells 
4.3±0.7 (21) 
7.5±0.9 (14) 
13.1 ±0.9 (II) 
16.6± 1.3 (6) 
14.5±2.4(4) 
7.2±0.8 (12) 
8.7± 1.6 (10) 
10.4± 0.9 (6) 
4.0 (2) 
6.0± 1.2 (6) 
5.1 ± 0.7 (6) 
14.4± 2.1 (5) 
Crypt cells 
12.1 ± 1.3 (21) 
15.3±2.0 (14) 
27.8 ± 5.2 (8) 
38.0±4.5 (4) 
20.9 ± 3.0 (4) 
17.5±2.9 (12) 
19.5 ± 2.3 (7) 
17.3± 1.9 (4) 
11.7±2.1 (3) 
9.3±2.0 (6) 
10.8 ± 1.7 (6) 
34.1 ± 4.2 (5) 
the possibility cannot be excluded that this effect is limited to the mucus-secreting goblet 
cells present in our preparations. 
Insulin and glucagon, tested over a broad concentration range, were without effect on 
cyclic AMP concentrations during the short incubation period used (H. R. DeJonge & 
W. C. Htilsmann, unpublished work). Although intestinal metabolism is generally con-
sidered to be insensitive to insulin under physiological conditions, the brush borders of 
the villus ceJls may contain insulin receptors responding to insulin added to the 
intestinal lumen. Further investigations in vivo, with prolonged exposure times and low 
insulin concentrations, to test this hypothesis, might have important implications in 
view of a possible therapeutic value of luminal-administrated insulin in cases of Vibrio 
cholera infections (compare Cuatrecasas, 1973). 
No effects ofchole:r'a toxin (O.l-5fLgfml) on cyclic AMP concentrations in villus and 
crypt cells were detected during a 15-60min period of incubation. After 1 h the cyclic 
AMP concentrations measured in vivo begin to rise (Schafer eta!., 1970; H. R. DeJonge, 
unpublished work), as a result of a stimulatory effect on adenylate cyclase activity in the 
intestinal cells (Kimberg eta!., 1971). In our system longer periods of incubation were 
not tested because of the occurrence of severe cellular damage. 
In order to study long-term effects of cholera toxin and hormones on intestinal cells 
we measured adenylate cyclase activities in freshly isolated villus and crypt cells from 
treated and control rats. Table 2 gives the results of control experiments. 
Basal and fluoride-stimulated values did not vary appreciably from duodenum to 
ileum. In agreement with cyclic AMP measurements, both villus-cell and crypt-celi 
adenylate cyclase activity showed a rapid, stimulated, response to prostaglandin Er and 
relatively high concentrations of adrenaline. The villus-cell/crypt-cell ratio of enzyme 
activity per mg of protein in the fluoride-stimulated state varied between 0.7 and 0.9, 
indicating an approximately equal enzyme content in upper villus and crypt cells. 
Because only the mature villus ceJis possess a well-developed brush border, this result 
argues strongly against a localization of the enzyme in the brush-border region and is in 
Table 2. A deny/ate cyclase activities in epithelial cells from different segments of rat small 
intestine 
Cells from the upper part of the villus were obtained by short vibration of the everted 
intestine (0-15 min), as described by DeJonge (1973). Enzyme activities in cell homogen-
ates, obtained by Polytron treatment (DeJonge, 1973), were measured in a volume of 
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501'1 at 30'C by the method of Krishna eta/. (1968), with 0.1 mM-[,-32P]ATP, IOmM-
theophylline and 0.1 roM-cyclic AMP. Protein samples contained 10--40p.g. The incuba-
tion period was lOmin; preincubation without ATP was for 5min. The results are ex-
pressed as means ± s.E.M. (n =number of animals). 
Adenylate cyclase activity 
(pmol of cyclic AMP/!Omin per mg of protein) 
Duodenum (n = 3) Jejunum (n = 3) Ileum (n ~ 6) 
Upper- Upper- Upper-
villus Crypt villus Crypt villus Crypt 
cells cells cells cells cells cells 
Basal 32±5 39±4 30±4 43±4 31 ± 3 38±4 
NaF (!OmM) 240± II 270± 14 241 ±9 332± 7 266±6 324±8 
Prostaglandin E, 60±3 83±3 58±4 78±3 59±3 70±4 
(20{'M) 
Adrenaline (20f'M) 42±3 57±5 
agreement with studies in rabbit small intestine (Parkinson et al., 1972) indicating a pre-
ferential localization in basal and lateral plasma membranes. 
Insulin (1-IOOng/ml) and cholera toxin (1-1 0 l'g/ml) did not influence the basal activity 
of adenylate cyclase to a significant extent during the 15min incubation procedure, in 
agreement with our studies of the cyclic AMP concentrations in isolated cells. 
Further work is required to localize the effects of cholera toxin on intestinal adenylate 
cyclase more precisely during the course of the infection period, in order to verify the 
hypothesis that only the crypt-cell population reacts, on stimulation of adenylate cyclase 
activity, with a hypersecretion of fluid and electrolytes (compare Roggin et al., 1972; 
Serebro eta/., 1969). 
We gratefully acknowledge the technical assistance of Mr. L. M. Scheek. Purified cholera 
toxin was a generous gift from Dr. R. A. Finkelstein, University ofTexas, Southwestern Medical 
School, Dallas, Tex., U.S.A., and Prostaglandin E1 from the Unilever Research Laboratories, 
Vlaardingen, The Netherlands. 
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THE RESPONSE OF SMALL INTESTINAL VILLOUS AND CRYPT 
EPITHELIUM TO CHOLERA TOXIN IN RAT AND GUINEA PIG 
EVIDENCE AGAINST A SPECIFIC ROLE OF THE CRYPT CELLS IN 
CHOLERAGEN-INDUCED SECRETION 
H.R. DEJONGE 
Department of Biochemistry I, Erasmus University, P.O. Box 1738, Rotterdam (The 
Netherlands) 
(Received July 9th, 1974) 
Summary 
1. Some kinetic properties of adenylate cyclase in separately isolated upper 
villous and crypt cells from rat and guinea pig small intestine were compared. 
An apparent Km of 0.4 mM was found for both enzymes in the rat. The slight 
difference between the V-values measured in the fluoride-stimulated state (132 
and 165 pmoles cyclic AMP formed per min per mg protein respectively) 
indicated an approximately equal enzyme content of both cell populations and 
argues strongly against a preferential localization in the brushborder region of 
the epithelial cell. 
2. Prolonged contact of the small intestine with luminally administered 
choleragen led to an irreversible activation of adenylate cyclase in both villous 
and crypt compartments. The maximal stimulation of the upper villous enzyme 
( 4-7 times) exceeded the maximal effect on the crypt enzyme by two-fold. 
3. A lag phase of at least 30 min was found between the first luminal 
contact with the purified choleragen and a significant activation of the adenyl-
ate cyclase associated with isolated intestinal brushborders from the upper 
villous region. 
4. By using a short exposure time (2 min) of the luminal surface to high 
amounts of choleragen, adenylate cyclase activity in the upper villus could be 
optimally stimulated in the absence of any alteration of crypt cell activity. 
5. By comparing, in vivo, the effects of short and prolonged contact with 
choleratoxin on the unidirectional and net flux of ions and water in ileal and 
jejunal segments, it was concluded that both villous and crypt regions contrib-
ute to the secretion of water and electrolytes (sodium, chloride and bicarbon-
ate ions) during cholera. The serosal to mucosal flux of sodium and chloride 
ions increased without a significant alteration of the opposite flux. These 
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results imply that absorptive and secretory processes occur within the same 
epithelial compartment. 
6. The view that the crypt epithelium fulfills a specific role during the 
choleragen·induced secretion of ions and water is incompatible with the results 
of the present study. 
Introduction 
The enterotoxin of Vibrio cholerae has been found to elevate cyclic AMP 
levels by stimulating the adenylate cyclase activity in a variety of mammalian 
cell types such as small intestinal epithelium [1], platelets [2], liver [3], 
adrenal cell [ 4], adipocytes [ 5], fibroblasts [ 6], leucocytes [7] and thymo· 
cytes [8,9]. This action of choleratoxin appears to be dependent on a highly 
specific interaction of the large subunit of the toxin molecule with GM 1 gan· 
glioside receptors of the cytoplasmic membrane [9-15]. During clinical chol· 
era, the receptors exposed to choleragen are located exclusively at the surface 
of the microvillous membrane of the small intestinal epithelial cells. Active 
immunization against cholera is probably due to inhibition of attachment of 
choleratoxin to these binding sites by intestinal antibodies [16] . 
The epithelium mainly consists of two distinct cell types localized in 
different compartments called villus and crypt. The absorptive villous cells arise 
by division, differentiation and migration of the crypt population [17]. Immu· 
nohistochemical and autoradiographic studies showed that both villous and 
crypt epithelium are able to bind choleratoxin to their surface [18]. The 
binding of labeled choleragen is finished within a few minutes and cannot be 
reversed by subsequent washings with excess of unlabeled choleratoxin or 
toxin-free solutions [13,16]. The activation of adenylate cyclase needs the 
presence of both subunits of the toxin molecule [9,12,14,19]. It is preceeded by 
a characteristic lag phase of 30-60 min [13] which is not found with Escheri· 
chia coli enterotoxin [20], prostaglandins [21-23] or hormones [23]. Activa· 
tion even persists in vitro in a solubilized form of the enzyme [24]. Also this 
irreversible character forms a clearcut difference with the reversible action of 
the fore-mentioned substances [20-23]. Stimulation of adenylate cyclase leads 
to elevated tissue levels of cyclic AMP, for phosphodiesterase activities are not 
influenced by choleragen [25]. 
In small intestine, the increase of adenylate cyclase activity and the 
change of water and ion fluxes occur simultaneously [26]. Moreover, various 
agents known to raise cyclic AMP levels (dibutyryl-cyclic AMP, theophylline, 
prostaglandins, E. coli enterotoxin) mimic the effect of choleragen on fluid 
secretion in vivo as well as in vitro [27]. Finally, stimulation of adenylate cy-
clase activity seems to be the only common factor in the response of different 
mammalian cell types to choleragen. Therefore, there are many reasons to 
assume a strong relationship between this stimulation and the diarrheal re· 
-sponse of small intestinal epithelium. However, the epithelium is composed of a 
variety of differentiated cell types with possibly a different response to ele· 
vated levels of cyclic AMP. For instance, the mucus-secreting Goblet cells, 
constituting about fifteen percent of the total epithelial cell population in rat 
villus and crypt, react on contact with choleragen by an increased outpouring 
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of mucus [28] and, most probably, de novo synthesis of mucin-glycoproteins 
[29]. The absence of any alteration in mucosal to serosal glucose and sodium 
fluxes in vivo, in spite of reversal of net fluid movement from absorption to 
secretion, led to the assumption of an anatomical separation of absorption and 
secretion sites [27,30]. Indeed, since cycloheximide-inhibited cholera secretion 
is not accompanied by impaired glucose absorption through the villus [31], 
fluid secretion might be a specific function of the crypts of Lieber kuhn. More-
over, damage to the villous surface by hypertonic sodium sulfate impaired 
glucose absorption without altering the secretory response to choleratoxin 
[32]. Also morphological observations suggest a specific secretory function of 
the crypt [33]. 
Other studies consider the possibility that the secretory function is limited 
to the Goblet cells of the epithelium [28]. 
According to a third model, the whole villous as well as the crypt cell 
population contribute to the secretion [27]. This implies that absorption and 
secretion may occur within the same epithelial region, either across the mucosal 
cell membrane or via interepithelial pathways. Also in this model, the charac-
teristics of ion fluxes through villous and crypt region may differ in qualitative 
or quantitative respect. 
Our study was especially designed to make a decision between the pres-
ented models by determining the relative contribution of villous and crypt 
epithelium to the choleragen-induced secretion in vivo. 
Experimental procedure 
Materials 
Choleratoxin (lot 0172), purified by the method of Finkelstein and Lo 
Spalluto [34], a gift from Dr R.S. Northrup, SEATO Cholera Research Pro-
gram, was prepared under contract for the National Institute of Allergy and 
Infectious Diseases by Dr R.A. Finkelstein, the University of Texas, South-
western Medical School, Dallas, Texas, U.S.A. [a- 32 P]ATP (adenosine 5'-
triphosphate, sodium salt (740-1530 Ci/mole)), 3 H2 0 (tritiated water (5 
Ci/ml)), 36 Cr(sodium chloride (73 mCi/g cr)) and cyclic [ 3 H] AMP (cyclic 
3 ',5 '-[ G- 3 H] adenosine mono phosphate )--ammonium salt (24.1 Ci/mmole) 
were obtained from the Radiochemical Centre, Amersham, Great Britain. 
24 Na+ (sodium chloride) was a gift from IRI, Delft, The Netherlands. Cyclic 
AMP (ammonium salt), ATP (sodium salt), 2-phosphoenolpyruvate (tricyclo-
hexylammonium salt), pyruvate kinase (EC 2.7.1.40) and myokinase (EC 
2.7.4.3) from rabbit muscle were products from Boehringer, Mannheim, West-
ern Germany. Dowex (50Wx8, 200-400 mesh) was purchased from Fluka A.G., 
Buchs, Switzerland; theophylline (1 ,3-dimethylxanthine) was from Sigma, St. 
Louis, Mo., U.S.A. Fatty acid poor serum albumin was obtained from Pentex, 
Kankakee, Ill., U.S.A. Instagel was obtained from Packard S.A., Brussels, 
Belgium. All other reagents were Analytical Grade. 
Animals 
Male Wistar rats and guinea pigs, weighing 250-300 g were maintained on 
a regular laboratory chow and water ad libitum. 
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Transport of water and electrolytes 
Rats or guinea pigs were anaesthetized with ether during the operation 
procedures. Their abdomen was opened by midline incision and a segment of 
small intestine (60-70 em) comprising the ileum and the distal part of the 
jejunum was tied off. The intestinal contents were removed through a small 
distal incision by gently rinsing the lumen with prewarmed isotonic saline 
introduced through a needle attached to a syringe, stuck into the proximal end 
of the segment. Any extension of the intestinal wall was avoided. Residual 
saline was largely removed by gently stripping the segment between the finger-
tips. The volume of the remaining fluid was determined by means of an air 
insufflation procedure in six rats and appeared remarkably constant (0.16 ± 
0.02 ml per segment). The segment was then closed by a distal ligature. Net 
transport of water was measured by introducing through the needle a fixed 
amount of isotonic saline, closing the abdomen with woundclips, removing the 
intestine from the animal exactly 1 h later and measuring the volume of the 
residual fluid by gently squeezing it out into a calibrated tube. The intestinal 
segment was further processed for measurements of adenylate cyclase activity 
as described below. In our hands, these discontinuous measurements of net 
absorption or secretion rates in these small animals were found more satisfac-
tory and reproducible than the commonly applied continuous perfusion tech-
nique using an unabsorbable marker as indicator for volume changes [ 35]. The 
latter method needs permanent narcotized animals, a relatively large perfusion 
volume and causes some dilatation of the gut and serious enzyme or cell loss 
from the tips of the intestinal villi as judged from a decrease of alkaline phos-
phatase and sucrose activity in upper villous cells from control rats, especially 
after prolonged perfusion times (2-5 h). Moreover, the markers tested by us 
( [ 3 H] inuline and phenol red) tend to adsorb to the mucus and require equili-
bration periods of 0.5-1 h (unpublished observations). 
Concentrations of ions were determined in the· secretion fluid, accumu-
lated during 1 h in initially emptied ileal-jejunal segments. Fluid samples were 
immediately covered with paraffine until analysis of their ion composition. 
Sodium and potassium were determined on a flame photometer with internal 
lithium standard (Instrumentation Lab. Inc., Lexington, Mass., U.S.A.), chlo-
ride was determined by volumetric titration with mercurinitrate using diphenyl-
carbazone as indicator [ 36] and bicarbonate was determined by measuring the 
original sample-pH, addition of a standardized portion of HCl in excess of the 
amount of HClO 3 and backtitration with alkali until the original pH had been 
reached. This method, recently published by den Boer eta!. [37], is insensitive 
to interference by high protein concentrations in the sample. 
Unidirectional ion and water flux in the rat 
After emptying and closing the ileo-jejunal segment as described in the 
foregoing, the segment was divided into two parts by placing a ligature approx. 
50 em from its distal end .. The proximal jejunal part (nearly 20 em) was used to 
obtain internal control values for flux measurement in rats, treated with chol-
eragen in the iieo-jejunal segment. Flux studies were started by rapidly intro-
ducing 3.0 ml of tracer-containing-isotonic saline into the distal part and i.5 ml 
into the proximal part of the segment. Tracer activities were 4 J.LCifml 2 4 Na, 1 
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!lCi/ml 3 H2 0 and 2 !lCi/ml 3 6 Cl respectively. Temperature was maintained at 
37 ± 2°C by means of a heating lamp and by continuously bathing the intestine 
in saline brought at 39'C. At 5 min intervals (in the case of 3 H2 0: 2 min 
intervals), 20 J.ll samples were removed from the luminal fluid by means of a 
Hamilton syringe and taken up in Instagel for subsequent counting. After 30 
min, the intraluminal fluid volume and sodium or chloride content were meas-
ured as described previously. The small volume of the residual fluid was deter-
mined by air insufflation and used for calculation of the true initial fluid 
volume. From this value and the calculated net transport rate of fluid, the 
luminal fluid volume could be calculated for each time point desired. 3 6 Cl and 
3 H2 0 activities were determined in a liquid scintillation spectrometer (Packard, 
Tri-Carb 3380), the 1 activity of 24 Na in an Auto-Gamma Counter (Packard, 
5120). For calculation of the mucosal to serosal flux rate (Jm ,) the equations 
derived by Curran and Solomon, originally applied for flux studies in rat ileum 
[35], were used. The final formula is identical to the formulation of Berger and 
Steele [38] if the initial and final ion concentrations of Na and Clare replaced 
by a mean value over the time period studied. This was allowed in our rat 
studies where the change of Cl- and Na • concentrations during the first 15 min 
appeared extremely small. This also held for cholera segments which secreted 
only very low amounts of bicarbonate(< 10 mM). 
Application of the formula for various time intervals between 0 and 30 
min showed that the calculated flux rates for sodium and chloride ions were 
constant between 5 and 15 min but slowly decreased afterwards, apparently 
caused by a backflow of label from blood to lumen. Therefore, the mean of the 
values obtained over three different time periods (5-10 min, 10-15 min and 
5-15 min) was considered as the best approximation of the Jm, for these ions. 
The rapid outflux of 3 H2 0 from the lumen already slowed down after the first 
5 min. In this case, the mean mucosal to serosal flux rate over the 0-2, 2-4 
and 0-4 time intervals was calculated. 
Administration of choleragen 
In one type of experiment, short contact of choleragen with the epithelial 
villi was ensured by gently filling the ilea-jejunal segment with 3 ml of isotonic 
saline supplied with 20 J.lg/ml of purified choleragen and removal of the unab-
sorbed toxin 2 min later by thorough flushing of the lumen with 60 ml saline. 
In the alternative experiments, both villous and crypt regions were ex-
posed to choleratoxin by incubating the segment for 1 h with 3 ml of saline 
containing 5 J.lg/ml choleragen. The control animals went through the same 
procedures in the absence of choleratoxin. 
Isolation of intestinal cells and brushborders 
Upper villous, lower villous and crypt epithelial cells were isolated sepa-
rately by application of the high-frequency vibration technique of Harrison and 
Webster [39], as described by Iemhoff et al. [ 40]. Short vibration (0-15 min, 
frequency 50 Hz, amplitude 2 mm) mainly delivered cells from the apical areas 
of the villi. In the next phase (15-30 min) the lower villous cells were shed off. 
Finally, crypt cells. were isolated after dilatation of the gut. This method guar-
antees rather homogeneous cell preparations, relatively free of lamina propria 
fragments, plasma cells and muscle tissue. 
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The ongm of the cells was routineously verified by measuring alkaline 
phosphatase (EC 3.1.3.1) as a marker enzyme for the intestinal brushborder 
and in some experiments also by measuring [ 3 H] thymidine incorporation as a 
typical crypt cell function (results not shown). If the specific activity of alka-
line phosphatase in the upper villous fraction was less than six times the activi-
ty in the crypt fraction, the separation was considered to be insufficient and 
the preparation discarded. 
Brushborders principally derived from the upper villous cells were isolated 
as described by Harrison and Webster [41] by vibration (50 Hz, amplitude 1.5 
mm) for 10 min in 2.5 mM EDTA containing 1 mM dithiothreitol (pH 7.4), 
followed by removal of nuclear aggregates and a washing procedure. 
Assay of adenylate cyclase activity 
Freshly isolated epithelial cells or brushborders were taken up in 15 ml of 
a homogenization buffer ( 30 mM Tris-HCl, 5 mM MgCl2 , pH 7.3) and gently 
homogenized by Polytron treatment as described earlier [ 42]. Samples of the 
homogenate (20 j.d, containing 10-40 11g of protein) were directly used for the 
assay of adenylate cyclase activity in principle according to Krishna et al. [43]. 
The incubation mixture (final volume: 50 11l) usually contained 30 mM Tris-
HCl (pH 7.5), 0.1 mM cyclic AMP, 0.1 mM ATP, 5 mM MgCl2 , 5 mM phos-
phoenolpyruvate, 40 11gjml pyruvate kinase, 20 11g/ml myokinase, 2 mM theo-
phylline, 0.02% bovine serum albumin and 1 11Ci [ce- 32 P]ATP. Occasionally, 10 
mM NaF was included in the mixture. For determinations of Lineweaver-Burk 
plots, the concentration of ATP was varied between 0.01 and 1.0 mM. Samples 
of the homogenate were preincubated during 5 min prior to the addition of 
radioactive substrate. During the incubation period (10 min at 30'C) cyclic 
AMP was produced linearly with time. Reaction blanks were measured in the 
absence of homogenate. Termination of the reaction and purification of the 
product using cyclic [ 3 H] AMP as internal standard were carried out exactly 
according to Krishna et al. [ 43] . The amount of cyclic AMP formed was 
calculated from the final specific activity of [ce- 32 P] ATP and the amount of 
cyclic AMP recovered (40-60 percent of the amount produced) minus the 
reaction blank. The variation between duplicate determinations was less than 
five percent. At a concentration of 0.1 mM cyclic AMP, 10-15 percent of this 
product was hydrolyzed by phosphodiesterase during the adenylate cyclase 
assay in the absence of theophylline. Addition of 2 mM theophylline inhibited 
the phosphodiesterase activity for about 60 percent (unpublished results). 
Accordingly, adenylate cyclase activities increased 5-10 percent in the pres-
ence of theophylline. 
Assay of protein concentration. 
Protein was determined according to Lowry et a!. [ 44] using bovine 
serum albumin as a standard. 
Results 
Villous and crypt activities of adenylate cyclase in ilea-jejunal segments 
Fig. 1 compares the kinetic properties of fluoride-stimulated adenylate 
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Fig. 1. Lineweaver-Buxk plots for fluoride-stimulated adenylate cyclase in isolated upper villous and 
crypt ce'Js from rat small intestinal epithelium. The Vis expressed as pmoles cyclic AMP formed per min 
per mg protein. 
cyclase measured in upper villous and crypt cell homogenates from rat ilea-
jejunal segments. The apparent Km of both enzymes was found to be 0.4 mM. 
The slight difference found between the Km values defined on a protein base 
disappears if expressed on a cellular base, taking into account the higher 
amount of proteins in the villous cell as compared to the crypt cell [ 45]. Also 
the basal activities of adenylate cyclase in control animals, measured at a sub-
optimal substrate concentration (0.1 mM), remained remarkably constant from 
crypt to upper villus (Table I). These activities appeared insensitive to repeated 
sham-operation (results not shown). 
Exposure of the ilea-jejunal lumen for 1 h to 15 flg of purified choler-
agen evoked a gradual rise of basal enzyme activity in the upper villous cells 
during the next 4 h (Fig. 2A and Table I). A much smaller rise, following 
approximately the same time course, was found in basal villous and crypt cells. 
Also the fluoride-stimulated activity appeared to be slightly but significantly 
increased after prolonged exposure to choleragen, in agreement with an earlier 
report of Sharp et al. [46]. 
A significant increase of adenylate cyclase activity in the upper villous 
cells, in first contact with the choleragen, was detected as early as 45 min after 
toxin-administration. This time lag could be shortened to 30 min by measuring 
enzyme activities in isolated brushborders from villous top cells. The specific 
activity of this enzyme in the non-activated state (30.1 ± 1.3 pmoles cyclic 
AMP formed per 10 min per mg protein; n = 5) approached the value measured 
in the whole cells. On the other hand, the brushborder marker alkaline phos-
phatase appeared six times enriched in these brushborder preparations (result 
not shown). 
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TABLE I 
ADENYLATE CYCLASE ACTIVITIES IN UPPER VILLOUS AND CRYPT CELLS FROM R.'\TS AND 
GUINEA PIGS FOLLOWING 5 h OF TREATMENT 
Enzyme activity is reported as pmoles cyclic AMP fanned per 10 min per mg protein± S.E. n represents 
the number of animals. 
Adenylate cyclase activity 
Upper villus 
Basal 
Rat Guinea 
pig 
Saline 30.1 35.2 
n"' 5 ± 3.4 ± 4.3 
Choleragen 
(2 min, 20 ,ugjml) 123* 240* 
n""5 ± 14 ± 12 
Choleragen 
(1 h, 5 ,ug/ml) 136* 268* 
n == 4 ± 9 ± 16 
* P <D.05 (one-tailed Student's t-test). 
** 0.05 <P<O.lO. 
Fluoride 
Rat 
258 
± 11 
zsg** 
± 15 
287** 
± 13 
Crypt 
Ba,U Fluoride 
Guinea Rat Guinea Rat Guinea 
pig pig pig 
300 39.6 62.3 330 361 
± 18 ± 2.9 ± 7.0 ± 10 ± 22 
329** 41.7 69.2 336 352 
± 24 ± 3.4 ± 11.4 ± 12 ± 26 
406* 103* 191* 387* 409** 
± 17 ± 8 ± 13 ± 16 ± 21 
Quite a different picture was obtained by raising the amount of toxin up 
to 60 }lg but drastically reducing simultaneously the period of contact from 60 
to 2 min (Fig. 2B, Table I). Whereas the rise of adenylate cyclase localized in 
the upper villous cells was of the same magnitude as shown in Fig. 2A, the 
response of the lower villus appeared strongly diminished and the crypt cell 
population did not respond to the choleragen at all. Apparently, these condi-
tions permitted saturation of binding sites at the villous tip but prevented the 
penetration of toxin molecules into the depth of the intestinal crypts. This 
selectivity of binding often diminished after mechanical dilatation of the gut. 
Unidirectional and net flux rates of water and electrolytes 
Fig. 2A (upper graph) shows that the gradual fall of net absorption rate of 
isotonic saline closely followed the rise of adenylate cyclase activity in the 
villous cells of cholera rats. Within 2.5 h net absorption changed to net secre-
tion that became constant 3 h afterwards. Net absorption in control rats was 
not clearly influenced by the operation procedures. A very short contact with 
choleratoxin (Fig. 2B), restricting its action to the villous region, also led to a 
gradual decrease of fluid absorption rates during the first 3 h. However, in this 
case the reversal of net absorption into net secretion rarely occurred. These 
results prove that the net fluid movement from mucosa to serosa (Jn,tl 
through the intestinal villi in vivo has been strongly depressed during cholera 
but do not decide whether the decrease is due to a diminished mucosal to 
serosal influx (Jm ,), an increased serosal to mucosal outflux (J,m) or to both. 
This question was further approached by measuring unidirectional flux rates of 
sodium and chloride ions and water in intestinal segments of control rats and 
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ate cyclase activity in upper and lower villous cells, crypt cells and brush borders. Each bar represents the 
ratio ± SE of the mean specific enzyme activity in cells isolated from five choleragen-treated and four 
control rats at the time points indicated on the abscis. 
rats, treated for 2 or 60 min with choleragen instilled exclusively into the 
ileo-jejunal part of the segments. 
As indicated in Fig. 3, the flux rates of sodium and chloride ions in 
sham-operated rats increased from the distal to the proximal end of the small 
intestine. To avoid this source of variation, care was taken to use completely 
corresponding regions of the gut for the flux studies in control and choleragen-
treated animals. Under this condition pretreatment with choleratoxin had no 
significant influence on the unidirectional mucosal to serosal flux of sodium 
and chloride ions (Fig. 3). The decrease of net absorption was apparently due 
to an increase of J,m solely in the villus (2 min choleragen) or in both villous 
and crypt compartments (1 h choleragen). In contrast, the flux rates in the 
adjacent jejunal segments of cholera rats appeared to be unaltered as compared 
to sham-operated animals. 
The bidirectional flux of 3 H2 0 in ileo-jejunal segments of rat intestine 
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(0.91 ml/h ·em; n = 4) nearly equalled the unidirectional flux rates (Jm, = 0.94 
ml/h ·em). For this reason, it could not be established with certainty whether 
J~.,i 0 , J!;,:; 0 or both had been changed in experimental cholera in the rat. 
However, it is generally accepted that the water flux follows movement of 
electrolytes approximately isoosmotically also during cholera [ 4 7]. 
In summary, an increased secretion of fluid exclusively derived from the 
villus may entirely account for the diminished uptake of water shown in Fig. 
2B. By elevating the cyclic AMP levels in basal villous and crypt cells, these cell 
populations further contribute to the secretion component J,m which finally 
exceeds the Jm" resulting in net secretion of water and electrolytes (Fig. 2A). 
138 
TABLE II 
VOLUME AND CONTENT OF ELECTROLYTES OF FLUID SECRETED BY GUINEA PIG SMALL 
INTESTINE 
Secretion was measured in ileo--jejunal segments between 4 and 5 h after luminal administration of 
choleragen. n represents the number of a.limals. Mean values are given followed bY their S.E. 
Net secretion Concentration of electrolytes (mM) 
mljh·60 em Na K Cl HC03 
Sham-operated 0.4 153 6.8 76 82 
n==4 ± 0.2 ± 3 ± 0.5 ± 3 ± 6 
Choleragen (2 min, 20 p.gfml) 4.8 156 6.4 79 86 
n=5 ±1.0 ± 4 ± 0.6 ± 5 ± 8 
Choleragen (1 h, 5 .ug/ml) 6.7 149 7.0 77 76 
n""4 ± 1.2 ± 4 ±0.5 ± 5 ± 7 
Jon composition of fluid secreted during cholera 
The previous section showed that during prolonged exposure of rat intes-
tine to choleragen the sodium and chloride ions in the accumulated fluid 
originate from both villous and crypt regions. However, the origin of the 
bicarbonate, contributing only a very small part (,;;; 7%) of the total anion 
concentration in the rat ileo-jejunal segments in our experiments, could not be 
easily established because no significant accumulation of fluid into the lumen 
occurred after short contact with choleragen (Fig. 2B). The guinea pig seemed 
more suitable as a model to solve this question. Even under our mild conditions 
(minimal dilatation of the gut, short anaesthesia, no mechanical damage) the 
small intestine of this animal spontaneously secreted appreciable quantities of 
fluid containing high amounts of bicarbonate (Table II). Stimulation of adenyl-
ate cyclase activity exclusively in the villous cells (Table I) was accompanied by 
a large increase of net fluid secretion which could be further stimulated by 
additionally affecting the adenylate cyclase in the crypt area by means of 
choleragen. The ion composition of the luminal fluid appeared unaltered after 
short or prolonged contact with the toxin (Table II). 
Discussion 
The kinetic data for adenylate cyclase, measured in isolated villous and 
crypt cells from control intestine, indicated a similar enzyme content and 
properties in both cell types. This result argues strongly against a preferential 
localization of the enzyme in the brushborder region of the mature villous cell. 
This structure is far less developed in the undifferentiated crypt cell. Using a 
different approach, other investigators also agree that adenylate cyclase must 
be localized mainly in the basal and lateral plasma membranes of the epithelial 
cell [48,49]. Although we detected some adenylate cyclase activity in purified 
brushborders of upper villous cells, the enzyme was not enriched in this com-
partment as was shown for alkaline phosphatase. It is conceivable that the 
adenylate cyclase is not integrated into the brushborder mosaic but resides in 
the adhering tags of lateral plasma membranes contaminating the preparations. 
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The brushborder-associated enzyme from the villous top is apparently affected 
first during cholera (Fig. 2A). Even in this preparation, a significant stimulation 
of its basal activity requires a lag time of at least 30 min after exposure to high 
amounts of choleragen. This lag phase is not unique for intestinal epithelium 
and seems therefore not related to a possible different localization of toxin 
receptor sites and the target enzyme in this tissue. Binding of the choleragen to 
its receptors proceeds extremely rapidly (compare Fig. 2B) and cannot be 
responsible for this time delay. Neither can it be explained by a need for 
protein, RNA or prostaglandin synthesis because enzyme activation also occurs 
in the presence of specific inhibitors of these processes [8,13,50,51]. Up till 
now it is not clear whether the lag time is needed for a chemical or physical 
modification of the toxin r.oolecule into an active state (e.g. splitting into its 
two major subunits [9,12-15], compare diphtheriatoxin [52]), a slow change 
of membrane structure causing the irreversible activation of adenylate cyclase 
[12,13], a slow diffusion of a small fraction of the toxin molecules or molecu-
lar fragments into the cell interior, or a combination of some of these factors. 
The action of choleragen seems to depend critically on an intact state of t 11e 
cellular structure, for the activation of adenylate cyclase has never been repro-
ducibly demonstrated in isolated cell membranes or broken cell preparations 
[13,23]. 
Prolonged exposure of the intestinal lumen to choleragen caused a gradual 
rise of basal adenylate cyclase activity in both villous and crypt compartments. 
This result agrees with the uniform distribution of choleragen from the tips of 
the villi to the crypt area detected by immunofluorescense in mice intestine 
[18] and additionally proves that both villous and crypt cells may functionally 
respond to the toxin-receptor interaction. The smaller response of the basal 
villous and crypt adenylate cyclase as compared to the upper villous enzyme 
may be explained by incomplete saturation of binding sites, a decreased num-
ber of microvillous receptor sites (compare [13] ), or a lower sensitivity of the 
enzyme to the choleragen-receptor interaction. The small but significant in-
crease of the fluoride-stimulated activity of adenylate cyclase during cholera, 
shown in Table I, is probably due to alteration of its kinetic properties rather 
than to de novo synthesis [13]. 
The lack of knowledge concerning the origin of fluid and electrolyte 
secretion during cholera [ 4 7 ,53] mainly arises from the extreme difficulty to 
measure the secretory response of villous and crypt cells separately under con-
ditions that all epithelial cell populations are affected by the choleragen. At 
best, only indirect evidence may be obtained in vitro based on measurements of 
electrical profiles by impalement of cells by microelectrodes [54]. Ion fluxes 
may be easily disturbed by these manipulations and the in vitro results usually 
do not apply to the in vivo situation [27]. To avoid these problems, we looked 
for a method to limit the action of choleragen to the villous epithelium without 
disturbing the normal crypt functions. We found these conditions by restricting 
the con tact between intestinal lumen and choleragen to a very brief period, 
concomitantly avoiding any mechanical extension of the gut. Unabsorbed toxin 
was thoroughly washed away after 2 min. Obviously, the time of contact is 
now too short for the toxin molecules to diffuse into the depth of the intesti-
nal crypts. Preferential localization of luminal administered proteins along the 
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tips of the villi, especially during the first period of contact, has also been 
demonstrated in horseradish peroxidase tracer studies [55] and immunohisto-
chemical studies with impure choleragen [56]. 
The irreversible increase of basal adenylate cyclase activity in the cell was 
taken as a criterion for a functional response to choleragen. This activation is 
still present in vitro and can be easily detected after the separate isolation and 
homogenization of the epithelial cells. As shown in Fig. 2B, our conditions 
ensured the complete absence of any stimulatory effect on crypt cell adenylate 
cyclase in short-contact experiments. Hypothetically, it may be argued that a 
hormone-like substance, possibly released by the cholera-affected cells, should 
evoke water and ion secretion from the choleragen-free crypts. Indeed, studies 
in rabbits indicated a fluid secretion in adjacent intestinal segments, not in 
direct luminal contact with the choleragen [57,58). If such a compound should 
act via an increase of adenylate cyclase, this might be missed in in vitro enzyme 
measurements due to its supposed reversible action. Our unidirectional flux 
studies however, simultaneously performed in choleragen-affected and toxin-
free segments of rat intestine, made this hypothesis highly improbable. We 
never detected any change of flux rate in the toxin-free segments when com-
pared with control animals. Therefore, alterations of net fluid movements and 
ion flux rates after 2 min exposure to choleragen will represent exclusively the 
response of the villus. 
From the gradual decrease of net fluid absorption under these conditions 
the conclusion has been drawn that choleragen primarily affects net movement 
of water and electrolytes through the villous epithelium. After prolonged expo-
sure t0 the toxin, also the basal villous and crypt region contribute to the flux 
changes. 
Comparison of unidirectional flux rates of ions under both conditions 
enabled us to discriminate between effects on mucosal to serosal flux (Jm ,), 
the opposite flux (J,m ) or on both flux rates simultaneously. These measure-
ments are complicated by the small size of the rats, soon leading to a significant 
backflow of labeled ions into the lumen, and the large bidirectional component 
particularly in the case of 3 H2 0 and 24 Na·. The latter implies that the per-
centual change of unidirectional flux rates in the rat during cholera will be 
relatively small. Moreover, the flux rates of water and ions are functions of the 
pore size in the epithelium and vary along the length of the gut; they reach a 
maximum in the proximal part of the intestine. For this reason, reproducible 
measurements need the use of perfectly corresponding intestinal segments. All 
unidirectional flnx studies were done 3 h after toxin administration. Up to then, 
net fluid loss into the intestinal lumen was negligible and plasma ion concentra-
tions were unaffected. Intravenous infusion of fluid and electrolytes to prevent 
dehydration seemed therefore unnecessary. 
Our results indicate that choleragen-treatment in vivo selectively increased 
the Jm, of sodium and chloride ions through villous as well as crypt epithelium 
without significantly impairing the opposite flux. Unequivocal results have 
been reported using rabbits and dogs or in studies of human cholera. According 
to most in vitro studies with stripped mucosa, choleragen primarily diminishes 
a glucose-independent neutral influx of sodium and chloride ions across the 
luminal border of the epithelial cells [27,47,59]. These results suggest that 
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choleratoxin (via cyclic AMP) unmasks a pre-existing secretion of ions by in-
hibiting their absorption. In contrast, a recent in vitro study [60] and most of 
the experiments in vivo [61-63] indicate a stimulatory action of choleragen 
on a neutral secretion process of NaCl or NaHCO 3 , in agreement with our 
conclusions for the rat. Of course, our results give no information about the 
relative importance of the interepithelial or transepithelial route followed by 
the secreted ions or about the steps between cyclic AMP increase and aug-
mented serosal to mucosal flux during cholera. Recent work in vitro suggests 
that the J,m for sodium ions mainly transverses the extracellular route [ 64] . 
Possibly the contribution of this pathway is changed by choleragen, e.g. via 
alteration of serosal membrane potential or membrane permeability or an in-
creased shunt conductance [ 47]. 
Bicarbonate is the third important ion in cholera fluid. As pointed out by 
Hubel [ 65], its formation is most probably due to an increased movement of 
hydroxyl ions from the epithelium into the lumen followed by equilibration 
with the C0 2 principally derived from cellular metabolism in the epithelium. 
The guinea pig offers a very useful model to study bicarbonate production. A'i 
sham-operated animals showed a spontaneous secretion of a bicarbonate-rich 
fluid. This seem to be a general finding in herbivorous animals [66]. Our results 
demonstrated that choleragen merely stimulates a pre-existing secretory process 
in the guinea pig without changing the ion composition of the fluid. A further 
elucidation of the mechanism of choleratoxin-induced secretion should there-
fore be of much value for the understanding of ion movements in the untreated 
state. Our experiments also excluded the possibility that the bicarbonate solely 
originates from the crypt region. The production of this ion normally pro-
ceeded in the absence of a choleragen -effect on the crypt. 
All results together strongly suggest a functional homogeneity of villous 
and crypt regions in rat and guinea pig in their secretory response to choler-
agen. They are conflicting with the concept that fluid secretion is a specific 
function of the crypt [31,32]. Also the suggestion that choleragen stimulates 
secretion of anions preferentially in the crypt cells and simultaneously inhibits 
active absorption of sodium and chloride by villous cells [59] must be criti-
sized in view of our results. 
The role of the Goblet cells during fluid secretion remains obscure. The 
greatly increased outpouring of mucus during cholera, also observed in our 
experiments, might b~ accompanied by an increased flux of water and electro-
lytes into the lumen. Alternatively, the situation should be comparable to that 
in the pancreas, where the secretion of water and electrolytes is provided by 
the ductular cells which are morphologically and functionally distinct from the 
protein-secreting acinar cells [ 67] . The question should be answered if fluid 
and mucin production could be studied under conditions in which cyclic AMP 
levels were stimulated selectively in either Goblet cells or absorptive cells. 
Adrenalin could be a possible candidate for use in such a study because the 
hormone is known to stimulate the synthesis of mucin glycoproteins in vitro 
[29] and to elevate slightly the levels of cyclic AMP in isolated intestinal 
epithelial cells [23]. Another approach was followed by us by studying the 
effect of choleragen on the rat colon. Preliminary results indicate a threefold 
stimulation of adenylate cyclase activity in the epithelial cells of the colon by 
142 
10 fJ-g choleragen, concomitantly with a significantly decreased rate of fluid 
absorption. If the observations of Yardley eta!. [28] are valid that the Goblet 
cells in the colon do not react to choleratoxin with an increased secretion of 
mucin, our results suggest that, at least in the colon, Goblet cells play no 
essential role during fluid secretion in experimental cholera. 
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tration was calculated from the total Mn2+ concen-
tration by subtracting the amounts of Mn 2+ seques-
trated in creatinephosphate and GTP [10]. Samples 
of 2-10 ~g protein were preincubated at 30°C for 
2 min and incubated in the presence of substrate for 
10 min. The reaction was stopped by adding O.l m1 
of a solution containing 5 mM GTP, 0.5 mM cyclic 
r~H]GMP (approx. 20 000 dpm) and 6 mM pyro-
phosphate, pH 7.6. The final mixture was applied 
to Ah 0 3 columns (1 g dry Al 2 0 3 (Merck) in 
Pasteur pipettes) and eluted with 2 m1 10 mM 
Tris-HQ, pH 7.6. The eluate was acidified with 30 ~1 
5 M HQ and applied to a Dowex 50H+-column 
(200-400 mesh, 4 X 1 em). During elution with 
0.05 M HQ 80-85 per cent of the applied cyclic 
[ 3 H} GMP was recovered in the 4th through 8th 
ml and directly counted in a Packard liquid scintil-
lation spectrometer (Tri-Carb 3380) for measure-
ments of 3 Hand 32 P activities using Dimilume 
(Packard) as the liquid scintillation mixture. Overall 
recovery of cyclic [3 H]GMP: 75--80%. Reaction 
blanks (complete system minus enzyme) were approxi-
mately 0.01 per cent of the initially added 32 P 
activity. About 95% of the 32 P-labelled product 
could be identified as cyclic GMP by means of a 
cyclic 3', 5'-phosphodiesterase degradation procedure 
followed by rechromatography on Dowex 50H+-
columns. Conversion of cyclic GMP during incubation 
was less than 5% with all preparations tested. In all 
experiments the production of cyclic GMP was linear 
with time and protein concentration. 
Alkaline phosphatase was determined at 37°C as 
described by lemhoff et al. [11], non-specific esterase 
activity was measured according to Higgins and 
Lapid<is [12] at 37°C, sucrase was tested for according 
to Dahlqvist [13], rotenone-insensitive NADPH-
cytochrome c reductase, succinate dehydrogenase 
and adenyl ate cyclase were determined as described 
earlier [5,14]. Ouabain-sensitive (Na +_K -f-)-ATPase 
was measured spectrophotometrically at 30°C according 
to- Ferard et al. [15], using I mM ouabain. Protein 
was determined by the Lowry procedure ( 16], 
using bovine serum albumin as standard. 
Biochemical products, if not stated, were obtained 
from Boehringer, Mannheim. Radioacti_ve materials 
were obtained from the Radiochemical Centre, 
Amersham. 
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3. Results 
By measuring guanylate cyclase activities in 
100 000 g supernatants of isolated villous and crypt 
cells after homogenization, using Potter-Elvehjem 
(Teflon-glass), Polytron homogenizers or a pressure 
bomb (table 3) it could be confirmed that over 95% 
of the total activity was particulate in both cell types. 
The stability of the enzyme at 0°C as well as at 30°C 
[ 6] appeared of much advantage in prolonged 
fractionation studies. 
Table l summarizes the specific enzyme activities 
measured in cell homogenates and brushborders from 
rat small intestine. On a protein base, sucrase, a 
marker enzyme of the microvillous membrane [17] 
is 5.4 times enriched in the purified brush borders as 
compared to upper villous cells. Alkaline phosphatase, 
localized in both microvilli and basal-lateral plasma 
membranes [18] appeared 4.2 times enriched in the 
brushborder preparations. However, the specific 
activities of (Na +.K +)-ATPase, a plasma membrane 
marker [19] and NADPH-cytochrome c reductase 
or non-specific esterase, both mainly localized in the 
endoplasmic reticulum [20,21] are similar or 
slightly diminished in the brushborders. The same 
holds for adenylate cyclase, also generally accepted 
as a basal-lateral plasma membrane marker in small 
intestinal epithelium [3-5]. In contrast, guanylate 
cyclase activity, measured at two different Mn2+ 
concentrations, is increased by 4.6-fold in the brush-
borders as compared to upper villous cells. The 
strongly increased specific activity is not due to a 
removal of enzyme inhibitors or release of activators 
during brushbl.lrder purification for combined assays 
of upper villous cell and brushborder samples gave 
completely additive results. 
The finding of a preferential localization of 
guanylate cyclase in the brushborder region agrees 
with the rise of its activity during the development of 
the epithelial cell from the proliferative stage 
(represented by the crypt-con A cells) via its 
differentiating phase (present in total crypt cell 
preparations) into mature villous cells (table 1 ). The 
activities of other brushborder-bound enzymes 
(sucrase, alkaline phosphatase) also increase together 
with the development of intestinal microvilli (table 1). 
However, the presence of an activity jump from 
Volume 53, number 2 FEBS LETTERS 
Table 1 
Specific enzyme activities in various cell preparations and brushborders isolated from rat 
small intestinal epithelium 
En:;:yme Upper villous Brush- Crypt cells Crypt cells 
cells borders (total) (con A-selected) 
--------· 
Guanylate cyclase* 
0.5 mM Mnf;ee 16.1 :t 1.0 (9) 75.6 ± 15.2 (6) 6.1 t 0.6 (5) 2.2 ± 0.3 (3) 
5.0 mM Mn<+ free 48.3 ~ 2.4 (9) 218 ± 18 (6) 16.5 ± 1.0 (5) 7.4±0.4(3) 
Adenylate cyclase 26.3 :t 1.2 (4) 24.9 ~ 1.5 (4) 34.5 ± 1.0 (4) 
( f1 uoride-stimu]a ted)* 
(Na+-K+)-ATPase 70.7;: 5.5 (4) 83.1 ± 4.8 (4) 28.3 ± 2.7 (3) 
( ouaba.in-sensi tive) * * 
NADPH-cytochrome c- 6.3 ± 0.4 (4) 4.1 t 0.5 (3) 2.4 ± 0.3 (3) 
reductase (rotenone-
insensitive)** 
Esterase** 2780 :t 70 (4) 1610 ± 40 (4) 980 ± 30 (4) 570 
Alkaline phosphatase** 410 ± 16 (8) 1710 .t 42 (6) 40 .t4 (5) 26 
Sucrase** 92.7 t 4.3 (3) 495 ± 24 (4) 12 
' 3 (4) 
* Specific activity expressed ~s picomoles cyclic GMP or cyclic AMP formed per min mg of protein. 
**Specific activity expressed as nanomoles substrate converted per min per mg of protein. 
Number of preparations tested is given in parentheses. 
Table 2 
(2) 
' 2 (3) 
Relative specific activities and distribution of enzymes after subfractionation of purified 
brushborders according to Forstner et al. [ 8]. 
Brushborder Relative specific activity* 
fractions** 
Sucrase Alkaline NADPH-cytochrome Esterase Guanylate 
phosphatase c reductase cyclase 
(rotenone-insensi-
tive) 
Membrane fraction I 1.33 1.72 3.70 3.33 1.40 
(microvillous) (24) (31) (65) (60} (25) 
Membrane fraction II 1.54 1.28 0.68 0.84 1.61 
(microvillous) (63) (52) (27) (34) (66) 
Fibrillar fraction 0.26 0.26 0.13 0.11 0.29 
(10) (10) (5) (4) (11) 
Recovery (%) 97 93 97 98 103 
* The relative specific activity represents the ratio of the specific activity of the enzyme in each fraction and its 
specific activity in the whole brushborder preparation (see table 1). 
'"*Terminology derived from the paper of Forstner eta!. [8]. 
The percentage of total brushborder activity recovered in the subfractions is given in parentheses. 
Mean values of two experiments are shown. 
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crypt to villus does not give sufficient proof for a 
typical localization in the brushborder region because 
marker enzymes of the endoplasmic reticulum (e.g. 
esterase, table 1 and [21]) and of basal-lateral plasma 
membranes ( (Na +_K+)-ATPase, table 1 and [22]) 
also rise in activity from crypt to upper villus. 
After separation of the isolated brushborders into 
microvillous and fibrillar fractions (table 2) the 
distribution of guanylate cyclase followed that of 
the microvillous enzymes sucrase and alkaline phos-
phatase and was clearly different from the endoplasmic 
reticulum markers. The distribution pattern also 
excludes a possible fibrillar origin of the enzyme. 
Finally, homogenates of isolated villous cells 
were subfractionated according to the fractionation 
scheme of Douglas eta!. [9] and the distribution of 
guanylate cyclase and a variety of marker enzymes 
among these fractions was studied. 
The distribution of alkaline phosphatase and 
guanylate cyclase followed the same pattern and was 
clearly different from that of the other membrane-
bound markers tested (table 3). The highest relative 
specific activity of both enzymes was found in the 
so-called M 1 fraction, enriched in the basal-lateral 
plasma membrane marker (Na +_K +)-ATPase and 
nearly devoid of mitochondrial and microvillous 
membranes. The conclusions drawn from the 
previous experiments with isolated brushborders are 
strengt!tened by the observation that the major part 
of the guanylate cyclase activity is recovered in the 
1500 g pellet (fraction B) that mainly consists of 
brushborders, nuclei and whole cells. The data from 
table 3 strongly suggest that most, if not all of the 
guanylate cyclase outside the brushborder is 
Table 3 
Cell fraction** 
Relative specific activities and distribution of enzymes in subcellular fractions prepared from rat 
small intestinal villous cells according to Douglas et al. [9] 
(Na•-K•}- Alkaline NADPH-cytochrome Sucrase Guanylate 
ATPase phosphatase c reductase cyclase 
ouabain- (rotenone-insensi-
sensitive tive) 
Succinate 
dehydrogenase 
~--------------
Fraction B 1.37 2.53 0.94 2.35 2.76 0.34 
(38) (71) (26) (66) (77) (9) 
Sorbitol layer 1.22 0.07 4.06 0.26 0.26 0.68 
(12) (!) (41) (3) (3) (7) 
Fraction D 3.02 3.00 1.23 1.44 2.32 7.70 
(30) (30) (12) (14) (23) (77) 
Fraction M, 7.69 3.69 2.79 I)_J! 3.93 0.50 
(10) (6) (4) (0) (5) (!) 
Fraction M, 2.43 1.26 5.64 0.04 1.60 0.42 
(6) (3) (14) (0) (4) (!) 
Supernatant 0.06 0.08 
(105 000 g) (0) (2) (0) (0) (3) (0) 
Recovery 87 113 97 83 115 95 
______ .. ___ 
* _The rela~ive specific activity compares the specific activity of each fraction (on a protein base) with that of the whole 
homogenate obtained by disruption of the villous cells in a pressure bomb. 
**Terminology used by Douglas et al. [9]. 
TheM, and M, fractions were isolated by dextran gradient centrifugation at barrier density of 1.075 exactly as described 
by Douglas et al. J9]. 
The percentage of total homogenate activity recovered in the subcellular fractions is given in parentheses. 
Fraction B mainly contains brush borders, nuclei and whole cells, the sorbitol layer is enriched in endoplasmic reticulum, 
fraction D contains a mixture of mitochondria, basal-lateral plasma membranes and some brushborder and endoplasmic 
reticulum activities, fraction M, consists mainly of basal-lateral plasma membranes and fraction M2 is enriched in endo-
plasmic reticulm membranes. 
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localized in the anti-luminal membranes of the 
villous cell, together with (Na+-K+)·ATPase, alkaline 
phosphatase and adenylate cyclase. 
4. Discussion 
Our results indicate that the bulk of guanylate 
cyclase is present in the apical region of the villous 
cell together with other microvillous enzymes like 
sucrase and alkaline phosphatase. A much smaller 
part of the enzyme content is integrated in the basal-
lateral plasma membrane as has been shown too for 
alkaline phosphatase [18]. The different distribution 
pattern of membrane-bound guanylate cyclase and 
adenylate cyclase together with their different 
propertie's [I , I 0] argues strongly against the hypo-
thesis [23] that the same enzyme system would be 
responsible for the synthesis of both cyclic GMP 
and cyclic AMP. 
The preponderance of guanylate cyclase in the 
brushborder presumably corresponds to the greater 
surface area of the microvilli. In proliferating crypt 
cells, lacking the microvillous structure [24], the 
enzyme activity is about 15% of the upper villous 
cell activity (table 1). The preferential localization in 
the brushborder may explain the high specific 
activity of this particulate enzyme in mucosal sera pin~ 
as compared to most other tissues of the rat in which 
microvillous structures are less well developed or 
nearly absent (compare [2}). Leakage of cyclic GMP 
from the brush border region into the lumen could also 
account for the considerable amounts of this nucleotide 
found in the intestinal contents [I]. 
It is tempting to speculate about the function of 
this brushborder-bound guanylate cyclase: Regulation 
of its activity by direct interaction with hormone 
receptors in the basel-lateral membranes of the 
epithelial cell seems very unlikely. Regulation by 
changes of the free Ca2+ concentration within the cell 
[25} seems equally questionable because Ca2+ has 
very little influence on the activity of the particulate 
enzyme in vitro [10]. 
Maybe the unique localization of guanylate 
cyclase in this cell type is related to the transport 
function of the microvillous membrane. In rabbit 
ileum in virto, addition of cyclic GMP caused an 
alteration of ion fluxes in the same direction as 
evoked by cyclic AMP (26] . A possible role of 
cyclic nucleotides in regulation of transport processes 
has been brought forward earlier in studies correlating 
cyclic AMP levels and transport rates of Na +, K+ 
and HC03 [5,27], Ca2 + [28] and amino acids [29] 
in small intestinal epithelium. 
Up till now no physiological conditions are known 
in which intestinal cyclic GMP levels undergo signifi· 
cant changes [10,27]. This might indicate that 
constant levels of cyclic GMP are necessary to 
maintain normal cellular functions and that deviations 
from this level, as in the case of cyclic AMP accumu-
lation [5,27], soon lead to pathological states. However, 
physiological alterations of cellular cyclic GMP levels 
could be very small, especially if confined to a 
certain compartment within the cell. In other tissues 
these are usually very rapid and transient phenomena. 
Such changes may therefore easily be missed in an 
experimental approach, particularly as long as the 
role of cyclic GMP in the small intestinal epithelium 
is a matter of mere speculation. 
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I. Introduction 
A number of studies on the mechanism of action 
of bacterial enterotoxins [1 ,2], prostaglandins [2] 
and the recently discovered gastrointestinal hormone 
vasoactive intestinal polypeptide (VIP)* [3] on 
small intestinal epithelium stress the role of cyclic 
AMP as a regulator of water and electrolyte trans-
port in this tissue. The function of cyclic GMP in 
the small intestine is however entirely unknown. Its 
level as well as the activity of the particulate form 
of the enzyme guanylate cyclase in rat small intestinal 
epithelium are relatively high as compared to most 
other mammalian tissues [4-7]. The soluble form 
of guanylate cyclase which, at least in rat heart [6] 
and lung [8], clearly differs from the particulate 
enzyme in kinetic and physical properties, is nearly 
absent in small intestinal mucosa [4,6,7]. Our 
previous work [7] showed that the major part of 
the intestinal enzyme activity is associated with the 
microvillous membrane of the brushborder, the 
remaining part being localized in the basal-lateral 
plasma membranes. Accordingly, proliferative crypt 
cells displayed a much lower guanylate cyclase 
activity than the mature villous cells [7]. Since 
intestinal brush borders, which are easily obtained 
in a relatively pure state, provide one of the richest 
sources of particulate guanylate cyclase in the rat, 
*Abbreviations: Cyclic GMP, cyclic 3', 5'-guanosine mono-
phosphate. Cyclic AMP, cyclic 3', 5'-adenosine !nonophos-
phate. GTP, guanosine 5'-triphosphate. PEP, phosphoenol-
pyruvate, tricyclohexylammonium salt. PTH, parathyroid 
hormone. VP, vasopressin. CP, creatinephosphate. 
North-Holland Publishing Company -Amsterdam 
the kinetic and other properties of this enzyme may be 
measured accurately even in the absence of an 
activating detergent used in other studies [6,8]. 
In the present investigation some characteristics 
of the brushborder-localized guanylate cyclase are 
compared with those of microsomal enzyme prepa-
rations from isolated villous and crypt cells, mainly 
representing enzyme bound to basal-lateral plasma 
membranes. A variety of hormones or hormone-like 
agents reported to raise cyclic AMP levels in rat 
small intestine, to elevate cyclic GMP in other tissues 
or to affect intestinal transport functions, were also 
tested for their ability to alter the intestinal guanylate 
cyclase activity in vitro or to regulate cyclic GMP 
levels in isolated villous and crypt cells and mucosal 
scrapings. The apparent insensitivity of the particulate 
enzyme to hormones and the possible function of 
cyclic GMP in the intestinal mucosa are discussed. 
2. Materials and methods 
Upper villous and crypt cells from the whole 
length of rat small intestine were harvested separately 
as described earlier [9,1 Oj. Brushborders were 
isolated and purified in principle according to Harrison 
and Webster [ 11] as described before [ 12] . Micro-
somal preparations from villous and crypt cells were 
obtained by homogenizing the cells in 0.25 M 
sucrose- I mM EDTA-1 mM Tris-HCI (pH=7 ,6) 
in a tightly fitting Potter-Elvehjem homogenizer, 
followed by differential centrifugation [10]. Mucosal 
scrapings were isolated by rinsing the intestinal 
lumen with icecold saline followed by gently scraping 
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the superflcial mucosal layer with a microscope slide. 
The cell sheets were taken up in saline and centrifuged 
for 2 min at 850g. This procedure was repeated twice. 
Brush borders, cell preparations and microsomes were 
taken up in 0.10 M Tris-HCI {pH=7 .6; final protein 
concentration: about 1 mg/ml) and homogenized in 
a Potter-E!vehjem homogenizer prior to enzyme assay. 
Assay of guanylate cyclase activity and purification 
of the labeled product were done essentially as before 
[7]. The concentration of free Mn2 + was calculated 
from [Mn~~tal] = [Mn}:eeJ + [MnCP1 + [MnGTP2 1. 
The stability constant of MnCP- used for calculating 
F>ooMnl'"n !oJ .. 
·-· 
O.JO ..• 0.2$ 
so ., o-o •. co 
~~~ 
60 
,, 
'·' LogMnGTP(J.tM} 
. ' 
> 
40 
20 
[MnCP-] was 1 10 M- 1 [13]. Conversion of creatine-
phosphate during the assay was less than IS per cent. 
In view of the high binding constants ofMn 2+-nucleo-
side triphosphates [14] it was assumed that all GTP 
was present as the MnGTP2 - complex. Binding of 
Mn 2+ to cyclic GMP and the possible binding of 
GTP to albumin were neglected. 
Cyclic GMP concentration was measured according 
to Dinnendahl [ 15 J, using a cyclic GMP-binding 
protein from lobster tail muscle {16] . Cyclic AMP 
concentration was measured according to Tovey eta\. 
[17], using a cyclic AMP-binding pro~ein isolated 
·-· 0.30 
ll.·-" Q.$0 
·-· 1.00 
o-o •. on 
• 10 .lfli MnGTP(mM.1) 
20 25 
Fig. I. Double reciprocal plots of cyclic GMP formation as a function of the MnGTP1 -concentration measured with the 
brushborder preparation." is expressed as nmoles cyclic GMP · min-• · mg-• protein. Inset: Hill plots. 
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from bovine skeletal muscle [ 18]. After further 
purification of the cyclic nucleotide samples by 
thinlayer chromatography on silica plates or 
chromatography on Dowex SOH+-columns, essentially 
the same results were obtained. 
Protein was determined according to Lowry eta!. 
[ 19 j, using bovine serum albumin as a standard. 
Biochemicals were usually from Boehringer, 
Mannheim. Radioactive materials were from the 
Radiochemical Centre, Amersham. Arginine-vaso-
pressin (synthetic, grade IV) was from Sigma, PTH 
(TC A-powder) from Inolex Corp. (Chicago), secretin 
from the Boots Company (Nottingham), concana-
valin A (3 times crystallized) from Miles Labs., 
insulin (pure) from Boehringer, pentagastrin (Peptavlon) 
from ICI (Maclesfield), bradykinin (synthetic) from 
Sandoz and glucagon from Lilly (Indianapolis). The 
I' 
• 
ionophore A-23187 was a gift from the Eli Lilly 
Company; it was dissolved in ethanol prior to use. 
Prostaglandins were gifts from the Unilever Research 
Lab. (Vlaardingen). Purified choleratoxin was kindly 
supplied by Dr R. S. Northrup, SEATO Cholera 
Research Program, and was prepared under contract 
for NIAID by R. A. Finkelstein, Ph.D., the University 
of Texas, Southwestern Medical .School, Dallas, Texas. 
3. Results 
Some kinetic properties of the brushborder-
bound guanylate cyclase are shown in fig. I and 2. 
Lineweaver-Burk plots for different concentrations 
of free Mn2+ (fig. I) showed a positive co-operative 
behaviour indicaU!1g multiple binding sites for 
MnGTP 
mM 
·-· 
0.04 
o-o o.o 5 
·-· 
0,1 0 
o-o 0,20 
·-· 
o.so 
' 2 3 4 5 
Free Mn2 +(mM-1'l 
1\g.2. Double reciprocal plots of cyclic GMP formation as a function of excess Mn'+ measured with the brush border 
preparation. vis expressed as nmoles cyclic GMP · min-' · mg·• protein. 
145 
Volume 55, number I FEBS LETTERS July 1975 
•60 
_, 
so 
...... "a." 
.. 
•-• Q.Oo 
'-S ? >.! ' 
Log MnGTP (J.<M) 
·-· ._.Q 
... - ....... 
o-o•-•• 
10 Hi 20 25 
Mn GTP (mM-1) 
Fig.3. Double reciprocal plots of cyclic GMP formation as a function of MnGTPZ·concentrations measured with the microsQmal 
preparation from upper villous cells. vis expressed as nmoles cyclk GMP · min-• . mg·' protein. Inset: Hill plots. 
MnGTP2 -: The Hill plot (fig.l, inset) gave a Hill 
coefficient (n) of 1.6. The S0_5 for MnGTP 2-
decreased from 0.25 to 0.14 mM when Mn~;e was 
changed from 0.3 to 4.0 mM. Double reciprocal 
plots of cyclic GMP formation as a function of 
excess Mn 2+ at flxed levels of MnGTP2 - gave 
straight lines with a common point of intersection 
(fig.2). The dissociation constant for excess Mn2-+, 
calculated from the position of this point, was 
2.5 mM. At [MnGTP21 > 0.5 mM the slopes of the 
plots approached zero, indicating that at saturating 
146 
substrate concentrations the guanylate cyclase no 
longer needs excess Mn2+ for optimum activity. 
The kinetic patterns of particulate guanylate 
cyclase from upper villous cell microsomes, presumably 
only slightly contaminated with brushborder material 
[ lO] , clearly showed different characteristics ( figs.3 
and 4). There was a marked loss of co-operativity 
with respect to MnGTP2 -, especially at low [Mni~el· 
At 0.3 mM Mnf~e the Hill coeffident approached 
1.2 and the value for S0_5was increased (fig.3). Even 
at near saturating concentrations of MnGTP2 - the 
Volume 55, number I FEES LETTERS Julyl975 
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Fig.4. Double reciprocal plots ol cyclic GMP formation as a function of excess MnH measured with the microsomal preparation 
from upper villous cells. vis expressed as nmoles cydic GMP ·min-' · mg·' protein. 
slope of the reciprocal plots of enzyme activity versus 
[Mnfr:CJ did not approach 7ero. At 0.10 mM 
MnGTP2 - the apparent Km for Mn:~ was 2.7 mM 
and decreased to 0.7 mM at 1.0 mM MnGTP2 - (fig.4). 
Guanylate cyclase from crypt microsome, displayed 
an intermediate type of kinetic behaviour showing n-
va!ues for MnGTP2 -between 1.3 and 1.4 (results not 
shown). These preparations. however, are seriously 
coJJtaminated with luminal membranes (compare [ 20]) 
and thus contain a mixture of guanylate cyclase 
activities localized in basal-lateral membranes and 
partially developed microvilli. 
Some regulatory properties of guanylate in vitro 
were tested with homogenates of isolated villous and 
crypt cells, mucosal scrapings, microsomes and brusb-
borders. Activities were measured at 0.1 mM MnGTP2-
and 0.3 or 4.0 mM Mn~;cc· Table 1 summarizes our 
results with the brush border preparation. In agree-
ment with Ishikawa et al. [4] we found that incub-
ation of the enzyme in the presence of 0.1% Triton 
X-100 gave a two-fold rise in activity. 1.4 mM CaC12 
slightly inhibited the enzyme at 0.3 mM Mnt;e but 
stimulated 1.2 fold at 4 mM Mnf;e. Strong inhibitory 
effects were found with PEP, oxaloacetate and ATP 
or ADP. Similar effects of metabolites have been 
reported earlier for the soluble enzyme from rat lung 
[21]. Alloxan, a strong inhibitor of intestinal adenylate 
cyclase (H. R. de Jonge, unpublished results), slightly 
depressed guanylate cyclase activity, possibly due to 
an in vitro oxidation of SH-groups (compare [22 ]). 
Aminoacids in physiological concentrations had a 
small stimulatory effect (table 1). D-isomers were 
ineffective in this respect. No significant differences 
from control values were obtained by addition of 
NaF, glucose, choleragen, prostaglandin E 1 , F 2 o: 
and A 1 , concanavalin A and a number of catechol-
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Table 1 
Guanylate cyclase activity in brush border preparations from 
rat small intestinal epithelium 
Agents Cyclic GMP formation at 0.1 mM GTP 
(%of basal rate) 
0.3 mM Mnf;ee 4.0 mM Mnf;ee 
-------
100 100 
Triton X-100 (0.1%) 190 210 
NaF (10 mM) 100 100 
D (+)glucose (1-50 mM) 100 100 
CaCJ2 (1.4 mM) 71 ll7 
PEP (I mM) 74 82 
PEP {10 mM) 56 62 
Oxaloacetate (0.5 mM) 52 6l 
ATP (1 mM) 26 29 
ADP (I mM) 32 36 
D-alanine (1 mM) 100 99 
L-alanine ( 1 mM) 119 120 
L-aspartate (I mM) 116 ll4 
L-arginine (l mM) 1!8 []5 
Glycine (1 mM) 109 llO 
Alloxan (5 mM) 70 75 
The following agents, tested in the presence of 1.4 mM CaCJ,, ]lad no effect as 
compared to CaCl2 alone: Concanavalin A (0.2-1 pM}, cholera toxin (I 0-100 
J.tg/ml), prostaglandin E,, A, and F,. o: ( 1·-50 ~J-M). the caterholamincs ~drenalin, 
noradrenalin and serotonin-creatinesu!phate ( l 0-100 JJM), the cholinergic agents 
carbamylchuline, acetylcholine and pilocarpine (0.5-50 pM} and the peptide 
hormones insulin (1-l 00 pg/ml), glucagon (1-1 0 J.tM)-! pentagastrin (I 0-50 J.tM), 
VP (4-50 mU/mll, PTH (0.04-2 U/ml) and bradykinin (50 ,_M). 
amines, cholinergic agents and peptide hormones 
specified in the legend of table I. These agents have 
been reported to alter intestinal transport of water 
and electrolytes (Na+, K +and HCOJ or Ca 2+) [2,3], 
to stimulate the soluble form of guanylate cyclase 
in liver in vitro (secretin, [23}) or to raise cyclic 
GMP levels in other tissues (compare [24].). Similu 
negative results were obtained using villous and 
crypt cell homogenates, microsomes or mucosal 
scrapings. Also after addition of Mg2+ (I mM) 
or Ca2+ ( 1 A mM), the insensitivity of the guany-
late cyclase for these agents was maintained. 
Because in other tissues cyclic GMP levels 
may be raised by hormones that are unable to 
stimulate the guanylate cyclase activity in vitro, 
our studies were extended with measurements of 
cyclic nucleotide levels in isolated villous and 
crypt cells during incubation at 37°C. Because 
hormone action may be disturbed by isolation 
148 
of cells in EDT A-cont<lining media, these studies 
were repeated with mucosal scrapings, isolated in 
3a!ine. 
As shown in table 2, the basal levels of cyclic 
GMP, like the ..:yclic AMP levels [25], det:reased from 
crypt to villous cells. In contrast, the guanylate 
cyclase activity of cell homogenates increased about 
three-fold [7]. This apparent discrepancy may indicate 
a concomitantly raised cyclic GMP degradation rate 
in the villous cells.. Moreover the assay conditions 
in vitro (concentrations of substrates <Jnd inhibitors) 
may considerably differ from the enzyme environ-
ment in the intact cells. The cyclic AMP/cyclic GMP 
ratio was relatively low as compared to a number 
of other tissues [4,26]. CaC12 (1.4 mM) alone caused 
a slight but statistically insignitlcant depression of 
basal cyclic GMP levels. Also the ionophore A-23187, 
known to mimic hormone actions in other tissues by 
stimulating C'a2+ transport through the plasma 
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membrane or releasing Ca2+from intracellular store~, 
had no effect of intestinal cyclic GMP concentrations. 
Again, no significant changes of cyclic GMP were 
found in a Ca2 .. -containing medium in the presence 
of choleratoxin, prostaglandins, cholinergic agents, 
conco.navalin A or the hormones mentioned above. 
Unexpectedly, incubation for 6- I 0 min in the 
presenl·e of the phosphodiesterase inhibitor t!Jeopllyl-
line (5 mM) with or without hormones, did not 
raise the cyclic G!v!P content whereas cyclic AMP was 
significantly elevated {table 2, [25]). A possible 
depression of net formation of cyclic GMP by 
cyclic-AMP-elevating agents would not be uniqu~ 
for intestinal epithelium (compare [26] ). It is 
also possible that theophylline induced ::1 selcniv~ 
leakage of cyclic (,MP to the medium where it 
may be rapidi,v· metabolized by the residual activity 
ofphosphodiestc"rases released from damaged cells. 
Alloxan (5 mM) strongly elented cyclic GlvlP 
in the isolated cells but had no int1uence on cyclic 
AMP levels (table 2). Apparently, the interaction of 
alloxan with cyclases in t11e intact cell is opposite to 
its in vitro effecr., or else alloxan possesses an additional 
inhibitory effect on intracellular cyclic nucleotide 
degradation. In either case this compound could be 
a useful tool in future studies of the relationship 
between elevated cyclic GMP levels and intestinal 
functions. 
4. Discussion 
A clear difference was found between the kinetic 
behaviour of guanylate cyclase in brush border and 
microsomal preparations from r::~t small intestinal 
villous cells. Whereas the brush border enzyme had 
many characteristics in common with the particulate 
form of guanylate cyclase from sea urchin sperm 
[27] and rat lung {8] (positive substrate co-opera-
tivity, independency from free Mn2 .. at saturating 
MnGTP2-concentrations), the kinetics of the micro-
somal enzyme, mainly localized in the basal-lateral 
plasma membranes, resembled more the soluble form 
of the enzyme in rat heart [6] and lung {8] (loss of 
co-operativlty, activation by free Mn 2+ at high 
MnGTP2-!evels). Maybe the nearly complete absence 
of a soluble guanylate cyclase in rat small intestine 
is due to a high affinity of this type of enzyme for 
!50 
thi:: basal-l<Jteral plasma membranes. An alternative 
interpretation, assuming a rapid release of guunylate 
cyclase from membranes in other tissues during homo-
genintion, has been suggested previously 126]. Also 
an alteration of kinetic beh<Jviour during prcp<~ration 
of the microsomes cannot be entirely excluded yet. 
The activity of the particulate gu<~nylute cyclase 
in vitro or the levels of cyclic GMP in isolated small 
intestin<.~l epithelial cells appeared insensitive to a 
large number of hormones or hormone-like agenb 
under our experimental conditions. This insensitivdy 
may be interpreted in different w<~ys: 
I) The epithelium l<.~cks receptors for the hormones. 
Consequently the reported hormonal effects on trans-
port rates should be ascribed to effects on in test in<.~ I 
smooth muscle or blood vessels. 
2) Hormone effects arc mediated by f<.~ctors 
JitTerent from cyclic GMP. 
3) Hormone receptors or coupling systems between 
receptors and guanylnte cyclase are d<nnaged during 
cell isolation or homogenization. Moreover_ 'permissive' 
serum factors needed for full expression of homwnc 
action may be lost in the in vitro system. The dcer-
mination of cyclic GMP in samples of intestine, obtained 
by freeze-clamping the tissue in situ, wuuld better 
retlect the physiologicul situation but lacks any tissue 
specificity. 
4) Cyclic GMP levels are indeed altered by some 
hormones but the changes were too small, transient 
or delayed to be measured in our experiments. Small 
effects m<~y be expected particularly if only tile 
guanylute cyclase outside the brushborder region 
responds to hormones. 
5) The reported action of cholinergic agents l24, 
26], insulin [24] and the ionuphore A-23187 (28, 
29] on cyclic GMP levels in other tissues could be 
mediated by the soluble form of guanylate cyclase 
which is almost completely missing from the intestinal 
epithelium, 
To our knowledge, a hormone effect on particulate 
gu<~nylate cyclase is only well-established in fibro-
blasts where cyclic GMP levels may be elevated by 
a speci!1c: growth factor, a peptide hormone secreted 
by the pituit<.~ry gland [JO].lt is not known if a 
simil<lr growth factor for proliferative crypt cells, 
regulating the guanylate cyclase activity in their 
basal-lateral plasma membranes exists. However, in 
mature villous cells, at least 70 per cent of the total 
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guanylate cyclase activity has been found in the micro-
villous srructure of the brush border, m<~king a direct 
coupling to hormone receptors at the anti luminal 
plasma membr:.mes highly unlikely. [7 j. Therefore, 
<1 possible role of cyclic GMP, generated by this 
enzyme, as a seconJ messenger of hormone action 
must be seriously questioned. 
The universal occurrence of specific cyclic GMP-
depcnJent protein kin:.~scs in rat tissues and the high 
levels of these enzymes in arthropod tissues, where 
the partkubte guanyl<~te cylasc is usually very active 
[31 j, strongly suggest that the biological effects of 
cyclic GMP are medi<Jted by this class of proteins. 
ln membranes from intestin<~l smooth muscle, and 
endogenous cyclic GMP-dependent protein kinase 
has been detected in :.~ssociation with two distinct 
submate proteins [3~]. lt would be interesting 
to look for a similar system in the intestinal brusll-
border. Should the ~ndogenous subsuates be trans-
port proteins, the slight stimulation of gunaylale 
cyclase <Jctivity in the brush border by aminmcids 
(table 1) might be of physiological significance. 
The striking resemblance between the tuhubr 
structure of microvilli and f1agellac [JJj. the 
high activity of guanylate cyclase in !lagellar membranes 
from sea urchin sperm [27,34] and in platelets [35], 
and the possibility th;Jt the microfilaments within the 
core of the intestinal micfO':illi are actin-like [33,36], 
lend some support to the idea that cyclic GMP has 
a role in the assembly or regubtion of contractile 
systems. 
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